CELLULASES, THE GENES ENCODING THEM AND USES THEREOF

Abstract: Genes encoding cellulases, and a gene encoding a protein that facilitates the action of such cellulases, the cellulases and a protein that facilitates the action of such cellulases, and enzyme preparations containing such proteins are described. The native hosts and the culture medium of said hosts containing said cellulases are also disclosed. These proteins are especially useful in the textile and detergent industry and in pulp and paper industry.

Description: CELLULASES, THE GENES ENCODING THEM AND USES THEREOF Background of the Invention Field of the Invention The present invention is related to genes encoding novel neutral cellulases and compositions containing the novel neutral cellulases. These compositions are especially useful in the textile, detergent and pulp and paper industries. Related Art Cellulose is a linear polysaccharide of glucose residues connected by β- 1,4 linkages. In nature, cellulose is usually associated with lignin together with hemicelluloses such as xylans and glucomannans. The practical use of cellulases has been hampered by the nature of the known cellulases, which are often mixtures of cellulases having a variety of activities and substrate specificities. For that reason, it is desirable to identify sources from which cellulases having only the desired activities may be obtained. A wide variety of cellulases are known in the art, most of which are acid cellulases. However, some neutral and alkaline cellulases have also been identified. Celluzyme® is a commercially-available cellulase preparation from Humicola insolens (Novo Nordisk, A/S). GB 2,075,028 and EP 406,314 describe the use of a Humicola insolens cellulase as an enzymatic additive in a wash detergent to reduce the harshness (stiffness) of cotton-containing fabrics. The cloning of a cellulase containing endoglucanase activity from Humicola insolens is described in WO 93/11249 and EP 531,372. EP 510,091 describes a cellulase from Bacillus spp. NCIMB 40250 that is useful in detergent compositions. EP 220,016 describes cellulases that are useful as clarification agents for colored fabrics. WO 94/07998 describes modified cellulases that possess an improved alkaline activity. WO 95/02675 describes detergent compositions that contain two different cellulases: a first cellulase that is catalytically amenable to particulate soil removal, and a second cellulase that is catalytically amenable to color clarification. WO 92/18599 describes a detergent preparation that contains both a cellulase and a protease. Cellulases have also been used industrially as an aid for the removal of printing paste thickener and excess dye after textile printing (EP 576,526). EP 383 828 describes granular detergent compositions, which contain surface-active agent, a fabric-softening clay material, and cellulase granulates containing calcium carbonate. US 5,433,750 describes detergent compositions containing a surface active agent, a builder system, a softening clay, a clay flocculating agent and a high activity cellulase, preferably Humicola insolens cellulase. US 5,520,838 describes granular detergent compositions, comprising surface-active agent, a builder and a cellulase, preferably a Humicola insolens cellulase, said compositions being in a compact form, having a relatively high density and containing a low amount of inorganic filler salt. Cellulase enzymes are used in a wide variety of industries in addition to the textile industry. For example, cellulases are used industrially for the deinking of newspapers and magazines (EP 521 ,999), for improving the drainage of pulp (WO 91/14822, WO 91/17243), and as a treatment for animal feed. The unique properties of each cellulase make some more suitable for certain purposes than others. While the enzymes differ in a number of ways, one of the most important difference is pH optimum. Neutral cellulases have useful cellulase activity in the pH range 6-8, alkaline cellulases have useful cellulase activity in the pH range 7.5-10. Acid cellulases are active in the range of pH 4.5- 6, but have little cellulase activity at higher pH values. Neutral and acid cellulases are especially useful in the textile industry Klahorst, S. et al., Textile Chemist and Colorist 26:13-18, 1994; Nilsson, T.E., Aachen Textile Conference, DWI Reports 774:85-88 (1995); Videbaek, T. et al, ITB Dyeing/Printing/Finishing, January 1994, pp. 25-29; Klahorst, S. et al, AATCCInt. Conf. & Exhibit, October 4-7, 1992, p. 243, Atlanta, GA; Kochavi, D. et al, Am. Dyestuff Resporter, September 1990, pp. 26-28; Tyndall, R. Michael, Textile Chemist and Colorist 24:23 (1992); Lange, N.K., in Proc. Second TRICEL Symp. on Trichoderma reesei Cellulases and Other Hydrolases, Espoo, Finland, 1993, ed. P. Suominen et al, Foundation for Biotechnical and Industrial Fermentation Research vol. 8, 1993, pp. 263-272. When used to treat fabric, cellulases attack the chains of cellulose molecules that form the cotton fibers, thereby affecting the characteristics of the fabric. Traditionally, in "stonewashing," pumice stones have been used to change the characteristics of the fabric. Gradually, cellulases are replacing pumice stones, which also give the fabric its desired final look but can cause damage to the machines, garments and sewage processing equipment. US 4,832,864, US 4,912,056, US 5,006,126, US 5,122,159, US 5,213,581 and EP 307,564 disclose the use of cellulases in biostoning. Cellulases are especially useful for stonewashing denim dyed with indigo as the dye mostly stays on the surface of the yarn and does not penetrate the fibers well. When used to treat cotton fabric, neutral cellulases generally require a longer wash time than do the acid cellulases. However, available neutral cellulases are less aggressive (active) against cotton than acid cellulases, and are reported not to compromise the strength of the fabric as readily as acid cellulases. Neutral cellulases have a broader pH profile and thus the pH increase that occurs during biostoning has little effect on the activity of the neutral enzyme. The use of acid cellulases is hampered by their tendency to promote backstaining and a weakening of fabrics. In addition, the pH must be adjusted to to a range suitable for the function of the acid cellulases. Consequently, there is a clear demand for neutral cellulase enzyme preparations that do not cause backstaining or weakening of fabrics. While it has become popular to use cellulases in the textile industry, simply changing the cellulase mixture that is used may produce a different finish. These problems have focused increasing attention on the search for reproducible mixtures of cellulases with desired properties. Thus there is a clear demand especially in the textile and detergent industry for novel cellulases active at neutral and alkaline pH values, not compromising the strength of fabrics, with good cleaning and/or fabric care and harshness reducing properties. Summary of the Invention Recognizing the importance of identifying enzymes useful in textile biofinishing and biostoning and in detergent applications, the inventors have screened fungal species for neutral and alkaline cellulases with enzymatic characteristics that would be useful in such technologies. These studies have resulted in novel cellulases originating from the genera Myceliophthora, Myriococcum, Melanocarpus, Sporotrichum and Chaetomium. The invention is further directed to the spent culture medium or enzyme preparations prepared from the native hosts producing such novel cellulases. The invention is further directed to the use of such culture medium or the use of such enzyme preparations in the textile and detergent industry and in the pulp and paper industries. These studies have further resulted in the identification of three novel cellulases that are especially useful in the textile and detergent industry. Purified preparations from Melanocarpus sp. or Myriococcum sp. have revealed a 20 kDa cellulase with endoglucanase activity (designated herein as "20K-cellulase"), a 50 kDa cellulase (" 50K-cellulase"), and a second 50 kDa cellulase ("50K- cellulase B"). A novel gene product with high homology to the cellulase family, herein called "protein-with-CBD" (where CBD means "cellulose binding domain") was also discovered. It is an object of the invention to provide enzyme preparations that contain one or more of the novel cellulases of the invention, especially the 20K-cellulase, the 50K-cellulase, the 50K-cellulase B and/or the protein-with-CBD. It is a further object of this invention to provide a method for using such preparations for the finishing of textiles, especially the biostoning of denim, for the use said preparations in detergent compositions, and especially methods that use the 20K-cellulase, the 50K-cellulase, the 50K-cellulase B and/or the protein-with-CBD. The invention is also directed to other neutral and/or alkaline cellulases having one or more of the amino acid sequences as described herein. The invention is further directed to the genes encoding the 20K-cellulase, 50K-cellulase, 50K-cellulase B and the protein-with-CBD. The invention is further directed to novel expression vectors comprising such genes and to novel hosts transformed with the vectors, especially hosts that are capable of high levels of expression of the proteins encoded by such genes. The invention is further directed to the spent culture medium of such transformed hosts, the culture medium containing the novel 20K-cellulase, 50K- cellulase, the 50K-cellulase B and or the protein-with-CBD, or enzyme compositions (enzyme preparations) containing one or more of these proteins that have been prepared from such culture media. The invention is further directed to the use of such culture medium or the use of such enzyme preparations in the textile and detergent industry and in the pulp and paper industries. Brief Description of the Figures Figure 1 (A and B) show the pH (Figure 1 A) and temperature (Figure IB) dependencies of the endoglucanase activities of ALKO4179, CBS 689.95 Figure 2 (A and B) show the pH (Figure 2A) and temperature (Figure 2B) dependencies of the endoglucanase activities of ALKO4124, CBS 687.95. Figure 3 (A and B) show the pH (Figure 3 A) and temperature (Figure 3B) dependencies of the endoglucanase activities of ALKO4237, CBS 685.95. Figure 4 (A and B) show the pH (Figure 4A) and temperature (Figure 4B) dependencies of the endoglucanase activities of ALKO4265, CBS 730.95. Figure 5 (A and B) show the pH (Figure 5A) and temperature (Figure 5B) dependencies of the endoglucanase activities of ALKO4125, CBS 688.95. Figure 6 (A and B) show the wash effect and backstaining (Figure 6A) and blueness (Figure 6B) with the neutral cellulases. Figure 7 (A and B) show the wash effect and backstaining (Figure 7A) and blueness (Figure 7B) with Ecostone L with gradually increasing enzyme dosages. IX corresponds the enzyme dosage of the neutral cellulases in Figures 6A and 6B. Figure 8 shows the purification of 20K-cellulase from Peak II by chromatography on SP-Sepharose™. A sample containing 11.7 g of protein and 576,000 ECU was applied to a 4.5 x 31 cm column, which was developed as described in Example 9. Fractions of 15 ml were collected. Endoglucanase activities in the peak at fractions 148 - 161 are underestimated because crystallization occurred before the enzyme could be sufficiently diluted for assay. Crystalline material from these fractions contained 486,000 ECU. Figure 9 (A and B) show SDS-PAGE analysis of the 20K-cellulase. The molecular masses of the standards are shown in kDa. A Partially crystalline material precipitated from the active S-Sepharose™ fractions (lane 1). B Fractions from chromatography of the partially crystalline material on G50 Sephadex. Fractions shown in lanes 19 and 25 contained no endoglucanase activity. For the other fractions, the amounts of activity (in ECU) applied to the gel was as follows: fraction 27, 0.4; 29, 2.4 (as 3.0 μg of protein); 30, 2.1; 31, 1.9; 33, 0.46; and 35, 1.1. Figure 10 shows the separation of 50K-cellulase and 50K-cellulase B from Peak III/IV by chromatography on SP-Sepharose™. A sample containing 200 mg of protein and 14,800 ECU was applied to the 2.5 x 11 cm column, which was developed as described in Example 9. Fractions of 6.8 ml were collected. A minor amount of 50K-cellulase eluted before the NaCl gradient, whereas most of the 50K-cellulase eluted at about 50 mM NaCl. 50K-cellulase B was found in the major protein peak at about 80 mM NaCl. Figure 11 shows an SDS-PAGE analysis of purified 50K-cellulase (1 1A) and 50K-cellulase B (1 IB). Lane numbers indicate the fractions (3.3 ml) eluted from Phenyl-Sepharose. For fractions 36-41, 2.5μl of each fraction was applied to the gel. For the other fractions, 2 μl was applied. The 50K-cellulase peak was found in fractions 37-38 (11A) (containing 780 and 880 ECU/ml, respectively). The 50K-cellulase B peak was in fractions 30 and 31 (1 IB), which contained negligible activity (less than 4 ECU/ml). Figure 12 shows the temperature dependence of the endoglucanase activity of 50K-cellulase at pH 7.0 and a reaction time of 60 min. Figure 13 shows the pH dependence of the endoglucanase activity of 50K- cellulase at 50°C (♦) and 70°C (D). Figure 14 shows a Western analysis using 20K-cellulase antiserum as a probe. Lanes 1, 2 and 3 contain 25 μg of protein from the DEAE-Sepharose peaks I, III and IV, respectively. Lanes 4 and 5 contain 2.0 and 0.2 μg of pure 50K- cellulase and lane 6 contains 0.6 μg of pure 50K-cellulase B. Lanes 7 and 8 contain about 25 μg protein from the whole growth medium of ALKO4237 and ALKO4124, respectively. Figure 15 shows the temperature dependence of the endoglucanase activity of 20K-cellulase at pH 7 (10 min reaction times). Figures 16 (A and B) show the pH-dependence of the endoglucanase activity of the 20K-cellulase for the reaction time of (a) 10 minutes or (b) 60 minutes. Figure 17 shows amino acid sequence data derived from sequencing the 20K-cellulase described in the exemplary material herein. Sequence 429 is from the N terminus of the protein and the other sequences are from internal tryptic peptides. Figure 18 shows the restriction maps of the Melanocarpus albomyces DNA in plasmids pALK1221, pALK1222 and pALK1223, which carry the 20K- cellulase gene. Figure 19 shows the DNA sequence of the 20K-cellulase gene. The arrow indicates the predicted signal peptidase processing site. Figure 20 shows the restriction maps of the Melanocarpus albomyces DNA in plasmids pALK1233, pALK1234, pALK1226 and pALK.1227, which carry the 50K-cellulase gene. Figure 21 (A and B) show the DNA sequence of the 50K-cellulase gene. The arrow indicates the predicted signal peptidase processing site. Figure 22 shows the restriction maps of the Melanocarpus albomyces DNA in plasmids pALK.1229 and pALK.1236, which carry the 50K-cellulase B gene. Figure 23 (A and B) show the DNA sequence of the 50K-cellulase B gene . The arrow indicates the predicted signal peptidase processing site. Figure 24 shows the plasmid map of pTTcOl . Figure 25 shows the plasmid map of pMS2. Figure 26 shows the restiction map of the Melanocarpus albomyces DNA in plasmid pALK.1230, which carries DNA encoding the protein-with-CBD. The sequence presented in Figure 27 is marked with an arrow in Figure 26. Figure 27 shows the DNA sequence of the the protein-with-CBD cellulase gene in pALK.1230. Figure 28 shows the plasmid map of pALK.1231. Figure 29 shows the plasmid map of pALK1235. Figure 30 shows a Western analysis using 20K-cellulase antiserum as a probe. Lanes 1 and 2 contain about 10 μg protein from the whole growth medium of transformants ALKO3620/pALK1235/49 and ALKO3620/pALK1235/40. Lane 3 contains about 10 μg protein from the whole growth medium of ALKO3620. Lanes 4 and 5 contain about 10 μg protein from the whole growth medium of transformants ALKO3620/pALK1231/16 and ALKO3620/pALK1231/14. Lane 6 contains 100 ng of pure 20K-cellulase. Figure 31 shows the plasmid map of pALK.1238. Figure 32 shows the plasmid map of pALK.1240. Deposits ALKO4179, Myceliophthora thermophila was deposited as CBS 689.95 on October 12, 1995, at the Centraalbureau voor Schimmelcultures, P.O. Box 273, 3740 AG BAARN. ALKO4124, Myriococcum sp. was deposited as CBS 687.95 on October 12, 1995, at the Centraalbureau voor Schimmelcultures, P.O. Box 273, 3740 AG BAARN. ALKO4237, Melanocarpus albomyces (^Myriococcum albomyces = Thielavia albomyces: Guarro et al. , 1996, Mycol Res. 100(1):75.) was deposited as CBS 685.95 on October 11, 1995, at the Centraalbureau voor Schimmelcultures, P.O. Box 273, 3740 AG BAARN. ALKO4125, Sporotrichum thermophile was deposited as CBS 688.95 on October 12, 1995, at the Centraalbureau voor Schimmelcultures, P.O. Box 273, 3740 AG BAARN. ALKO4265, Chaetomium thermophilum La Touche was deposited as CBS 730.95 on November 8, 1995, at the Centraalbureau voor Schimmelcultures, P.O. Box 273, 3740 AG BAARN. Plasmid pALK1221 was deposited as DSM 11024 on June 21, 1996 and λ4237/5.1 was deposited as DSM 11012 on June 21, 1996, at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg IB, D-38124 Braunschweig, Germany. Both contain the 20K-cellulase gene from Melanocarpus albomyces CBS 685.95. Plasmid pALK1227 was deposited as DSM 11025 on June 21, 1996 and 4237/35 was deposited as DSM 11014 on June 21, 1996, at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg IB, D-38124 Braunschweig, Germany. Both contain the 50K-cellulase gene from Melanocarpus albomyces CBS 685.95. Plasmid pALK1229 was deposited as DSM 11026 on June 21, 1996 and 4237/3 was deposited as DSM 11011 on June 21, 1996, and λ4237/18 was deposited as DSM 11013 on June 21 , 1996, at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg IB, D-38124 Braunschweig, Germany. pALK.1229 contains DNA coding for the 50K- cellulase B, Λ4237/3 and X4237/18 contain the 50K-cellulase B gene from Melanocarpus albomyces CBS 685.95. Plasmid pALK 1230 was deposited as DSM 11027 on June 21 , 1996 at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg IB, D-38124 Braunschweig, Germany. pALK1230 contains the protein-with-CBD gene from Melanocarpus albomyces CBS 685.95. Detailed Description of the Preferred Embodiments In the description that follows, a number of terms used in textile industry technology are extensively utilized. In order to provide a clear and consistent understanding of the specification and claims, including the scope to be given such terms, the following definitions are provided. Biostoning. "Biostoning" of fabric or garment means the use of enzymes in place of, or in addition to, the use of pumice stones for the treatment of fabric or garment, especially denim. Bioβnishing. "Biofinishing" refers to the use of enzymes in a controlled hydrolysis of cellulosic fibers in order to modify the fabric or yam surface in a manner that prevents permanently pilling, improves fabric handle like softness and smoothness, clears the surface structure by reducing fuzzing, which results in clarification of colours, improves the drapability of the fabric, improves moisture absorbability and which may improve also the dyeability. Backstaining. Released dye has a tendency to redeposit on the surface of the fabric fibers. This effect is termed "backstaining." Detergent. By "detergent" is meant a cleansing agent that can contain surface active agents (anionic, non-ionic, cationic and ampholytic surfactants), builders and other optional incredients such as antiredeposition and soil suspension agents, optical brighteners, bleaching agents, dyes and pigments and hydrolases. Suitable listing of the contents of detergents is given in U.S. Patent No. 5,433,750, a suitable list of surfactants is given in U.S. Patent No. 3,664,961. Enzyme preparation. By "enzyme preparation" is meant a composition containing enzymes. Preferably, the enzymes have been extracted from (either partially or completely purified from) a microbe or the medium used to grow such microbe. "Extracted front" means that the desired enzymes are separated from the cellular mass. This can be performed by any method that achieves this goal, including breaking cells and also simply removing the culture medium from spent cells. Therefore, the term "enzyme preparation" includes compositions containing medium previously used to culture a desired microbe(s) and any enzymes that have been released from the microbial cells into such medium during the culture or downstream processing steps. By a host that is "substantially incapable" of synthesizing one or more enzymes is meant a host in which the activity of one or more of the listed enzymes is depressed, deficient, or absent when compared to the wild-type. By an amino acid sequence that is an "equivalent" of a specific amino acid sequence is meant an amino acid sequence that is not identical to the specific amino acid sequence, but rather contains at least some amino acid changes (deletions, substitutions, inversions, insertions, etc) that do not essentially affect the biological activity of the protein as compared to a similar activity of the specific amino acid sequence, when used for a desired purpose. The biological activity of a cellulase, is its catalytic activity, and/or its ability to bind to cellulosic material. The biological activity of the 50K-cellulase B further includes its ability to act synergistically with the cellulases. Preferably, an "equivalent" amino acid sequence contains at least 80% -99% identity at the amino acid level to the specific amino acid sequence, most preferably at least 90% and in an especially highly preferable embodiment, at least 95% identify, at the amino acid level. Cloning vehicle. A cloning vehicle is a plasmid or phage DNA or other DNA sequence (such as a linear DNA) that provides an appropriate nucleic acid carrier environment for the transfer of a gene of interest into a host cell. The cloning vehicles of the invention may be designed to replicate autonomously in prokaryotic and eukaryotic hosts. In fungal hosts such as Trichoderma, the cloning vehicles generally do not autonomously replicate and instead, merely provide a vehicle for the transport of the gene of interest into the Trichoderma host for subsequent insertion into the Trichoderma genome. The cloning vehicle may be further characterized by one or a small number of endonuclease recognition sites at which such DNA sequences may be cut in a determinable fashion without loss of an essential biological function of the vehicle, and into which DNA may be spliced in order to bring about replication and cloning of such DNA. The cloning vehicle may further contain a marker suitable for use in the identification of cells transformed with the cloning vehicle. Markers, for example, are antibiotic resistance. Alternatively, such markers may be provided on a cloning vehicle which is separate from that supplying the gene of interest. The word "vector" is sometimes used for "cloning vehicle." Expression vehicle. An expression vehicle is a cloning vehicle or vector similar to a cloning vehicle but which is capable of expressing a gene of interest, after transformation into a desired host. When a fungal host is used, the gene of interest is preferably provided to a fungal host as part of a cloning or expression vehicle that integrates into the fungal chromosome, or allows the gene of interest to integrate into the host chromosome. Sequences that are part of the cloning vehicle or expression vehicle may also be integrated with the gene of interest during the integration process. In T. reesei, sites of integration to which the gene of interest can be directed include the cbh and/or the egl loci. Most preferably, the gene of interest is directed to replace one or more genes encoding undesirable characteristics. The gene of interest is also preferably placed under the control of (i.e., operably linked to) certain control sequences such as promoter sequences provided by the vector (which integrate with the gene of interest). Alternatively, the control sequences can be those at the insertion site. The expression control sequences of an expression vector will vary depending on whether the vector is designed to express a certain gene in a prokaryotic or in a eukaryotic host (for example, a shuttle vector may provide a gene for selection in bacterial hosts). Expression control sequences can contain transcriptional regulatory elements such as, promoters, enhancer elements, and transcriptional termination sequences, and/or translational regulatory elements, such as, for example, translational initiation and termination sites. According to the invention, there are provided neutral and alkaline cellulases, and methods for producing such useful neutral and alkaline cellulases, that are desirable for the treatment of textile materials. The native hosts that produce the proteins of the invention are: 1 ) ALKO4179, Myceliophthora thermophila; deposited as CBS 689.95 at the Centraalbureau voor Schimmelcultures, P.O. Box 273, 3740 AG BAARN. 2) ALKO4124, Myriococcum sp.; deposited as CBS 687.95; 3) ALKO4237, Melanocarpus albomyces, deposited as CBS 685.95; 4) ALKO4125, Sporotrichum thermophila, deposited as CBS 688.95; and 5) ALKO4265, Chaetomium thermophilum La Touche, deposited as CBS 730.95 One specific preferred embodiment of the invention is the spent culture medium of the native hosts or enzyme preparations prepared from the culture medium. In specific preferred embodiments of the invention, the purified 20K- cellulase, 50K-cellulase, 50K-cellulase B and or protein-with-CBD is provided. These proteins can be obtained for example from Melanocarpus sp. or Myriococcum sp. as described herein, and especially in Example 9. Amino acid sequence data have been generated from the cellulases described herein. Accordingly, the invention is also directed to neutral or alkaline cellulases containing one or more of the amino acid sequences shown herein. Thus, the invention is intended to be directed to any neutral or alkaline cellulase that is a functional equivalent of the 20K-cellulase, the 50K-cellulase, the 50K- cellulase B and/or protein-with-CBD and having one or more of the amino acid sequences described herein, or substantially the same sequence. Such neutral or alkaline cellulases can be derived from other strains of the same species or from divergent organisms. In further preferred embodiments, the 20K-cellulase is provided with the material from separate peaks formed during the exemplified purification procedures (e.g., DEAE-Sepharose Pools I, III, or IV in Table VIII herein). In still further embodiments, other proteins in the Melanocarpus albomyces ALKO 4237 medium may be used, either alone or in combination with other such proteins. In further preferred embodiments, the 50K-cellulase is provided with the material from separate peaks formed during the exemplified purification procedures. In still further embodiments, other proteins in the ALKO 4237 medium may be used, either alone or in combination with other such proteins. In further preferred embodiments, the 50K-cellulase B is provided with the material from separate peaks formed during the exemplified purification procedures. In still further embodiments, other proteins in the ALKO 4237 medium may be used, either alone or in combination with other such proteins. As described herein, ALKO 4265, Chaetomium thermophilum La Touche, deposited as CBS 730.95, is used herein as an example of a neutral cellulase that is not preferred in biostoning method of the invention because it causes backstaining. However, there is evidence that it is useful in other applications (e.g. in detergents). The process for genetically engineering the hosts of the invention is facilitated through the cloning of genetic sequences that encode the desired protein and through the expression of such genetic sequences. As used herein the term "genetic sequences" is intended to refer to a nucleic acid molecule (preferably DNA). Genetic sequences that encode the desired protein are derived from a variety of sources. These sources include genomic DNA, cDNA, synthetic DNA and combinations thereof. Vector systems may be used to produce hosts for the production of the enzyme preparations of the invention. Such vector construction (a) may further provide a separate vector construction (b) which encodes at least one desired gene to be integrated to the genome of the host and (c) a selectable marker coupled to (a) or (b). Alternatively, a separate vector may be used for the marker. A nucleic acid molecule, such as DNA, is said to be "capable of expressing" a polypeptide if it contains expression control sequences which contain transcriptional regulatory information and such sequences are "operably linked" to the nucleotide sequence which encodes the polypeptide. An operable linkage is a linkage in which a sequence is connected to a regulatory sequence (or sequences) in such a way as to place expression of the sequence under the influence or control of the regulatory sequence. Two DNA sequences (such as a protein encoding sequence and a promoter region sequence linked to the 5' end of the encoding sequence) are said to be operably linked if induction of promoter function results in the transcription of the protein encoding sequence mRNA and if the nature of the linkage between the two DNA sequences does not (1) result in the introduction of a frame-shift mutation, (2) interfere with the ability of the expression regulatory sequences to direct the expression of the mRNA, antisense RNA, or protein, or (3) in¬ terfere with the ability of the template to be transcribed by the promoter region sequence. Thus, a promoter region would be operably linked to a DNA sequence if the promoter were capable of effecting transcription of that DNA sequence. The precise nature of the regulatory regions needed for gene expression may vary between species or cell types, but shall in general include, as necessary, 5' non-transcribing and 5' non-translating (non-coding) sequences involved with initiation of transcription and translation respectively. Expression of the protein in the transformed hosts requires the use of regulatory regions functional in such hosts. A wide variety of transcriptional and translational regulatory sequences can be employed. In eukaryotes, where transcription is not linked to translation, such control regions may or may not provide an initiator methionine (AUG) codon, depending on whether the cloned sequence contains such a methionine. Such regions will, in general, include a promoter region sufficient to direct the initiation of RNA synthesis in the host cell. As is widely known, translation of eukaryotic mRNA is initiated at the codon which encodes the first methionine. For this reason, it is preferable to ensure that the linkage between a eukaryotic promoter and a DNA sequence which encodes the protein, or a functional derivative thereof, does not contain any intervening codons which are capable of encoding a methionine. The presence of such codons results either in a formation of a fusion protein (if the AUG codon is in the same reading frame as the protein encoding DNA sequence) or a frame-shift mutation (if the AUG codon is not in the same reading frame as the protein encoding sequence). In a preferred embodiment, a desired protein is secreted into the surrounding medium due to the presence of a secretion signal sequence. If a desired protein does not possess its own signal sequence, or if such signal sequence does not function well in the host, then the protein's coding sequence may be operably linked to a signal sequence homologous or heterologous to the host. The desired coding sequence may be linked to any signal sequence which will allow secretion of the protein from the host. Such signal sequences may be designed with or without specific protease sites such that the signal peptide sequence is amenable to subsequent removal. Alternatively, a host that leaks the protein into the medium may be used, for example a host with a mutation in its membrane. If desired, the non-transcribed and/or non-translated regions 3' to the sequence coding for a protein can be obtained by the above-described cloning methods. The 3 '-non-transcribed region may be retained for its transcriptional termination regulatory sequence elements; the 3-non-translated region may be retained for its translational termination regulatory sequence elements, or for those elements which direct polyadenylation in eukaryotic cells. The vectors of the invention may further comprise other operably linked regulatory elements such as enhancer sequences. In a preferred embodiment, genetically stable transformants are constructed whereby a desired protein's DNA is integrated into the host chromosome. The coding sequence for the desired protein may be from any source. Such integration may occur de novo within the cell or, in a most preferred embodiment, be assisted by transformation with a vector which functionally inserts itself into the host chromosome, for example, DNA elements which promote integration of DNA sequences in chromosomes. Cells that have stably integrated the introduced DNA into their chromosomes are selected by also introducing one or more markers which allow for selection of host cells which contain the expression vector in the chromosome, for example the marker may provide biocide resistance, e.g., resistance to antibiotics, or heavy metals, such as copper, or the like. The selectable marker gene can either be directly linked to the DNA gene sequences to be expressed, or introduced into the same cell by co-transformation. Factors of importance in selecting a particular plasmid or viral vector include: the ease with which recipient cells that contain the vector may be recognized and selected from those recipient cells which do not contain the vector; the number of copies of the vector which are desired in a particular host; and whether it is desirable to be able to "shuttle" the vector between host cells of different species. Once the vector or DNA sequence containing the construct(s) is prepared for expression, the DNA construct(s) is introduced into an appropriate host cell by any of a variety of suitable means, including transformation as described above. After the introduction of the vector, recipient cells are grown in a selective medium, which selects for the growth of transformed cells. Expression of the cloned gene sequence(s) results in the production of the desired protein, or in the production of a fragment of this protein. This expression can take place in a continuous manner in the transformed cells, or in a controlled manner. Accordingly, the protein encoding sequences described herein may be operably linked to any desired vector and transformed into a selected host, so as to provide for expression of such proteins in that host. The subject matter of the invention are also nucleic acid molecules coding for proteins having the biological activity of a cellulase and that hybridize to any of the nucleic acid molecules described above or which are defined in the following: A nucleic acid molecule encoding a polypeptide having the enzymatic activity of a cellulase, selected from the group consisting of: (a) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence as depicted in Figure 19 or 21; (b) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence as depicted in Figure 23 or 27; (c) nucleic acid molecules comprising the coding sequence of the nucleotide sequence as depicted in Figure 19 or 21 ; (d) nucleic acid molecules comprising the coding sequence of the nucleotide sequence as depicted in Figure 23 or 27; ( e) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence encoded by the DNA insert contained in DSM 11024, DSM 11012, DSM 11025 or DSM 11014; (f) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence encoded by the DNA insert contained in DSM 11026, DSM 11011, DSM 11013 or DSM 11027; ( g) nucleic acid molecules comprising the coding sequence of the DNA insert contained in DSM 11024, DSM 11012, DSM 11025 or DSM 11014; (h) nucleic acid molecules comprising the coding sequence of the DNA insert contained in DSM 11026, DSM 11011, DSM 11013 or DSM 11027; ( i) nucleic acid molecules hybridizing to a molecule of any one of (a), (c), (e) or (g); and (j) nucleic acid molecules the coding sequence of which differs from the coding sequence of a nucleic acid molecule of any one of (a) to (i) due to the degeneracy of the genetic code. (k) nucleic acid molecules encoding a polypeptide having cellulase activity and having an amino acid sequence which shows at least 80 % identity to a sequence as depicted in Figure 19, 21, 23 or 27. The term "hybridization" in this context means hybridization under conventional hybridization conditions, preferably under stringent conditions such as described by, e.g. Sambrook et al. (1989, Molecular Cloning, A Laboratory Manual 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY). These nucleic acid molecules that hybridize to the nucleic acid molecules according to the present invention in principle can be derived from any organism possessing such nucleic acid molecules. Preferably, they are derived from fungi, namely from those of the genera Melanocarpus, Myriococcum, Sporotrichum, Myceliophthora and Chaetomium. Nucleic acid molecules hybridizing to the nucleic acid molecules of the present invention can be isolated, e.g., from genomic libraries or cDNA libraries of various organisms, namely fungi. Such nucleic acid molecules can be identified and isolated by using the nucleic acid molecules of the present invention or fragments of these molecules or the reverse complements of these molecules, e.g. by hybridization according to standard techniques (see Sambrook et α/.(1989)). As hybridization probe, e.g. nucleic acid molecules can be used that have exactly or substantially the same nucleotide sequence indicated in the Figures or fragments of said sequence. The fragments used as hybridization probes can also be synthetic fragments obtained by conventional synthesis techniques and the sequence of which is substantially identical to that of the nucleic acid molecules according to the invention. Once genes hybridizing to the nucleic acid molecules of the invention have been identified and isolated it is necessary to determine the sequence and to analyze the properties of the proteins coded for by said sequence. The term "hybridizing DNA molecule" includes fragments, derivatives and allelic variants of the above-described nucleic acid molecules that code for the above-described protein or a biologically active fragment thereof. Fragments are understood to be parts of nucleic acid molecules long enough to code for the described protein or a biologically active fragment thereof. The term "derivative" means in this context that the nucleotide sequences of these molecules differ from the sequences of the above-described nucleic acid molecules in one or more positions and are highly homologous to said sequence. Homology is understood to refer to a sequence identity of at least 40%, particularly an identity of at least 60%, preferably more than 80% and still more preferably more than 90% . The deviations from the nucleic acid molecules described above can be the result of deletion, substitution, insertion, addition or combination. Homology furthermore means that the respective nucleotide sequences or encoded proteins are functionally and/or structurally equivalent. The nucleic acid molecules that are homologous to the nucleic acid molecules described above and that are derivatives of said nucleic acid molecules are regularly variations of said molecules which represent modifications having the same biological function. They may be naturally occurring variations, such as sequences of other organisms or mutations. These mutations may occur naturally or may be achieved by specific mutagenesis. Furthermore, these variations may be synthetically produced sequences. The allelic variants may be naturally occurring variants as well as synthetically produced or genetically engineered variants. The proteins encoded by the various variants of the nucleic acid molecules of the invention share specific common characteristics, such as enzymatic activity, molecular weight, immunological reactivity, conformation, etc., as well as physical properties, such as electrophoretic mobility, chromatographic behaviour, sedimentation coefficients, solubility, spectroscopic properties, stability, pH optimum, temperature optimum, etc. Enzymatic activity of the cellulase can be detected e.g. as described on page 11 and in Examples 1 and 25. The present invention furthermore relates to nucleic acid molecules the sequences of which differ from the sequences of the above-identified molecules due to degeneracy of the genetic code, and which code for a protein having the biological activity of a cellulase. The nucleic acid molecules of the invention are preferably RNA or DNA molecules, most preferably genomic DNA or cDNA. The present invention also relates to antibodies which specifically recognize one of the above-described proteins according to the invention as well as to antibody fragments which have this property. These antibodies may be monoclonal or polyclonal. Methods for their production are well known in the art and are described in detail, for example, in Harlow and Lane " Antibodies, A Laboratory Manual", CSH Press, Cold Spring Harbor Laboratory (1988). Furthermore, the present invention relates to oligonucleotides which specifically hybridize with a nucleic acid molecule according to the invention or with the complementary strand of such a nucleic acid molecule. In this respect the term "specifically hybridize" means that such an oligonucleotide hybridizes under stringent hybridization conditions specifically to a nucleic acid molecule of the invention and does not show under such conditions cross- hybridization with sequences coding for other polypeptides. Preferably such oligonucleotides have a length of at least 10 nucleotides, more preferably of at least 15 nucleotides and most preferably of at least 30 nucleotides. They are preferably no longer than 100 nucleotides, more preferably no longer than 80 nucleotides and most preferably no longer than 60 nucleotides. In order to ensure that they specifically hybridize to a nucleic acid molecule of the present invention such oligonucleotides show over their total length an identity of at least 80%, preferably of at least 95% and most preferably of at least 99% with a corresponding nucleotide sequence of a nucleic acid molecule of the present invention. These oligonucleotides may be used, e.g., as probes for screening for sequences encoding cellulases in genomic or cDNA libraries or as PCR primers. The protein encoding sequences described herein may be fused in frame to other sequences so as to construct DNA encoding a fusion protein. For example, a recombinant vector encoding a 50K-cellulase, a 20K-cellulase, a 50K-cellulase B or the protein-with-CBD gene can be prepared as above, except that the protein encoding sequence is fused with the sequence of a T. reesei cellulase, hemicellulase or mannanase, or at least one functional domain of such cellulase, hemicellulase, or mannanase as described in US 5,298,405, WO 93/24622 and in GenBank submission L25310, each incorporated herein by reference. Especially, the cellulase, hemicellulase, or mannanase is selected from the group consisting of CBHI, CBHII, EGI, EGII, XYLI, XYLII and MANI, or a domain thereof, such as the secretion signal or the core sequence. Mannanase has the same domain structure as that of the cellulases: a core domain, containing the active site, a hinge domain containing a serine-threonine rich region, and a tail, containing the binding domain. Fusion peptides can be constructed that contain a mannanase or cellobiohydrolase or endoglucanase or xylanase core domain or the core and the hinge domains from the same, fused to the desired protein encoding sequence of the invention. The result is a protein that contains mannanase or cellobiohydrolase or endoglucanase or xylanase core or core and hinge regions, and a 50K-cellulase, 20K-cellulase, 50K-cellulase B or the protein-with-CBD sequence. The fusion protein contains both the mannanase or cellobiohydrolase or endoglucanase or xylanase, and the 50K-cellulase, 20K-cellulase, 50K- cellulase B or the protein-with-CBD activities of the various domains as provided in the fusion construct. Fusion proteins can also be constructed such that the mannanase or cellobiohydrolase or endoglucanase or xylanase tail or a desired fragment thereof, is included, placed before the 50K-cellulase, 20K-cellulase, 50K- cellulase B or the protein-with-CBD sequence, especially so as to allow use of a nonspecific protease site in the tail as a protease site for the recovery of the 50K-cellulase, 20K-cellulase, 50K-cellulase B or the protein-with-CBD sequence from the expressed fusion protein. Alternatively, fusion proteins can be constructed that provide for a protease site in a linker that is placed before the 50K-cellulase, 20K-cellulase, 50K-cellulase B or the protein-with-CBD sequence, with or without tail sequences. New properties for the 20K- and 50K-cellulases and for the 50K-cellulase B can be created by fusing domains, such as a cellulose binding domain (CBD), preferably with its linker, to the proteins of the invention. Preferably, such CBD's and linkers are the corresponding CBD and linker domains of a Trichoderma cellulase, mannanase or of the Melanocarpus albomyces protein- with-CBD. The invention provides methods for producing enzyme preparations that are partially or completely deficient in an undesirable cellulolytic activity (that is, in the ability to degrade cellulose) and enriched in the 50K-cellulase, 20K- cellulase, 50K-cellulase B or the protein-with-CBD protein, as desired for the textile or detergent industry or for pulp and paper processing. By "deficient in cellulolytic activity" is meant a reduced, lowered, or repressed capacity to degrade cellulose to smaller oligosaccharides. Such cellulolytic activity deficient preparations, and the making of same by recombinant DNA methods, are described in US 5,298,405, incorporated herein by reference. Preferably, the preparation is deficient in EG activities, and/or CBHI activity. As described herein, the 50K-cellulase, 20K-cellulase, 50K-cellulase B or the protein-with-CBD may be provided directly by the hosts of the invention. Alternatively, spent medium from the growth of the hosts, or purified 50K-cellulase, 20K-cellulase, 50K-cellulase B or the protein-with-CBD therefrom, can be used. Further, if desired activities are present in more than one recombinant host, such preparations may be isolated from the appropriate hosts and combined prior to use in the method of the invention. To obtain the enzyme preparations of the invention, the native or recombinant hosts described above having the desired properties (that is, hosts capable of expressing economically feasible quantities of the desired 50K- cellulase, 20K-cellulase, 50K-cellulase B or protein-with-CBD, and optionally, those that are substantially incapable of expressing one or more other, undesired cellulase enzymes) are cultivated under suitable conditions, the desired enzymes are secreted from the hosts into the culture medium, and the enzyme preparation is recovered from said culture medium by methods known in the art. The enzyme preparations of the invention can be produced by cultivating the recombinant hosts or native strains in a fermentor on a suitable growth medium (such as, for example, shown in Example 1 or in Example 30). The enzyme preparation can be the culture medium with or without the native or transformed host cells, or is recovered from the same by the application of methods well known in the art. However, because the 50K-cellulase, 20K- cellulase or 50K-cellulase B are secreted into the culture media and display activity in the ambient conditions of the cellulolytic liquor, it is an advantage of the invention that the enzyme preparations of the invention may be utilized directly from the culture medium with no further purification. If desired, such preparations may be lyophilized or the enzymatic activity otherwise concentrated and/or stabilized for storage. The enzyme preparations of the invention are very economical to provide and use because (1) the enzymes may be used in a crude form; isolation of a specific enzyme from the culture medium is unnecessary and (2) because the enzymes are secreted into the culture medium, only the culture medium need be recovered to obtain the desired enzyme preparation; there is no need to extract an enzyme from the hosts. Preferably the host for such production is Trichoderma, and especially T. reesei. The enzyme preparations of the invention may be provided as a liquid or as a solid, for example, in a dried powder or granular or liquid form, especially nondusting granules, or a stabilized liquid, or the enzyme preparation may be otherwise concentrated or stabilized for storage or use. It is envisioned that enzyme preparations containing one or more of the neutral cellulases of the invention can be further enriched or made partially or completely deficient in specific enzymatic activities, so as to satisfy the requirements of a specific utility in various applications e.g. in the textile industry. A mixture of enzyme activities secreted by a host and especially a fungus, can be chosen to be advantageous in a particular industrial application, for example biostoning. The enzyme preparations of the invention can be adjusted to satisfy the requirements of specific needs in various applications in the textile, detergent or the pulp and paper industry. Blends may be prepared with other macromolecules that are not all secreted from the same host (for example, other enzymes such as endoglucanases, proteases, lipases, peroxidases, oxidases or amylases) or chemicals that may enhance the performance, stability, or buffering of the desired enzyme preparation. Non-dusting granules may be coated. Liquid enzyme preparations can be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid, according to established methods. Liquid detergents generally contain up to 90% water and 0-20% organic solvent. Protected forms of the enzymes of the invention may be prepared as described in EP 238,216. The enzyme preparations of the invention can contain a surfactant which can be anionic, non-ionic, cationic, amphoteric or a mixture of these types, especially when used as a detergent composition,. Useful detergent compositions are described e.g. in WO 94/07998, U.S. Patent No. 5,443,750 and U.S. Patent No. 3,664,961. If required, a desired enzyme may be further purified in accordance with conventional conditions, such as extraction, precipitation, chromatography, affinity chromatography, electrophoresis, or the like. The enzyme preparations of this invention are especially useful in textile industry preferably in biostoning and in biofinishing or in detergent industry. Other useful areas are in pulp and paper industry . Non-enzymatic stonewashing has three steps: desizing, abrasion and aftertreatment. The first step, desizing, involves the removal of the starch coating, or that of its derivatives, by amylase. The second step, abrasion, when performed without cellulase, is generally performed by washing the denim with pumice stones, and, when lightening is desired, bleach. The abrasive effect is the result not only of the effect of the stones but also the rubbing together of the denim fabric. Abrasion is generally followed by the third step, a washing step to remove excess dye, during which softeners or optical brighteners can be added. In enzymatic stonewashing, or biostoning, abrasion with pumice stones is completely or partially eliminated and cellulase is added to facilitate the abrasion of indigo dye from the fiber surface. After this treatment, the cellulase is removed with a detergent wash to ensure that the mechanical strength of the fiber is not further compromised by the continued presence of the enzyme. Treatment with a cellulase(s) can completely replace treatment with pumice stones (for example, 1 kg commercial enzyme per 100 kg stones). However, cellulase treatment can be combined with pumice stone treatment when it is desired to produce a heavily abraded finish. A peach skin effect in which a fine protruding hair-like covering is created is also achieved by a wash combining a neutral cellulase with pumice stones. The cellulases of this invention are useful especially to minimize backstaining and enhance lightening (abrasion) in biostoning. Biostoning is preferably performed from about pH 4.5-9.5, and most preferably between pH 6.0-8.5. The temperature of the reaction can range from about 40-80°C, preferably between 50-70°C, and most preferably between 50- 60 °C. The liquid ratio (the ratio of the volume of liquid per weight of fabric) may range from about 2:1 - 20:1, preferably 4:1- 10:1, and most preferably 4:1 - 7:1. The enzyme dosage can range from about 25- 1500 nkat/g fabric, preferably 50-500 nkat/g fabric and most preferably 75-300 nkat/g fabric. The cellulases of the invention are useful in the textile industry for biofinishing of fabrics or garments e.g. depilling, defuzzing, colour clarification, harshness reduction, the creation of different finishes (for example, a 'peach skin,' 'worn out,' 'sand washed,' or 'antique look' effect) and biofinishing of yarn (for example reduction of hairiness, improvement of smoothness). The cellulases of this invention can be used in biofinishing in acidic and in neutral conditions. The cellulases of this invention are useful in detergent compositions to improve the textile cleaning effect e.g. soil removal, to improve the fabric-care properties by reducing the harshness of the textiles, the cellulases having also defuzzing and colour clarification and restoring effects. The textile material that is treated with the enzyme preparations of the invention may be manufactured of natural cellulose containing fibers or manmade cellulose containing fibers or mixtures thereof. Examples of natural cellulosics are cotton, linen, hemp, jute and ramie. Examples of manmade cellulosics are viscose, cellulose acetate, cellulose triacetate, rayon, cupro and lyocell. The above mentioned cellulosics can also be employed as blends of synthetic fibers such as polyester, polyamide or acrylic fibers. The textile material may be yarn or knitted or woven or formed by any other means. The cellulases of the invention, besides being especially useful for the treatment of fabric, are useful in general in any area requiring cellulase activity. In the pulp and paper industry, neutral cellulases can be used, for example, in deinking of different recycled papers and paperboards having neutral or alkaline pH, in improving the fiber quality, or increasing the drainage in paper manufacture. Other examples include the removal of printing paste thickener and excess dye after textile printing, and as a treatment for animal feed. For example, if the intended application is improvement of the strength of the mechanical pulp, then the 50K-cellulase, 20K-cellulase, 50K-cellulase B or the protein-with-CBD preparations of the invention may provide one or more of these proteins so as to enhance or facilitate the ability of cellulose fibers to bind together. In a similar manner, in the application of pulp refining, the 50K- cellulase, 20K-cellulase, 50K-cellulase B or protein-with-CBD preparations of the invention may provide one or more of these proteins at a level that enhance or facilitate such swelling. The invention is described in more detail in the following examples, These examples show only a few concrete applications of the invention. It is self evident for one skilled in the art to create several similar applications. Hence the examples should not be interpreted to narrow the scope of the invention only to clarify the use of the invention. Examples Example 1 Shake Flask and Fermentor Cultivations For maintenance, the strains ALKO4179, ALKO4124, ALKO4237, ALKO4265 and ALKO4125 were streaked on sporulation agar (ATCC medium 5, American Type Culture Collection, Catalogue of Filamentous Fungi, 18th edition, eds., S.C. Jong and M.J. Edwards, (1991): 1 liter contains 1 g yeast extract, 1 g beef extract, 2 g tryptose, a trace amount of FeSO 4 , 10 g glucose and 15 g agar; the pH was 7.2. Agar slants were incubated at 45° for 3-6 days. For the applications tests of ALKO4237 (Examples 3 and 4), a colony was inoculated in 500 ml of the following mineral medium (Moloney, A.P. et al, Biotechnol Bioeng. 25:1169 (1983)): 1 liter contains 15 g KH 2 PO 4 , 15 g (NH 4 ) 2 SO 4 , 2.4 ml of 1 M MgSO 4 x7H 2 O, 5.4 ml 1 M CaCl 2 , 20 g Solka floe, 15 g corn steep powder, 1 g yeast extract and 10 ml 100 x trace element solution 1, where 1 liter of 100 x trace element solution 1 contains 0.5 g FeSO 4 x7H 2 0, 0.156 g MnSO 4 xH 2 O, 0.14 g ZnSQ x7^ O and 0.49 g Co§O x?H O; the pH was adjusted to pH 6.5. Cultivation was performed at 45°C for 3 days in a rotatory shaker (250 rpm). Endoglucanase activity of about 20-25 nkat/ml was obtained. Cellulase activity was routinely measured as endoglucanase activity according to Bailey, M.J. et al, Enzyme Microb. Techno 5:153 (1981)), using 1% (w/v) hydroxyethylcellulose, HEC (Fluka AG #54290) as a substrate. The assay conditions were, if not otherwise stated, pH 7.0 and 50°C with a 10 minute reaction time. One endoglucanase unit (1 nkat = 1 ECU) is defined as the amount of enzyme that produces reducing carbohydrates having a reducing power corresponding to one nanomole of glucose in one second from HEC under the assay conditions. However, with the purified enzymes described in Examples 9- 12, the assay conditions of Bailey et al, Enzyme Microb. Technol. 3:153 (1981) exceed the linear range, and the assay was therefore modified as described in Example 10. With every strain, the filter paper activity assay (which measures the total hydrolysis of cellulose and indicates the presence of cellobiohydrolase activity) was either under the reliable detection limit or very low. For the determination of pH and temperature dependency (Example 2), as well as for the application tests of the strains ALKO4179, ALKO4124, ALKO4265 and ALKO4125 (Examples 3 and 4), colonies were inoculated in 500 ml of the modified thermomedium B (G. Szakacs, Technical University of Budapest, Hungary): 1 liter contained 6 g Solka floe, 6 g distiller's spent wheat grain, 3 g oat spelt xylan, 2 g CaCO 2 , 1.5 g soybean meal, 1.5 g (NH 4 ) 2 HPO 4 , 1 g barley bran, 0.5 g KH 2 PO 4 , 0.5 g MgSO 4 x7H 2 O, 0.5 g NaCl, 0.5 ml trace element solution 1 (1 liter contains: 1.6 g MnSO 2 , 3.45 g ZnSO 4 x7H 2 O, and 2.0 g CoCl 4 x6H 2 O) and 0.5 ml trace element solution 2 (1 liter contains: 5.0 g FeSO 4 x7H 2 O and two drops of concentrated H 2 SO 4 ); the pH was adjusted to pH 6.5. Cultivations were performed at 45°C for 3 days in a rotatory shaker (250 rpm). Because in thermomedium B the endoglucanase activities of the strains ALKO4179, ALKO4124, and ALKO4237 were about 5 nkat/ml, culture filtrates were concentrated about 10 fold in an Amicon concentrator using a cut-off of 30 kDa. Endoglucanase activity obtained with ALKO 4265 was about 20 nkat/ml and with ALKO 4125 30-40 nkat/ml. The 1 liter fermentor cultivation of ALKO4179 was performed in the following medium: 1 liter contained 10 g Solka floe, 3 g cellobiose, 4 g com steep powder, 1.5 g (NH 4 ) 2 HPO 4 , 0.3 g MgSO 4 x7H 2 , 0.5 g NaCl, 2 g CaCO 3 , 0.5 ml trace element solution 1 and 0.5 ml trace element solution 2, 0.5 g KNO 3 , 0.3 g CaCl 2 , 1 g Tween 80; the pH was adjusted to pH 6.5. The 1 liter fermentor cultivation of ALKO4124 was performed in the modified thermomedium B: 1 liter contained: 10 g Solka floe, 1 g Roth's xylan, 40 g whey, 30 g soybean meal, 2 g CaCO 3 , 5 g (NH 4 ) 2 SO 4 , 0.5 g KH 2 PO 4 , 1.0 g MgSO 4 x7H 2 0, 1.0 g NaCl, 1 g antifoam, 0.5 ml trace element solution 1 and 0.5 ml trace element solution 2. The 1 liter fermentor cultivation of ALKO4237 was performed in the mineral medium mentioned above. 10% (v/v) inoculum was used. pH was maintained at pH 6.5 + 0.4 by the addition of ammonia [12.5% (v/v)] and phosphoric acid [17% (v/v)]. The fermentation temperature was 45°C. The fermentor (Biostat M, B. Braun, Melsungen, Germany) was stirred at 400 rpm and the air flow as 1 wm. The endoglucanase activities obtained were the following: ALKO4179 about 40 nkat/ml, ALKO4124 about 90 nkat/ml and ALKO4237 about 30 nkat/ml. ALKO4265 and ALKO4125 were not cultivated in a fermentor. ALKO4179, ALKO4124, ALKO4237 and ALKO4125 were cultivated in a 100 liter pilot fermentor in media and conditions described above. Endoglucanase activities obtained were about 40 nkat ml with ALKO4179 and ALKO4237, about 90 nkat ml with ALKO4124 and about 100 nkat/ml with ALKO4125. Culture filtrates were concentrated 10-20 fold in a Millipore PUF100 ultra filter and a Pellicon Us cassette concentrator using a cut-off of 10 kDa. Example 2 Determination ofthepH and the temperature dependence of the endoglucanase activities in the culture filtrates For the determination of pH and temperature dependence, the strains ALKO4179, ALKO4124, ALKO4237, ALKO4265 and ALKO4125 were grown in the modified thermomedium B. Samples from the shake flask cultivations (culture filtrates) were diluted in 50 mM Mcllvain's buffers (50 mM citric acid- 100 mM Na 2 HPO 4 ) of pH range 4.5-8.5. The final pH values of the culture filtrate buffer mixtures were 4.3, 5.4, 6.3, 7.3, 8.1 and 8.7 for the strain ALKO4179; 4.3, 5.4, 6.4, 7.3, 8.1 and 8.5 for the strain ALKO4124; 4.4, 5.3, 6.2, 7.1, 8.0 and 8.5 for the strain ALKO4237; 4.3, 5.4, 6.3, 7.2, 8.1 and 8.5 for the strain ALKO4265 and 4.3, 5.4, 6.4, 7.3, 8.1 and 8.5 for the strain ALKO4125. BSA was added as a protein carrier to the concentration of 100 μg/ml. Pepstatin A and phenyl methyl sulphonyl fluoride (PMSF) were added as protease inhibitors at 10 μg/ml and 174 μg/ml, respectively. Endoglucanase activity was measured at each pH at 50 °C with 60 minutes reaction time. The endoglucanase activity of ALKO4179 exhibited more than 90% of its maximum in the pH range of about 4.5-7.5, the maximum activity was detected at about pH 5.4-6.3 (Figure 1A). The endoglucanase activity of ALKO4124 exhibited more than 80% of its maximum activity in the pH range about 5.5-7.5, the maximum activity was detected at about pH 6.4 (Figure 2A). The endoglucanase activity of ALKO4265 exhibited more than 80% of its maximum activity in the pH range about 4.5-7.0, the maximum activity was detected at about pH 5.5-6.5 (Figure 4A). The endoglucanase activity of ALKO4237 exhibited more than 80% of its maximum in the pH range of about 4.5-6.0, the maximum activity was detected at about pH 5.3 (Figure 3A). The endoglucanase activity of ALKO4125 exhibited about 90% of its maximum in the pH range of about 4.5-7.5, the maximum activity was detected at about pH 6.5 (Figure 5A). For the temperature dependency determination of the endoglucanase activity, samples from the culture filtrates were diluted in 50 mM Mcllvain's buffer, pH 7.0. BSA was added as a protein carrier to the concentration of 100 μg/ml. Pepstatin A and phenyl methyl sulphonyl fluoride (PMSF) were added as protease inhibitors to 10 μg/ml and 174 μg/ml, respectively. The final pH values of the culture filtrate buffer mixtures were 7.3 (ALKO4179, ALKO4124 and ALKO4125) and 7.2 (ALKO4237 and ALKO4265). Samples were incubated at 40 °C, 50 °C and 60 °C for 60 minutes. The maximum endoglucanase activity of ALKO4179 was detected at 50°C and 60°C, about 30% of the activity was retained at 40 °C (Figure IB). The maximum endoglucanase activity of ALKO4124 was detected at 60°C, about 70% of the activity was retained at 50°C and 30% at 40 °C (Figure 2B). The maximum endoglucanase activity of ALKO4237 was detected at 60°C, about 60% of the activity was retained at 50°C and 40% at 40°C (Figure 3B). The maximum endoglucanase activity of ALKO4265 was detected at 60°C, about 50% of the activity was retained at 50°C and 30% at 40 °C (Figure 4B). The maximum endoglucanase activity of ALKO4125 was detected at 60°C, about 80% of the activity was retained at 50°C and 70% at 40 °C (Figure 5B). Example 3 Indigo Dye Release in Neutral Conditions Cellulase preparations derived from the strains ALKO4179, ALKO4124, ALKO4237, ALKO4265 and ALKO4125 (Examples 1 and 2) were tested for their ability to release dye in neutral conditions from the indigo dyed cotton- containing denim fabric to give a stone-washed look. Commercial acid cellulase product Ecostone L (Primalco Ltd, Biotec, Finland) was used as a control. Denim fabric was obtained from Lauffenmuehl (Germany). Test fabric was prewashed 10 min at 60 °C with Ecostone A 200 (1 ml/liter, Primalco Ltd, Biotec, Finland). The fabric was then cut into 12 x 12 cm swatches. The colour from both sides of the fabric swatches was measured as reflectance values with the Minolta (Osaka, Japan) Chroma Meter CM 1000R L*a*b* system. Cellulase treatments were performed in LP-2 Launder-Ometer (Atlas, Illinois, USA) as follows. About 7 g of denim swatches were loaded into the 1.2 liter container that contained 200 ml of 0.05 M citrate/phosphate buffer at pH 7, or, 0.05 M citrate buffer at pH 5.2. 0.06 ml of 10% Berol 08 (Berol Nobel AS, Sweden) was added as a surfactant. A quantity of steel balls were added into each container to help the fiber removal. Finally the cellulase solutions were added to the container as endoglucanase activity units (Example 1). The containers were then closed and loaded into a 50 °C Launder-Ometer bath. The Launder-Ometer was run at 42 rpm for 2 hours. After removing swatches from the containers they were soaked for 10 min in 200 ml of 0.01 NaOH and rinsed for 10 min with cold water. Swatches were then dried for 1 hour at 105°C and air dried overnight. The color from both sides of the swatches was measured with the Minolta Chroma Meter. Results from the color measurements of treated denim fabrics are shown in Table I. Table I. Color Measurement of Denim Fabrics Treated with Different Cellulase Preparations. ND = not done. * the ECU activity was measured at pH 7.0. ** the ECU acticity was measured at pH 4.8. To compare the final look of the denim fabrics after washing with different cellulase preparations, the color from both sides (reverse side and right side) of the fabrics was measured. From the results shown in Table I, it can be seen that the lightness and blueness units are clearly increased on the right side of the garments washed with preparations of ALKO4179, ALKO4124, ALKO4237 and ALKO4125 cellulases, showing a good stone-washed effect. The blueness unit was also increased on the right side of the fabric washed with the ALKO4265 preparation but there was no increase in the lightness unit. This is probably because the enzyme does work at this pH but at the same time causes a lot of backstaining. There was no stone washing effect on the fabric with commercial acid product Ecostone L at pH 7 at this ECU activity. In this study, backstaining on the reverse side of the fabric is used as an indication of the degree of backstaining on the right side of the fabric. To quantify the level of backstaining, the color was measured on the reverse side of the fabric before and after the cellulase treatment. As shown in Table I, when the ECU amounts are the same, there was practically no backstaining in the fabrics treated with the ALKO4179, ALKO4124, ALKO4237 and ALKO4125 preparations when compared to the fabrics treated with ALKO4265 or Ecostone L (pH 5.2 and 7) preparations. Example 4 Dye Release in Neutral Conditions, No Berol The experimental set-up was as described in Example 3 except that no Berol was used. Results from the color measurements of treated denim fabrics are shown in Table II. Table II. Color Measurement of Denim Fabrics Treated with Different Cellulase Preparations - no Berol. When compared with results obtained with the inclusion of Berol (Example 3), the data in Table II show that almost the same stone-washing effect can be achieved with the ALKO4179, ALKO4124, ALKO4237 and ALKO4125 cellulase preparations in the absence of the helping agent Berol. Example 5 Backstaining in denim wash with different cellulases In the literature, it is reported that backstaining is dependent on pH and/or the type of enzyme. However, as shown herein, it was found that backstaining depends only indirectly on pH (Figures 6A and 6B and 7A and 7B). Two neutral cellulase preparations from ALKO4237 and from ALKO4265 and acid cellulase product Ecostone L were studied in small scale denim wash with an equal enzyme dosage at pH 5 and pH 7. The stonewash effect was determined by measuring the increase of lightness and blueness as reflectance units on the right side of the fabric and backstaining (redeposition of indigo on the surface of fibers) was determined as blueness increase and lightness decrease on the reverse side. At pH 7, the neutral cellulases from ALKO4237 caused a clear increase in lightness and blueness on the right side and no backstaining was observed (Figure 6A and 6B). A similar stonewash effect was found at pH 5 but with a slight backstaining. At pH 7, the other neutral cellulase, ALKO4265, brightened blueness on the right side but backstained intensively on the reverse side. At pH 5 similar effects were obtained with both ALKO4265 and ALKO4237 preparations. At pH 7, the acid cellulase did not backstain or impart a lightness on the right side (when using similar endoglucanase activity dosages as with ALKO4265 and ALKO4237, Figure 7A and 7B, 1 x dosage), probably because it did not work at this pH. On the other hand, at pH 5, lightness and blueness were increased on the right side and backstaining was clearly perceptible on the reverse side. Based on these results, backstaining can occur at both pH values depending on the cellulase preparation used. Example 6 Use of the Neutral Cellulose-Containing Enzyme Preparations in Biofinishing of Cotton-Containing Woven Fabric 100 % cotton woven fabric was subjected to treatment with ALKO4237 (Example 1) and ALKO4467 cellulases in Launder-Ometer. ALKO4467 is a UV-mutant with higher cellulase activity derived from ALKO4125. 100 % cotton woven fabric (obtained from Pirkanmaan Uusi Varjaamό Ltd) was pretreated as in Example 7. The cellulase treatment conditions were as described in Example 3 except that no Berol was used and the liquid ratio was 1 :15 (volume of liquid per weight of fabric). Cellulases were dosed as ECU activity units (Example 1). The following methods were used for evaluation of the effect of the enzyme preparations in biofinishing of cotton fabric: Weight loss of the treated fabrics was defined as percentage from weight of the fabric before and after the test (before weighing the fabrics were conditioning in a atmosphere of 21+2°C and 50 +5% RH). Evaluation of the surface cleaning effect of the enzyme treated fabrics was performed by a panel consisting of three persons. The fabrics were ranked on a score from 1 to 5, where 5 gave a clean surface. The Martindale Rubbing method (SFS-4328) was used for evaluation of pilling. Pilling was evaluated by a panel after 200 and 2000 cycles of abrasion (1 = many pills, 5 = no pills). In Table III is shown that treatment of the cotton fabric with ALKO4237 and ALKO4467 cellulase preparations results in a good surface cleaning and marked reduction in the pilling tendency at both pH 5 and 7. Table III. Weight loss, surface cleaning effect and pilling tendency of the cotton fabrics treated with neutral cellulases in Launder-Ometer. Example 7 Use of the Neutral Cellulose-Containing Enzyme Preparations of the Invention in Biofinishing 7a. Use of enzyme preparations in the biofinishing of woven fabric and knit. 100% cotton woven fabric or 100% cotton knit are subjected to treatment with the cellulases of the invention (Example 1 ) in a semi-industrial drum washer (Esteri 20 HS-P). The treatment conditions are as follows: A. Pretreatment (only for woven fabrics) 60 °C, 10 minutes, Ecostone A200 (Primalco Ltd, Biotec, Finland) 1 ml/1 water. B. Enzyme treatment temperature 50-60°C, pH 7; liquid ratio 5-20: 1 (volume of liquid per weight of fabric); treatment time 20-90 minutes, preferably 30-60 minutes; and enzyme dosage 50-900 nkat/g fabric or knit, preferably 200-600 nkat/g fabric or knit. C. "After-washing" treatment 40°C, 10 minutes, alkaline detergent D. Drying treatment The following standard methods are used for evaluation of the surface cleaning effect of enzyme preparations: The Martindale Rubbing Method (SFS- 4328) and the Laundering Durability Test (SFS-3378). Treatment with the cellulase preparations of the invention results in a surface cleaning effect, an improvement in the softness and smoothness of the fabric and knit and a reduction in the pilling tendency. 7b. Use of enzyme preparations in the finishing of lyocell fabrics and knits. The cellulase preparations of the invention can be used in fibrillation control and different finishing processes of 100% lyocell fabrics and knits and blends thereof. The following treatment conditions in semi-industrial drum washer (Esteri 20 HS-P) are used in order to create the peach effect on lyocell fabric: A. Sodium carbonate 2.5 g/1; 60°C, treatment time of 60 minutes; B. Rinse; C. Enzyme treatment: temperature of 50-60°C, pH 7, liquid ratio 5-20:1, treatment time 40-120 minutes, preferably 45-90 minutes, and an enzyme dosage of 100-1500 nkat/g fabric, preferably 400-800 nkat/g fabric; D. Aftertreatment: Alkaline detergent wash at 40 °C for 10 minutes; E. Rinse; and F. Dry. The result is a peach skin effect. Example 8 Use of Enzyme Preparations in Biostoning Denim garments were subjected to treatment with the neutral cellulase preparations (Example 1) in a semi-industrial drum washer (Esteri 20 HS-P) to give the garments a stonewashed appearance. About 1.0 kg of denim garments (contained two different kinds of fabric) were used per machine load. The treatment conditions were as follows. A. Desizing. 100 liters water, 60°C, 10 minutes; 100 ml Ecostone A200 (Primalco Ltd, Biotec, Finland). B. Cellulase Treatment 100 liter water, 50°C, 45 minutes; 10 g Berol 08 (Berol Nobel AS, Sweden); 30 g citric acid + 128 g Na 2 HPO 4 x 2 H 2 O to give pH 7. Neutral cellulase preparations were dosed as endoglucanase activity units (ECU, Example 1): 1. ALKO4237, 260 ECU/g of garment 2. ALKO4179, 260 ECU / g of garment 3. ALKO4124, 300 ECU / g of garment 4. ALKO4125, 250 ECU / g of garment C. Afterwashing. Alkaline detergent wash, 40 °C, 10 minutes. D. Drying. The results were evaluated by visual appearance of the garments and by measuring the color as reflectance values with the Minolta Chroma Meter CM 1000R L*a*b system (Table IV). A good stonewashed effect was obtained with all these cellulase-treated garments. No backstaining (examined on the inside of the garment) could be seen visually in any of these cellulase-treated garments. From the results of the color measurements shown in Table IV, it can be seen that the lightness and blueness units are clearly increased on the outside of the garments washed with the neutral cellulase preparations, showing a good stonewashed effect. Table IV. Color Measurement of Denim Garments with Different Cellulase Preparations L = Lightness unit of garment after the treatment (the higher the value, the lighter the garment). b = Blueness unit of garment after the treatment (the more negative value, the more blueing in the garment). Example 9 Purification of Neutral Cellulases Concentrated growth medium from ALKO4237 was fractionated at 7°C on DEAE Sepharose CL6B with a linear gradient from zero to 0.5 M NaCl in 25 mM Tris/HCl pH 7.2. Four peaks of endoglucanase activity at pH 4.8 were found. Peak I, containing about 10 % of the recovered ECU, eluted at about 150mM NaCl, Peak II (about 30 % of ECU) at 230 mM NaCl, Peak III (about 20 % of ECU) at 270 mM NaCl and Peak IV (about 40 % of ECU) at 320 mM NaCl. Table V shows the results when these peaks were tested for their utility in biostoning at neutral pH and 50°C. These results show that on both an ECU basis and a total protein basis, Peak II was more effective than any other peak or than the unfractionated concentrate. A mixture of Peaks I and II containing 70 ECU of each/g denim was also tested. This resulted in an L (right) value of 7.3 and b (reverse) of 2.5. Thus, this mixture was more effective than either peak alone. The purification procedure was scaled up to obtain homogenous samples of some of the desired proteins in these peaks. Concentrated ALKO4237 growth medium (4.5 liters) was fractionated with ammonium sulphate. The proteins that precipitated between 17g and 42g of ammonium sulphate per 100 ml of concentrate were suspended in 0.9 liter of 25 mM Tris/HCl pH 7.2 containing 0.25 mM EDTA and then diluted with water to a conductivity of 4 mS/cm and adjusted with IM NaOH to pH 8.0. The resulting solution (about 45 liters) was pumped at 150 ml/min through a 6.3 liter column of DEAE-Sepharose FF™ at room temperature. Peak I endoglucanase activity did not bind under these conditions. Bound proteins were eluted at 110 ml/min with a linear gradient from 0.0 to 0.5 M NaCl in 20 liters of 25 mM Tris/HCl pH 7.7 containing 0.25 mM EDTA. Peak II endoglucanase eluted at about 14 mS/cm. Instead of the separate Peaks III and IV seen with small scale separations in DEAE in the cold room, a single peak, called Peak III/IV, eluted at about 25 mS/cm. Table V. Indigo Dye Release by DEAE-Sepharose™ Pools in Neutral Conditions (A (0 H m (0 x rn m H m The parameter L (right) indicates the lightening of the right side of the blue denim, and b (reverse) indicates the blueing of the reverse side (i.e., ro backstaining). The fabric was washed in the LP-2 Launder-Ometer and then measured with the Minolta ChromaMeter, as described in Example 3, except that no Berol was used and the buffer that was used was 0.05M Mcllvaine pH 7 (see Data for Biochemical Research, Dawson, R., et al, eds., 1969, Oxford Univ. Press). The dosage is shown as both ECU/g of denim and mg protein/g of denim. Proteins in Peak II (3.5 liters) were precipitated with ammonium sulphate (450 g/liter) and suspended in 170 ml 25 mM PIPES/KOH pH 6.0 containing 1 mM EDTA. Portions of this material were transferred to 25 mM sodium acetate pH 4.0 containing 1 mM EDTA by gel-filtration on a 5 x 29 cm column of G25 Sephadex™ (coarse) and then fractionated on SP-Sepharose™. Figure 8 shows the result that was obtained when 11.7 g of these proteins was applied to a 4.5 x 31 cm column of SP-Sepharose™ in 25 mM sodium acetate pH 4.0 containing 1 mM EDTA at 150 ml/h and the column developed at 75 ml/h with a linear gradient from 0.0 to 0.4 M NaCl in 3.4 liters of the same buffer. Most of the endoglucanase eluted at 0.2 M NaCl. The modified assay described in Example 10 was used. When active fractions were stored at 7°C, a crystalline precipitate appeared in them and contained nearly all the endoglucanase activity. Active fractions (15 ml) in which crystallization was slow, were induced to form crystals by seeding with 30 μl of suspension from fractions already containing crystals. After 2 to 3 days, the crystals were collected by centrifugation, washed with 25 mM PIPES/KOH pH 6.0 containing 1 mM EDTA and disolved in 25 mM Tris/HCl pH 7.2 containing 0.25 mM EDTA. Analysis by SDS-PAGE showed the washed crystals contained a virtually homogenous protein with an apparent molecular mass close to 20 kDa (the error in SDS-PAGE estimations of molecular mass is at least ± 10%, and may be much greater for unusual proteins). This protein is called the 20K-cellulase. Contaminating protein could also be removed by gel-filtration on G50 Sephadex™ in 50 mM PIPES/KOH pH 6.0 containing 1 mM EDTA. An example of this is shown in Figure 9, where unwashed crystals were purified by gel-filtration. The endoglucanase activity co- eluted with the 20 kDa protein well after the cytochrome c (11.2 kDa) volume, showing that this 20 kDa protein is abnormally retarded by interaction with Sephadex™. Proteins in Peak III/IV were precipitated with ammonium sulphate and transferred to 25 mM sodium acetate pH 4.0 containing 1 mM EDTA in the same way as described for the Peak II proteins. Upon transfer to 25 mM sodium acetate pH 4.0, a large precipitate formed and was discarded. The active supematant was fractionated on SP-Sepharose™. At low protein loading (e.g. 200 mg protein to a 2.5 x 11 cm column as shown in Figure 10, most of the endoglucanase activity bound to the column and was eluted with a NaCl gradient at about 50 mM NaCl. This active peak was followed by a second peak of inactive protein. SDS-PAGE analysis showed that the active and inactive peaks both contained several proteins, including proteins with apparent molecular masses close to 50 kDa that could not be distinguished from each other by SDS-PAGE. Both peaks were further purified by chromatography on Phenyl Sepharose™. The active fractions (fractions 15 to 18 in Figure 10) were pooled, adjusted to 50 mM PIPES/KOH pH 6.0 (by addition of 0.25 M PIPES/KOH pH 6.0) and 15 g % ammonium sulphate (by addition of solid ammonium sulphate) and applied to a 1.5 x 8.5 cm column of Phenyl Sepharose™ equilibrated with 25 mM PIPES/KOH pH 6.0 containing 1 mM EDTA and 15 g % of ammonium sulphate. The column was developed with a linear gradient from 15 to 0 g % ammonium sulphate in 104 ml of 25 mM PIPES/KOH pH 6.0. After the end of the gradient, the column was further washed with 25 mM PIPES/KOH pH 6.0. Two protein peaks eluted on the gradient, first a small peak of inactive protein and then a major peak containing most of the endoglucanase activity. SDS-PAGE analysis (Figure 11 A and B) showed that both peaks contained essentially homogenous proteins with apparent molecular masses close to 50 kDa (i.e., they migrate slightly slower than the BioRad prestained ovalbumin standard, which has an apparent molecular mass of 47 kDa). These two proteins could not be distinguished by the inventors' SDS-PAGE analyses, even when they were run together as mixtures. The protein in the active peak was called 50K-cellulase and the protein in the inactive peak was called 50K-protein B. Larger amounts of 50K-cellulase B were obtained by fractionation of the second (and inactive) peak eluted from SP-Sepharose™ (fractions 19 to 23 in Figure 10) on Phenyl Sepharose™ in exactly the same way as described above for the active fractions. Production of still larger amounts of 50K-cellulase and 50K-cellulase B was facilitated by overloading the SP-Sepharose™ column. For example, when 15 g of protein was applied to a 4.5 x 31 cm column of SP-Sepharose™, instead of binding to the column, the 50K-cellulase was apparently displaced by more strongly bound proteins, and eluted before the NaCl gradient. This material was already highly purified, and homogenous 50K-cellulase was isolated from it by chromatography on Phenyl Sepharose™ as described above. In order to speed up the purification of larger amounts of 50K-cellulase the SP-Sepharose and Phenyl Sepharose columns were reversed. After adjusting the ammonium sulphate concentration to about 15 g%, the proteins precipitated in Peak III/IV were applied into Phenyl Sepharose as described before. With high overloading (e.g. 17 g of protein applied to a 3.2 x 25 cm column of Phenyl Sepharose) most of the total protein ran through the column, but 50K-cellulase (containing most of the endoglucanase activity) was bound and eluted at the end of linear gradient from 15 to 0 g% of ammonium sulphate in 25 mM PIPES/KOH pH 6.0. Western analysis with a rabbit antiserum recognizing 50K-cellulase B showed that the 50K-cellulase B eluted just before 50K-cellulase. Further purification was achieved by fractionation on SP-Sepharose as described earlier. In this reversed order of SP-Sepharose and Phenyl Sepharose the proteins in Peak III/IV precipitated with ammonium sulphate could be applied directly to the next purification step without removing salt. The large protein precipitate, which appeared upon transfer of the concentrated proteins in Peak III/IV directly into 25 mM sodium acetate pH 4.0 for SP-Sepharose, could also be avoided this way. As the 50K-cellulase only just binds to SP-Sepharose, the preceeding fractionation on Phenyl Sepharose markedly reduced the apparently interfering total protein load on SP-Sepharose. 50K-cellulase and 50K-cellulase B were each tested in the Launder- Ometer to see if they are responsible for the beneficial effects of Peak IV reported in Example 10. Both proteins were found to have beneficial effects (Table VI). At the low concentrations used in this experiment, they did not themselves increase the release of indigo dye from the outer face of the denim (i.e., L nght did not increase) but they effectively decreased the back-staining of dye onto the inner face of the denim (L^^ became more positive and b πvme became smaller) especially when used together with 20K-cellulase. The 20K-cellulase performed well in Launder-Ometer tests at pH 5 as well as at pH 7. At pH 5, 0.2 mg of 20K-cellulase per g of denim increased L nght from 3.2 to 5.2. Addition of 50K-cellulase at 0.1 mg per gram of denim together with the 20K-cellulase also decreased the backstaining at pH 5 (L reverse and q^^ changed from 0.0 and 2.6 with 20K-cellulase alone to 1.3 and 1.5, respectively, with the mixture of 20K- and 50K-cellulases). Table VI. Indigo Dye Release by 20K-cellulase, 50K-celIuIase and 50K- cellulase B Conditions were the same as in Table V. The dose is shown as mg protein per gram of denim. Example 10 Properties of the 20K-cellulase Although polyclonal antibodies prepared against cellulases purified from Trichoderma reesei (designated anti-EGI, anti-CBHI and anti-CBHII antibodies) recognized proteins in the ALKO4237 growth medium, there was only a very weak cross-reaction with pure 20K-cellulase under the same conditions of Western blot analysis. When growth medium from ALKO4237 was probed on Western analysis with antiserum raised in rabbits against pure 20K cellulase, a strong band at about 35 kDa was observed in addition to the 20 kDa band. No apparent endoglucanase activity could be detected for this 35 kDa protein. Also, a weaker band was seen immediately ahead of the 20 kDa band (Figure 14). ALKO4124 gave an almost identical pattern as ALKO4237, indicating that this and other fungi probably contain cellulases very similar to the 20K-cellulase of the present invention. Amino acid sequences of tryptic peptides derived from 20K-cellulases are shown in Figure 17. Purified 20K-cellulase performed well in biostoning at neutral pH without the addition of other enzyme activities as shown in Table VII. Table VII. Biostoning by Purified 20K-cellulase Conditions were as in the experiment shown in Table V. Dosage is shown as mg protein/g denim fabric. "Whole medium" indicates the unfractionated ALKO4237 concentrated growth medium. Compared to the unfractionated medium, 20K-cellulase resulted in the same degree of lightening (L nght = 6.0-6.1 ) at l/80th the protein dosage. Further, there was less backstaining onto the reverse side face of the fabric (L^,^ = -0.5 compared to -2.9 and b reverse = 3.6 compared to 5.5). Fabric treated with 20K- cellulase had an agreeable soft texture. Although 20K-cellulase performed surprisingly well without other additions, even better fabric appearance and texture resulted when 20K was used together with the DEAE-Sepharose pools I, III or IV (Table VIII). Table VIII. Synergy in Biostoning Between 20K-cellulase and Endoglucanase Pools Eluted from DEAE-Sepharose Conditions were as in Table V. The mixtures of 20K-cellulase with Pools I, III and IV caused more lightening (increased L πghI ) than either component alone. At least for the combination of 20K-cellulase with Pool IV, it is clear that this is because of synergy and not merely an additive effect. Further, the backstaining with all mixtures was actually less (L^^ more positive, b^^. less) than the backstaining observed with 20K-cellulase alone. The combination of 20K with Pool IV was particularly effective. Pool IV contains many proteins, one of which (a 50 kDa polypeptide) copurifies with endoglucanase activity during chromatography of Pool IV on Sephadex G100 and S-Sepharose. While good biostoning is achieved with 20K-cellulase alone, better results are possible with 20K-cellulase plus one or more proteins purified from Pool IV. Biostoning with mixtures of the 20K- cellulase and the 50K-cellulase and the 50K-cellulase B purified from Pool III/IV have already been presented (Table VI in Example 9). Therefore, the present invention is not limited to the use of only the 20K-cellulase. Other proteins in the ALKO4237 medium are useful alone or in suitable combinations. In the standard endoglucanase assay described by Bailey et al. (1981, loc. cit.), the enzyme amount is chosen that produces, in 10 min and pH 4.8 (0.05 M Na-citrate buffer), about 0.6 mM reducing equivalents from 1% hydroxyethylcellulose, resulting in a final absorbance change (ΔA 540 ) of between 0.2 and 0.25. This far exceeds the range in which ΔA 540 is proportional to the amount of 20K-cellulase. Therefore, the procedure was modified as follows. Enough enzyme was used to produce about 0.2 mM reducing equivalents in 10 min in 0.05 M HEPES buffer (pH 7.0). To reach the threshold concentration of reducing equivalents above which color is formed in the DNS system, 0.12 mM glucose was freshly added to the stock DNS reagent. This method (called the "modified" method) was used when characterizing the endoglucanase activity of the 20K-cellulase and also the 50K-cellulase. With 1 % hydroxyethylcellulose as substrate, the range in which ΔA 540 is proportional to the amount of 20- and 50K-cellulase is relatively narrow, and so 2% carboxymethylcellulose was taken as an altenative substrate. With 2% carboxymethylcellulose, the range of linear correlation between ΔA^o and the amount of 20K- and 50K-cellulase was broader than with 1% hydroxyethylcellulose. The endoglucanase activity determined with 2% carboxymethylcellulose was about 8- 10-fold for 20K-cellulase and about 50-fold for 50K-cellulase compared with that determined with 1 % hydroxyethylcellulose. No activity of 20K-cellulase was detectable for 4-methylumbelliferyl-β-D- lactoside, a characteristic substrate of cellobiohydrolases. The activity towards filter paper was also very low, but detectable. The 20K-cellulase was relatively heat stable. It was incubated at 7 μg/ml and 100°C in 25 mM Tris-HCl, 0.2 mM EDTA, for 30 or 60 min. and then assayed at pH 7.0 and 50°C. 52% and 35% respectively, of the endoglucanase activity remained at pH 7.2. 40% and 22%, respectively, remained at pH 8.8. (These pH values were measured at room temperature; the actual pH at 100°C is somewhat lower.) At 80°C, pH 7.2, 70% of the activity remained for 60 min. These results indicate that the enzyme is suitable for applications in which it may be (e.g., accidentally) exposed to elevated temperatures. As well as being resistant to irreversible inactivation at high temperatures, the enzyme exhibited an optimum temperature of 70 °C during 10 min. assays at pH 7.0 (Figure 15). The decreased activity observed above 70 °C was mainly due to a reversible change in enzyme conformation: the enzyme recovered most of its activity when returned to 50 °C. At 50 °C, the 20K-cellulase exhibited 80% or more of its maximum activity throughout the pH range 4 to 9, and nearly 50% at pH 10. This was the case in both 10 min. (Figure 16A) and 60 min. (Figure 16B) assays. These figures also show the pH dependence of the enzyme at 70 °C. With 10 min. assays, the enzyme was more active at 70°C than it was at 50°C over the range pH 4.5 to 8 and about equally active at pH 10 (Figure 16A). With 60 min. assays (i.e., approaching commercial conditions), the enzyme was more active at 70°C than it was at 50°C between pH 5.5 and 7.5. However, it was only slightly less active at 70°C than at 50°C up to pH 10. In practice, this means that the enzyme can be used equally well over a wide range of pH and at temperatures up to at least 70°C. Example 11 Properties of the 50K-cellulase Pure 50K-cellulase had both endoglucanase activity (against hydroxyethylcellulose) and cellobiohydrolase activity (against 4- methylumbelliferyl-β-D-lactoside, assayed essentially as described by van Tilbeurgh et al, in Methods in Enzymology [1988] vol. 160, pp 45-59). A sample of the pure enzyme with an A 2g0 of 1.8 contained 2030 ECU/ml and 300 PCU/ml at pH 7.0 and 50°C (one PCU is the amount of activity that liberates 1 nmol of methylumbelliferone per second). In Western analyses, 50K-cellulase was strongly recognized by antiserum (KH 1057) raised against endoglucanase I of T. reesei, but only weakly by antisera (KH 1050 and KH 1053, respectively) against cellobiohydrolases I and II of T. reesei. It was not recognized by the antiserum raised against 20K- cellulase (Figure 14). When the growth medium of ALKO 4237 was probed in Western analyses with rabbit antiserum raised against 50K-cellulase itself, only one obvious band (which had a molecular mass between 33 and 47 kDa) was seen in addition to the very strong band at about 50 kDa. The apparent molecular mass of 50K-cellulase by SDS-PAGE decreased by about 2 to 5 kDa when the protein was treated with endoglycosidase H f , indicating that the enzyme contains carbohydrate removable by this endoglycosidase. 50K-cellulase was unusually resistant to tryptic digestion, indicating that it has an unusually stable structure. However, it was cleaved by treatment with cyanogenbromide, and the resulting fragments could then be digested with trypsin or with lysylendopeptidase C. Sequences of some of the peptides so obtained are shown in Table IX. Table IX Sequences of peptides isolated from the 50K-cellulase (uncertain residues in lower case) #507 VYLLDETEHR #509 XXLNPGGAYYGT #563 MsEGAECEYDGVCDKDG #565 NPYRVXITDYYGNS #603 DPTGARSELNPGGAYYGTGYXDAQ #605 XXVPDYhQHGVda #610 NEMDIXEANSRA #611 LPXGMNSALYLSEMDPTGARSELNP #612 VEPSPEVTYSNLRXGEIXgXF #619 DGCGWNPYRVvITtDYYnN #620 LPCGMXSALY #621 ADGCQPRTNYIVLDdLlHPXXQ The 50K-cellulase is a stable enzyme that exhibits endoglucanase activity over a wide range of pH values and at high temperatures, so it is suitable for use in many industrial conditions. At pH 7.0 and with 60 min reaction times, it has an optimum temperature between 65 and 70°C, and even with this long reaction time still exhibits, at 75°C, 50% of the activity observed at 50°C (Figure 12). With 60 min reaction times, the pH optimum was very broad at 50°C, with essentially constant activity between pH 4.4 and 7.0, and activities at pH 9 and 10 equal to 50% and 30%, respectively, of that at pH 7.0. At 70°C, there was a clear optimum at pH 6, and, between pH 5 and 7, the activity (with 60 min reaction times) was 3-fold or more greater than that at 50°C. However, at pH 4.4 and pH values above 8, the activity was greater at 50°C than at 70°C (in 60 min assays), suggesting that the stability of the enzyme decreases at 70°C right side the pH range 5 to 7.5. The pH-dependence is illustrated in Figure 13. Example 12 Properties of 50K-cellulase B No detectable endoglucanase activity could be measured for the 50K- cellulase B (previously called 50K-protein B) with hydroxyethylcellulose or carboxymethylcellulose. At acidic pH, the 50K-cellulase B had a low cellobiohydrolase activity, which (measured with 4-methylumbelliferyl-β-D- lactoside) at pH 5 was less than 0.1% of that of the 50K cellulase. In addition, the 50K-cellulase B had a detectable activity towards filter paper at pH 4.8 and acid swollen, amorphic Solca Floc-cellulose at pH 5 and 7 used in enzyme activity determinations. In Western analyses, 50K-cellulase B was strongly recognized by antiserum (KH1050) raised against cellobiohydrolase I of T. reesei, but only weakly by antisera against cellobiohydrolase II or endoglucanase I of T. reesei or against the 50K-cellulase. It was not recognized by antiserum raised against the 20K-cellulase (Figure 14). Table X shows sequences of peptides isolated from 50K-cellulase B. Table X Sequences of peptides isolated from the 50K-cellulase B (uncertain residues in lower case) #534 vGNPDFYGK #535 FGPIGSTY #631 LSQYFIQDGeRK #632 FTVVSRFEENK #636 HEYGTNVGSRFYLMNGPDK Example 13 Stability of neutral cellulases in different detergents Stability of the neutral cellulase preparations were tested in three different detergent solutions. The detergent solutions were OMO ® Total (or OMO ® Neste, Lever UK), OMO ® Color (Lever S.A.) and Colour Detergent Liquid (Unilever, The Netherlands). The tested cellulase preparations were ALKO4125, ALKO4179, ALKO4237 and ALKO4265 (Example 1) concentrated culture filtrates and purified 20K- and 50K-cellulases from the ALKO4237 strain (Example 9). Cellulase preparations were incubated at 40°C in 0.25 % detergent solutions. The activity against hydroxyethylcellulose (ECU / ml, Example 1) was measured (pH 7, 50°C) from samples taken after 5 - 30 minutes incubation. The tested preparations were as follows: Culture filtrates: ALKO4125: 780 ECU / ml (pH 7, 50°C) ALKO4179: 830 ECU / ml ALKO4265: 760 ECU / ml ALKO4237: 650 ECU / ml Purified proteins: 20K-cellulase: 9423 ECU / ml 50K-cellulase: 10100 ECU / ml The results are shown in Tables XI - XIII. ALKO4179, ALKO4265 and ALKO4237 cellulase preparations and 20K- and 50K-cellulases stay almost 100 % stable for 30 minutes at 40°C in all three tested detergents. ALKO4125 stays stable for 30 minutes at 40°C in Colour Detergent Liquid and in OMO ® Neste. Table XI. Stability of different cellulases in 0.25 % Colour Detergent Liquid (pH 7.5 - 7.9). * pH of the 0.25 % detergent + enzyme solution after 30' incubation Table XII. Stability of different cellulases in 0.25 % OMO" Total (or OMO*Neste pH 8.5). Purified proteins from ALK04237: 20K-cellulase 50K-cellulase * pH of the 0.25 % detergent + enzyme solution after 30' incubation Table XIII. Stability of different cellulases in 0.25 % OMO* Color (pH 9.6 - 10) Purified proteins from AL 04237: 20K-cellulase 50K-cellulase * pH of the 0.25 % detergent + enzyme solution after 30' incubation Example 14 Function of neutral cellulases in detergents in HEC substrate The function of different neutral cellulases in detergents was determined by using hydroxyethylcellulose (HEC) as a substrate. The tested cellulase preparations were ALKO4265 and ALKO4237 concentrated culture filtrates and purified 20K- and 50K-cellulases from ALKO4237 strain. HEC substrates were prepared by dissolving 1 % HEC into 0.25 % detergent solutions. By using these substrates the activity against HEC (ECU / ml) was measured at 40°C from each cellulase preparations as described in Example 1. Detergents and cellulase preparations used in these experiments are described in Example 13. pH of the substrates: HEC / buffer pH 7 HEC / Colour Detergent Liquid pH 7.5 HEC / OMO ® Total pH 7.8 HEC / OMO ® Color pH 9.7 Table XIV. ECU of the cellulase preparations in different detergents (compared as % from the ECU activity measured in pH 7 buffer) ALKO4237 and ALKO4265 cellulase preparations and 20K- and 50K-cellulases function in all three tested detergents when using HEC as a substrate. Example 15 Use of neutral cellulases in detergents on cotton woven fabrics In this experiment is described the ability of the neutral cellulases to function as fabric-softening agent and to prevent fuzzing and thus to reduce pilling tendency from cotton fabric after repeated launderings in detergents. The tested cellulase preparations were ALKO4237 concentrated culture filtrate and the purified 20K- and 50K-cellulases from ALKO4237 strain (Examples 1 and 9). The washing experiment was carried out with a Launder-Ometer LP-2 (Atlas, Illinois, USA). About 10 g of prewashed (Example 3) unbleached cotton woven fabric swatch was loaded into 1.2 liter container that contained 150 ml of 0.25 % detergent solution with or without cellulase. Cellulase dosages were based on protein amounts. Detergent solutions were OMO ® Total (Lever, UK) and Colour Detergent Liquid (Unilever, The Netherlands). A quantity of steel balls were added into each container to increase the mechanical action. The Launder- Ometer was run at 42 rpm for 0.5 or 1 hour at 40°C. The material was washed 4 times with intermediate rinsing and drying. Weight loss (see Example 6) was used to decribe the amount of fuzz removed from the fabrics surface. Table XV. Weight loss of the fabrics after the first washing time with neutral cellulases in detergents. sample preparation enzyme dosage time weight loss no as protein / h % g fabric In Colour Detergent Liquid: 0.05 0.3 0.7 0.1 0.5 1.0 0.1 0.2 0.5 0.2 0.5 0.5 0.03 1.1 0.5 0.1 0.5 0.7 In the Table XV it is shown that after the first washing in Launder-Ometer weight loss of the fabrics were increased clearly more with cellulase treated fabrics than with the fabrics treated with the sole detergent. Also weight loss was increased as a function of cellulase dosage and further with 20K-cellulase weight loss was increased when washing time was raised from 0.5 hour to 1 hour. 20K- cellulase worked equally well in Colour Detergent Liquid and in OMO ® Total. These results indicate that particularly the 20K-cellulase and ALKO4237 cellulase preparation function in detergents as fuzz removing agents after already one wash time. After three further washing times with samples 1, 2, 4 and 7 (Table XV) the evaluation of the fabrics was performed by a panel consisting of three persons. Panelists were asked to evaluate the softness and visual appearance of the treated fabrics as follows. The softness of the fabrics: A. the fabric treated with cellulase is softer than the fabric treated without cellulase B. the fabric treated with cellulase is as soft as the fabric treated without cellulase C. The fabric treated with cellulase is harder than the fabric treated without cellulase The results are shown in Table XVI. Visual appearance of the fabrics was evaluated by ranking the fabrics on a score from 1 to 5. Score of 5 gave no fuzz or pills and the fabric texture became more apparent. Score of 1 gave many pills and fuzz. Total score for each fabric was calculated and divided by the number of the panelists. The average score of the visual appearance of each fabric is shown in Table XVI. Table XVI. Softness and visual appearance of the fabrics after 4 repeated washing times with neutral cellulases in detergents. preparation enzyme dosage time softness visual as protein / h appearance g fabric In Colour Detergent Liquid: 1 1 100%: softer with cellulase 3.2 100%: softer with cellulase 3.7 100%: no difference 1.7 After the 4 treatments the cellulase treated fabrics had clearly better visual appearance than the fabrics that were treated with sole detergent. Thus fabrics treated with these cellulases maintained good appearance and the fuzziness was prevented after repeated washings compared to the fabric treated without cellulases. Also after 4 wash times the ALKO4237 and 20K-cellulase treated fabrics were softer than the fabric treated with sole detergent. Example 16 Use of neutral cellulases in detergents on cotton fleecy knit In this experiment is described the ability of the neutral cellulases to function as fabric-softening agent and to prevent fuzzing and thus to reduce pilling tendency from coloured cotton fleecy knit after repeated launderings in detergents. The tested cellulase preparations were ALKO4237 concentrated culture filtrate and the purified 20K-cellulase from ALKO4237 strain (Examples 1 and 9). Green cotton fleecy knit swatches were washed at Launder-Ometer in Colour Liquid Detergent or in OMO ® Total for 1 h 3 or 10 times with or without cellulases as described in Example 15. The evaluation of the knits was performed by a panel consisting of three persons. Panelists were asked to evaluate the softness and visual appearance (both right and reverse sides) of the treated knits as described in Example 15. Weight loss of the knits was determined as described in Example 15. The results are shown in Table XVII. After the 3 washing times the 20K-cellulase treated knits had better visual appearance both on the right and reverse side than the knits treated with sole detergent. Knits treated 10 times with ALKO4237 cellulase preparation had clearly better visual appearance and brighter green colour than the knits treated only with detergent. The better visual appearance of the cellulase treated knits was detected already after 1 wash time (especially on the reverse side) and it was further developed during the additional washings. The cellulase treated knits were also softer than the knits treated with sole detergent. Table XVII. Softness, weight loss and visual appearance of the fleecy knits after 3 or 10 repeated washing times with or without cellulases in detergents. Before washings pH of the 0.25 % Colour Detergent Solution was 7.9 and 8.4 of the 0.25 % OMO ® Total solution. softness visual appearance right reverse side (A C σ co 1 1 H 33%: softer with cellulase 1.5 2.7 C H m 1 1 (/> x 100%: softer with cellulase 2.5 2.8 m m H 3 c 15 1 r- m 100%: softer with cellulase 2.3 2.8 ro * - 20K-cellulase Example 17 Use of neutral cellulases in detergents on aged cotton fleecy knit In this experiment is described the ability of the neutral cellulases to function as fabric-renewal and -softening agent. Green cotton fleecy knit was washed 10 times, with intermediate drying, in Cylinda washing machine with programme 3 at 60°C, 10 ml of OMO ® Color (Lever, UK). This was to simulate the washings of the knit in practice. After 10 treatments this aged knit had unattractive and faded appearance with a lot of fuzz at the surface. After these 10 repeated washes the fleecy knit was used for the washing experiments with or without cellulase. Knit swatches were washed at Launder- Ometer in Colour Liquid Detergent for 1 h 1 to 3 times as described in example 15 with intermediate rinsing and drying. The cellulase preparations used were ALKO4237 concentrated culture filtrate and purified 20K- and 50K-cellulases from ALKO4237 (Example 9). The evaluation of the knits was performed by a panel consisting of three persons. Panelists were asked to evaluate the softness and visual appearance (both right and reverse sides) of the treated knits as described in Example 15. Weight loss of the knits was determined as described in Example 15. The results are shown in Table XVIII. After one wash time ALKO4237 and 20K-cellulase treated knits had slightly better visual appearance than the knit treated with sole detergent. The good visual appearance and more attractive look was further developed to the 20K-cellulase treated knits after 2 and 3 wash times. Visual appearance was also improved after two wash times on the knits treated with 50K-cellulase compared to the knit treated with sole detergent. As general, the knits treated with cellulases had clearly improved and attractive look while the knits treated without cellulase had still unattractive and faded appearance. Table XVIII. Softness, weight loss and visual appearance of the aged fleecy knits after 1 to 3 repeated washing times with or without cellulases in detergents. Before washings pH of the 0.25 % Colour Detergent Solution was 7.9. preparation enzyme washing pH weight softness visual dosage as times after loss % appearance mg protein / washings right reverse g fabric side 0) c 00 0) H 1 1 H 100%: no difference 1 1.5 C H 100%. no difference 1.5 1.5 m z 2 1 1 m m 2 100%: softer with cellulase 2.5 2.2 H 2 100%: no difference 1 1.2 3 c 15 2 100%: no difference 1 1.3 r m ro 1 1 20K* 100%: softer with cellulase 3.0 2.2 20 ND = not determined * = 20K- or 50K-cellulase Example 18 Isolation of the ALK04237 chromosomal DNA and construction of the genomic library Melanocarpus albomyces ALKO4237 was grown in shake flask cultures in potato dextrose (PD; Difco, USA)- medium at 42°C, 250 rpm for 3 days. The chromosomal DNA was isolated according to Raeder and Broda, Lett. Appl. Microbiol 7:17-20 (1985). Briefly, the mycelium was washed with 20 mM EDTA and lysed in extraction buffer (200 mM Tris-HCl (pH 8.5), 250 mM NaCl, 25 mM EDTA, 0.5% SDS). The DNA was extracted with phenol and a mixture of chloroformύsoamyl alcohol (24:1 v/v). RNA was digested with RNase. The chromosomal DNA was partially digested with Sau3A (Boehringer Mannheim, Germany) and treated with calf intestine alkaline phosphatase. DNA ranging from 5 - 15 kb was isolated from an agarose gel using beta-agarase (Boehringer Mannheim, Germany) and used to construct the genomic ALKO4237 library. The predigested Lambda DASH ® II BamHI Vector Kit (Stratagene, USA) was used to construct the library and the instructions of the manufacturer were followed in all the subsequent steps. Briefly, about 200 ng of the size- fractionated DNA was ligated into 1 μg of DASH ® II prepared arms, and packaged using Gigapack II packaging extract (Stratagene, USA). The titer of the library was determined by infecting E. coli XL 1 -Blue MRA (P2)-cells with serial dilutions of the packaged phage and plating on NZY plates. The library was stored at 4°C in SM-buffer, with 4% (v/v) chloroform. It was used for screening without amplification. Example 19 Amplification, cloning and sequencing of the 20K-cellulase DNA with degenerate primers To amplify the 20K-cellulase gene by polymerase chain reaction (PCR), a pair of degenerate primers based on the peptide sequences (Figure 17) was synthesized. Primer 1 (429-32) was derived from the amino acids #8-14 of the N-terminal peptide #429 (Figure 17), and primer 2 (&28-16) was designed as the antisense strand for the amino acids #2 - 8 of the peptide fr28 (Figure 17). Additional EcoRI restriction sites were added at the 5'-termini to facilitate the cloning of the amplified fragment. Primer 1 (429-32) EcoRI 5'- ATA GAATTC TA(C/T) TGG GA(C/T) TG(C/T) TG(C/T) AA(A/G) CC Y W D C C K P Primer 2(fr28-l 6) EcoRI 5'- ATA GAATTC TT (A/G)TC (A/C/G/T)GC (A/G)TT (C/T)TG (A/G)AA N D A N Q F CCA In the PCR reaction, 1 μg of the purified ALKO4237 genomic DNA (Example 18) was used as the template. Dynazyme DNA polymerase (Finnzymes Ltd, Finland) was used according to the supplier's instructions. Total 101.4 μl The PCR reaction was performed under the following conditions: Ten μl of reaction mixture was analyzed by agarose gel electrophoresis, and a single band corresponding to about 600 bp in length was detected. The remaining of the PCR product was digested with EcoRI restriction endoglucanase, and run by agarose electrophoresis. The agarose section containing the DNA fragment was excised, and purified by the Magic PCR Preps (Promega, USA) method according to supplier's instructions. The isolated fragment was ligated with pBluescript II SK+ (Stratagene, USA) plasmid which was cut similarly with EcoRI. Competent Escherichia coli XL -Blue cells (Stratagene, USA) were transformed with the ligation mixture. Plasmid DNA from a few of the resulting colonies was isolated by the Magic Minipreps (Promega, USA) method according to supplier's instructions. The plasmid DNA was analyzed by agarose electrophoresis, and one clone with expected characteristics was designated pALK549. The Melanocarpus DNA from pALK549 was sequenced by using ABI (Applied Biosystems, USA) kits based on fluorescent-labeled T3 and T7 primers, or sequence-specific primers with fluorescent-labeled dideoxynucleotides by the Taq dye primer cycle sequencing protocol in accordance with the supplier's instructions. Because of high GC content of the Melanocarpus DNA, the sequencing reactions were performed at annealing temperature of 58°C, with 5% (v/v) DMSO. Sequencing reactions were analyzed on ABI 373 A sequencer (Applied Biosystems, USA), and the sequences obtained were characterized by using the Genetics Computer Group Sequence Analysis Software Package, version 7.2. The insert (594 bp) in pALK549 was found to encode the majority of the 20K-cellulase derived peptides (Figure 17). The PCR amplified DNA (in addition to the primers) corresponds to the nucleotides 175-716 in Figure 19. Chromosomal DNA from Myriococcum sp. ALKO4124 was isolated as described in Example 18. A PCR reaction with the primers 429-32 and fr28-16 and ALKO4124 chromosomal DNA as the template produced a fragment of same size as from ALKO4237 DNA. This fragment was partly sequenced, and was almost identical to the ALKO4237 sequence. It is concluded that Myriococcum sp. ALKO4124 has a protein, which is almost identical to the 20K- cellulase of Melanocarpus albomyces ALKO4237. This result is also in agreement with the observation that the ALKO4237 20K-cellulase specific antibodies also recognize a 20K protein band from ALKO4124 growth medium in Western analysis (Figure 14). Enzymes from both strains gave similar good results in biostoning experiments (Examples 3 and 4). Example 20 Cloning and sequencing the Melanocarpus albomyces ALK04237 20K- cellulase gene E. coli XL 1 -Blue MRA (P2) -cells (Stratagene, USA) were grown in LB + 0.2% maltose + 10 mM MgSO 4 , and diluted to OE =0.5. The cells were infected with the Melanocarpus albomyces ALKO4237 genomic library (Example 18) for 15 min at 37°C, and plated with NZY top agar on the NZY plates. Plates were incubated at 37°C overnight. The plaques were transferred onto a nylon filter (Hybond, Amersham, UK) according to Stratagene's instructions. The purified PCR fragment (Example 19) was labeled with digoxigenin according to Boehringer, DIG DNA Labeling and Detection Nonradioactive, Application Manual. Hybridization was performed at 68°C. The positive clones were picked in SM buffer/chloroform, and purified with a second round of screening. Under these conditions 4 positive clones were found. The large scale bacteriophage lambda DNA isolation from the clones was done according to Sambrook et al. , in Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989. The phage DNAs were analyzed by digestion of the DNA with several restriction enzymes, and the digested DNA was hybridized with the PCR-probe. Three hybridizing fragments were isolated: about 2.6 kb EcoRI -Xhol fragment, about 4.9 kb Xhol fragment and about 3 kb Sacl fragment. These were inserted into similarly cut pBluescript II SK+ vector (Stratagene, USA), creating plasmids pALK.1221, ρALK1222 and pALK1223, respectively (Figure 18). The Melanocarpus albomyces DNA in pALK1221 was sequenced as described in Example 19. The DNA sequence encoding the Melanocarpus albomyces 20K-cellulase is shown in Figure 19. The sequence is 936 bp in length, and has an open reading frame (ORF) coding for 235 amino acids; the gene has two introns. The putative signal peptide processing site is after alanine- 21, and the N-terminus of the mature protein begins at alanine-22, as suggested by the peptide sequencing results (Figure 17, peptide #429). The ORF predicts a protein with a molecular weight of 25.0 kDa for the full-length preprotein, and 22.9 kDa for the mature protein. This is in good agreement with the results obtained from the protein purification work (Example 10). These results also verify that the about 35 kDa protein detected previously with the 20K-cellulase antiserum (Example 10) is a different gene product than the 20K-cellulase. The 20K-cellulase of Melanocarpus albomyces appears to belong to family K of cellulases and family 45 of glycosyl hydrolases (Henrissat & Bairoch, Biochem. J. 295:781-788 (1993)). The 20K-cellulase shows homology (about 76% identify in 235 amino acid overlap) towards the Humicola insolens endoglucanase V (embl:a23635), but the 20K-cellulase has the surprising feature that it does not harbor the cellulose binding domain (CBD) and its linker, which are characteristic of the Humicola insolens endoglucanase V and other related endoglucanases (Schϋlein et al, 1993, In: Suominen & Reinikainen (eds), Foundation for Biotechnical and Industrial Fermentation Research, Helsinki, vol. 8, 109.; Saloheimo et al, 1994, Mol Microbiol. 13, 219). This feature of the 20K-cellulase may account for the excellent performance of the enzyme in biostoning experiments (Example 10). Example 21 Amplification, cloning and sequencing of 50 K-cellulase DNA with degenerate primers The peptides derived from the 50K-cellulase (Table IX) shared some homology towards Humicola grisea endoglucanase I (DDBJ:D63516). To amplify the 50 K-cellulase gene by polymerase chain reaction (PCR) a pair of degenerate primers based on the peptide sequences (Table IX) was synthetized Primer 1 (507-128) was derived from the amino acids #5-10 of the peptide #507 (Table IX), and primer 2 (509-rev) was designed as the antisense strand for the amino acids #4 - 9 of the peptide 509 (Table IX). The order of the two peptides in the protein - and the corresponding sense-antisence nature of the primers - was deduced from comparison with the Humicola grisea endoglucanase I. Primer 1 (507-128) 5 ' - GA (C/T) GA (A/G) AC (A/C/G/T) GA (A/G) CA ( C/T) (A/C) G D E T E H R Primer 2 (509-rev) 5 ' -TA (A/C/G/T) GC (A/C/G/T) CC (A/C/G/T) CC (A/C/G/T) GG (A/G) TT Y A G G P N In the PCR reaction, 1.5 μg of the purified ALKO4237 genomic DNA (Example 18) was used as the templete. Dynazyme DNA polymerase (Finnzymes Ltd, Finland) was used according to the supplier's instructions. Total 102 μl The PCR reaction was performed under the following conditions: Step 5 go to "step 2" 29 more times Step 6 72°C 8 min Step 7 4°C hold Ten μl of reaction mixture was analyzed by agarose gel electrophoresis, and a single band corresponding to about 160 bp in length was detected. The remaining of the PCR product was loaded on a agarose gel electrophoresed, and the agarose section containing the DNA fragment was excised, and purified by the Magic PCR Preps (Promega, USA) method according to the supplier's instructions. The isolated fragment was ligated with pBluescript II SK+ (Stratagene, USA) plasmid which had been digested with EcoRV endonuclease, and ddT- tailed as described in Holton and Graham (1990) Nucl. Acids Res. 19, 1156. Competent Escherichia coli XL-Blue cells (Stratagene, USA) were transformed with the ligation mixture. Plasmid DNA from a few of the resulting colonies was isolated by the Magic Minipreps (Promega, USA) method according to the supplier's instructions. The plasmid DNA was analyzed by agarose electrophoresis, and one clone with expected characteristics was designated pALK1064. The insert (161 bp) in pALK1064 was sequenced as described in Example 19, and was found to contain an ORF, which predicted a peptide homologous to Humicola grisea endoglucanase I (DDBJ:D63516). The ORF also encoded the peptide #612 (Table IX) from the purified 50K-cellulase. The PCR amplified DNA (in addition to the primers) corresponds to the nucleotides 404-530 in Figure 21. PCR with the primers 507 and 590-rev with ALKO4124 chromosomal DNA as template (Example 19) produced a fragment of same size as from ALKO4237 DNA. This suggests that Myriococcum sp. ALKO4124 has a protein very similar to the 50K-cellulase of Melanocarpus albomyces ALKO4237. This is also supported by the fact that enzymes from both strains gave similar good results in biostoning experiments. Example 22 Cloning and sequencing the Melanocarpus albomyces ALK04237 50K- cellulase gene The genomic bank of Melanocarpus albomyces ALKO4237 was prepared for hybridization as described in Example 20. The purified PCR fragment carrying part of the 50K-cellulase gene (Example 21) was labeled with digoxigenin according to Boehringer, DIG DNA Labeling and Detection Nonradioactive, Application Manual. Hybridization was performed at 68°C. The positive clones were picked in SM buffer/chloroform, and purified with a second round of screening. Under these conditions 10 positive clones were found. The large scale bacteriophage lambda DNA isolation from the clones was done according to Sambrook et al, 1989. The phage DNAs were analyzed by digestion of the DNA with several restriction enzymes, and the digested DNA was hybridized with the 50K-cellulase-specific PCR-probe. Four hybridizing fragments were isolated: about 2.8 kb Sacl-Xhol fragment, about 5 kb Sacl fragment, about 3.2 kb Xhol fragment, and about 2 kb EcoRI fragment. These were inserted into similarly cut pBluescript II SK+ vector (Stratagene, USA), creating plasmids pALK1234, pALK1233, pALK1226 and pALK1227, respectively (Figure 20). The Melanocarpus albomyces ALKO4237 DNA was sequenced from the 50K-cellulase specific plasmids mentioned above. The sequencing protocol has been described in Example 19. The DNA encoding the Melanocarpus albomyces 50K-cellulase is shown in Figure 21 (A and B). The sequence reveals an ORF of about 1363 bp in length, interrupted by one intron. The ORF codes for 428 amino acids. The predicted protein has a molecular weight of 46.8 kDa and after signal peptide cleavage of 44.8 kDa. All the peptides in Table IX are found in the predicted protein sequence (Figure 2), although some amino acids identified with uncertainty during the peptide sequencing proved to be incorrect. The protein shows homology to Humicola grisea endoglucanase I (DDBJ:D63516). Example 23 Amplification, cloning and sequencing of 50K-cellulase B DNA with degenerate primers The peptides derived from the 50K-cellulase B (Table X) shared some homology towards Humicola grisea cellobiohydrolase I (DDBJ:D63515). To amplify the 50K-cellulase B gene by polymerase chain reaction (PCR) a pair of degenerate primers based on the peptide sequences (Table X) was synthesized. Primer 1 (636) was derived from the amino acids #1 - 5 of the peptide #636 (Table X) (the first amino acid was guessed to be lysine, because this peptide was isolated after digestion with a protease cleaving after lysines), and primer 2 (534-rev) was designed as the antisense strand for the amino acids #3 - 8 of the peptide #534 (Table X). The order of the two peptides in the protein - and the corresponding sense-antisense nature of the primers - was deduced from comparison with the Humicola grisea cellobiohydrolase I. Primer 1 (636) 5 ' - AA (A/G) CA ( C/T) GA (A/G) TA ( C/T) GG (A/C/G/T) AC K H E Y G T Primer 2 (534-rev) 5 ' - CC (A/G) TA (A/G) AA (A/G) TC (A/C/G/T) GG (A/G) TT G Y F D P N In the PCR reaction, 1.5 μg of the purified ALKO4237 genomic DNA (Example 18) was used as the template. Dynazyme DNA polymerase (Finnzymes Ltd, Finland) was used according to the supplier's instructions. Total 104.4 μl The PCR reaction was performed under the following conditions: Step 4 72°C 2 min Step 5 go to "step 2" 34 more times Step 6 72°C 8 min Step 7 4°C hold Twenty μl of reaction mixture was analyzed by agarose gel electrophoresis, and a few bands were detected. One of the bands had an apparent size of 700 bp, which size was in agreement with size one would expect, when comparing with Humicola grisea cellobiohydrolase gene, particularly, if the fragment contained one or more introns. The PCR products were purified by the Magic PCR Preps (Promega, USA) method according to the supplier's instructions. The isolated fragments was ligated with pBluescript II SK+ (Stratagene, USA) plasmid which had been digested with EcoRV endonuclease, and ddT- tailed as described in Holton and Graham, Nucl Acids Res. 79:1156 (1990). Competent Escherichia coli XL-Blue cells (Stratagene, USA) were transformed with the ligation mixture. Plasmid DNA from a few of the resulting colonies was isolated by the Magic Minipreps (Promega, USA) method according to the supplier's instructions. The plasmid DNA was analyzed by agarose electrophoresis, and one clone with about 700 bp insert was designated pALK1224. The insert in pALK1224 was sequenced as described in Example 19, and was found to contain an ORF encoding the whole peptide #636 from the 50K- cellulase B (Table X). The ORF predicted a peptide homologous to Humicola grisea cellobiohydrolase I (DDBJ:D63515). The PCR amplified DNA (in addition to the primers) corresponds to the nucleotides 371-1023 in Figure 23. Example 24 Cloning and sequencing the Melanocarpus albomyces ALK04237 50K- cellulase B gene The genomic bank oi Melanocarpus albomyces ALKO4237 was prepared for hybridization as described in Example 20. The insert in pALK1224 was removed by digesting the plasmid with restriction endoglucanases EcoRI and Hmdlll. The digested plasmid DNA was run by agarose electrophoresis. The agarose section containing the about 700 bp DNA fragment was excised, and purified by the Magic PCR Preps (Promega, USA) method according to the supplier's instructions. The purified PCR fragment from pALK1224 carrying part of the 50K- cellulase B gene (Example 23) was labeled with digoxigenin according to Boehringer, DIG DNA Labeling and Detection Nonradioactive, Application Manual. Hybridization was performed at 68°C. The positive clones were picked in SM buffer/chloroform, and purified with a second round of screening. Under these conditions 3 positive clones were found. The large scale bacteriophage lambda DNA isolation from the clones was done according to Sambrook et al, in Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989. The phage DNAs were analyzed by digestion of the DNA with several restriction enzymes, and the digested DNA was hybridized with the 50K-cellulase B specific PCR probe. A hybridizing 3.5 kb Noil fragment was isolated, and inserted into similarly cut pBluescript II SK+ vector (Stratagene, USA), creating plasmid pALK1229 (Figure 22). The extreme 5 '-end of the gene was found by hybridizing the phage DNAs with 0.2 kb from pALK1229. A hybridizing 2.4 kb jPstl-fragment was isolated and inserted into similarly cut pBluescript II SK+ vector (Stratagene.USA), creating plasmid pALK1236 (Figure 22). Part of the inserts in pALK1229 and pALK1236 were sequenced as described in Example 19. The DNA encoding the Melanocarpus albomyces 50K-cellulase B is shown in Figure 23 (A and B). The sequence reveals an ORF of 1734 bp in length interrupted by five introns. The ORF codes for 452 amino acids. The predicted protein has a molecular weight of 49.9 kDa and after signal peptide cleavage of 47.6 kDa. All the peptides in Table X are found in the predicted protein sequence (Figure 23A and B), although some amino acids identified with uncertainty during the peptide sequencing proved to be incorrect. The predicted protein shows homology to Humicola grisea cellobiohydrolase I (DDBJ:D63515) and other cellobiohydrolases. However, 50K-cellulase B has the surprising feature that it does not harbor the cellulose binding domain (CBD) and its linker, which is characteristic to Humicola grisea cellobiohydrolase I and many other cellobiohydrolases. Example 25 Screening the Melanocarpus albomyces ALK04237 genomic library with Trichoderma reesei cellulases genes The genomic bank of Melanocarpus albomyces ALKO4237 was prepared for hybridization as described in Example 20. A DNA fragment carrying Trichoderma reesei cbhl specific DNA was isolated by cutting plasmid pTTcOl (Figure 24) with restriction endonuclease Hindi, and isolating the about 1.6 kb fragment from agarose gel after electrophoresis. A DNA fragment carrying Trichoderma reesei egl2 specific DNA was isolated by cutting plasmid pMS2 (Figure 25) with restriction endonucleases BamHI and EcoRI, and isolating the about 1.5 kb fragment from agarose gel after electrophoresis. The cloning of the cbhl gene is described in Teeri et al, Bio/Technology 7:696-699 (1983) and the DNA sequence is described in Shoemaker et al, Bio/Technology 1: 691-696 (1983). The egl2 (originally called "eg/5") gene is described in Saloheimo et al, Gene 63: 1-21 (1988). The fragments were labeled with digoxigenin according to Boehringer, DIG DNA Labeling and Detection Nonradioactive, Application Manual. Hybridization was performed at 68°C with the cbhl probe and at 60 °C with the egl2 probe. The positive clones were picked in SM buffer/chloroform, and purified with a second round of screening. Under these conditions 13 cbhl positive and 6 egl2 positive clones were found. One clone hybridized to both probes. The lambda DNA was isolated from the clones as described above. The phage DNAs were analyzed by digestion of the DNA with several restriction enzymes, and the digested DNA was hybridized with the cbhl and egl2 probes. The clones were also hybridized with the 20K-cellulase-specific PCR fragment (Example 19). One clone (lambda- 16) was clearly positive, and two other clones (lambda- 8/ 1 and lambda- 5/2) were weakly positive; all these clones were originally picked with the cbhl probe. An about 4 kb EcoRI fragment from lambda- 16, which hybridized to both the Trichoderma reesei cbhl probe and to the 20K-cellulase specific PCR fragment, was isolated from agarose gel after electrophoresis, and inserted into similarly cut pBluescript II SK+. The resulting plasmid was named p,ALK1230 (Figure 26). Part of the insert in pALK1230 was sequenced as described in Example 19. The DNA appears not to encode the 20K-cellulase, but codes for a protein homologous to several cellulases, particularly at the cellulose binding domain (CBD) area. Thus the gene product very likely has high affinity towards cellulosic material, and therefor this gene product was designated as protein- with-CBD. The sequence is shown in Figure 27. PCR reactions with the primers 636 and 534-rev (Example 23) were performed with the DNA from the 19 lambda clones as templates. One lambda clone, lambda-3, gave a band about 700 bp in size, similar to that in Example 23 when ALKO4237 chromosomal DNA was used as a template. This clone had originally been picked by the Trichoderma cbhl probe. The lambda DNA was digested with several restriction endonucleases, and hybridized with the 50K- cellulase B specific probe. The clone showed similar restriction enzyme pattern s the 3 clones in Example 24. It is concluded that lambda-3 also carries the 0K-cellulase B gene. Example 26 Fusion proteins A recombinant vector encoding the 20K-cellulase, 50K-cellulase or the 50K-cellulase B is prepared by fusing the cellulase encoding sequence with the sequence of Trichoderma reesei cellulase or hemicellulase or at least one functional domain of said cellulase or hemicellulase, as described in US 5,298,405, WO 93/24621 and in Genbank submission L25310, incorporated herein by reference. Especially, the enzyme is selected from the group consisting of CBHI, CBHII, EGI, EGII, XYLI, XYLII and MΛNI, or a domain thereof, such as the secretion signal or the core sequence. Fusion proteins can be constructed that contain an N-terminal mannanase or cellobiohydrolase or endoglucanase core domain or the core and the hinge domains from the same, fused to one of the Melanocarpus cellulase sequences. The result is a protein that contains an N-terminal mannanase or cellobiohydrolase or endoglucanase core or core and hinge regions, and a C- terminal Melanocarpus cellulase. The fusion protein contains both the Trichoderma mannanase or cellobiohydrolase or endoglucanase and the Melanocarpus cellulase activities of the various domains as provided in the fusion construct. Alternatively, mutations that modify the activities of the Trichoderma mannanase or cellobiohydrolase or endoglucanase, or the Melanocarpus cellulase activities, may be included in the constructions. In this case, the fusion proteins contain both the modified Trichoderma enzyme activity and the Melanocarpus cellulase activity of the various domains as provided in the fusion construct. Fusion proteins can also be constructed such that the mannanase or cellobiohydrolase or endoglucanase tail or a desired fragment thereof, is placed before one of the Melanocarpus cellulase sequences, especially so as to allow use of a nonspecific protease site in the tail as protease site for the recovery of the Melanocarpus cellulase part from the expressed fiision protein. Alternatively, fusion proteins can be constructed that provide for a protease site in a synthetic linker that is placed before one of the Melanocarpus cellulases, with or without the tail sequences. Example 27 Hosts The recombinant construct encoding the desired fusion proteins or Melanocarpus proteins are prepared as above, and transformed into a filamentous fungus such as Aspergillus spp., preferably Trichoderma spp. Example 28 Trichoderma background for 20K-cellulase production In this example is described stone- washing experiments to determine the most suitable background of Trichoderma cellulases for 20K-cellulase production. The purpose of these experiments was to determine which Trichoderma cellulases would cause backstaining in stone-washing at neutral conditions. Trichoderma reesei strain ALKO3620 (endoglucanase 2 gene is deleted) was chosen as host for these experiments. In previous studies Trichoderma EGII (endoglucanase II) enzyme has been shown to cause detrimental effects to cotton fibre structures and thus to weaken the strength properties of cotton-containing fabrics (In: Miettinen-Oinonen et al.: Effects of cellulases on cotton fiber and fabrics. In: Proceedings of the TIWC96 Conference, 1996, Vol.l (2), pp. 197 .). Stone-washing experiments were performed at pH 6.5 and 7 as described in Example 3 except that no Berol was used. The tested Trichoderma cellulase preparations were: ALKO3133 (eg/2 and cbh2 deleted) ALKO3269 (eg/2 and eg/1 deleted) ALKO3268 (eg/2 and cbhl deleted) The dosage of Trichoderma preparations was about 2.5 mg (= low dosage, L) or about 5 mg (= high dosage, H) of total protein per g of fabric. 0.4 mg of purified 20K-cellulase per g of fabric was used when needed. Results of color measurements of treated denim fabrics are shown in Table XIX. The stone- washing results show that ALKO3269 (eg/2 and eg/1 deleted) background causes less backstaining at neutral conditions than ALKO3268 (eg/2 and cbhl deleted) or ALKO3133 (eg/2 and cbhl deleted) background. Thus the preferred host for 20K-cellulase production for biostoning is an ALKO3269-like strain. Although with higher 20K-cellulase concentrations the Trichoderma background has probably only very minor importance. An ALKO3269-like background is probably as good for 50K-cellulase and 50K-cellulase B production for biostoning as it is for 20K-cellulase production. Table XIX. Color measurements of denim fabrics treated with different Trichoderma cellulase preparations with (+) or without (-) 20K-cellulase. Example 29 Production of Melanocarpus albomyces ALK0423720K-cellulase in T. reesei The Trichoderma reesei strains were constructed for Melanocarpus albomyces ALKO4237 20K-cellulase production. Strains produce Melanocarpus 20K-cellulase and are unable to produce T reesei' s endoglucanase II and cellobiohydrolase I or endoglucanase I. Such preparations deficient in Trichoderma cellulolytic activity, and the making of same by recombinant DNA methods, are described in US 5,298,405 or Suominen et al. (1993) High frequency one-step gene replacement in Trichoderma reesei. II. Effects of deletions of individual cellulase genes. Mol Gen. Genet. 241 : 523., incorporated herein by reference. In construction of the Melanocarpus albomyces 20K-cellulase producing strains, the parental Trichoderma reesei strain ALKO3620 was transformed with the expression cassettes from the plasmid pALKl 231 or pALK1235 (Figs. 28 and 29). In the cassettes 20K-cellulase is expressed from the strong cbhl promoter. The integration of the expression cassettes resulted in the replacements of the parental cbhl (pALK1231) or the eg/7 (pALK1235) genes. In the host strain ALKO3620 the egl2 gene has been replaced by the 3.3 kb Xbal-BgHl fragment of the ble gene from Streptoalloteichus hindustanus (Mattern et al. (1988) A vector of Aspergillus transformation conferring phleomycin resistance. Fungal Genet. Newslett. 35: 25.; Drocourt et al. (1990) Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance. Nucl. Acids Res. 18: 4009.) using the recombinant DNA methods described in US 5,298,405, incorporated herein by reference. The plasmids pALK1231 and pALK1235 that were used in the construction of the Melanocarpus cellulase producing strains are identical to each other with respect to cbhl promoter, 20K-cellulase gene and cbhl terminator which are described below: * T. reesei cbhl (cellobiohydrolase 1) promoter: The promoter is from Trichoderma reesei VTT-D-80133 (Teeri et al. (1983) The molecular cloning of the major cellulase gene from Trichoderma reesei. Bio/Technology 1 : 696.). The 2.2 kb EcoRI - Sacϊl fragment (Karhunen et al. (1993) High frequency one-step gene replacement in Trichoderma reesei. I. Endoglucanase I overproduction. Mol Gen. Genet. 241: 515.) was used in the construct. The sequence of the promoter area preceeding the ATG was published by Shoemaker et al. (1983) Molecular cloning of exo-cellobiohydrolase from Trichoderma reesei strain L27. Bio/Technology 1. 691.). The last 15 nucleotides of the T reesei L27 cbhl promoter (the Sacll site is underlined) are CCGCGGACTGGCATC (Shoemaker et al. 1983). The cbhl promoter from the T. reesei strain VTT-D-80133 has been sequenced at Alko Research Laboratories, and an one nucleotide difference in the DNA sequence has been noticed within the above mentioned region. In the T reesei strain VTT-D-80133 the sequence preceeding the ATG is CCGCGGACTG/C/GCATC (the Sacll site is underlined, the additional cytosine in the DNA sequence is between the slashes). The nucleotides missing from the promoter ( 10 bps after the Sacll to the ATG) were added and the exact promoter fusion to the first ATG of the Melanocarpus 20K-cellulase (see below) was done by using the PCR (polymerase chain reaction) method. The fusion and the PCR fragment were sequenced to ensure that no errors had occurred in the reaction. In pALK1231 the promoter area is also functioning as a homologous DNA (together with the cbhl 3 '-fragment; see below) to target the integration of the transforming DNA into the cbhl locus. * Melanocarpus albomyces 20K-cellulase gene: The nucleotide sequence and deduced amino acid sequence of the 20K-cellulase gene encoding an 20 kDa cellulase is presented in Example 20 (Figure 19). A 0.9 kb fragment beginning from ATG-codon was used in both plasmids. * Treesei cbhl terminator: The 739 bpΛvαll fragment (Karhunen et al. (1993) High frequency one-step gene replacement in Trichoderma reesei. I. Endoglucanase I overproduction. Mol Gen. Genet. 241: 515.) starting 113 bp before the STOP codon of the cbhl gene was added after the 20K-cellulase gene to ensure termination of transcription. In addition the material described above the plasmid pALK1231 contains: * amdS gene: The gene has been isolated from Aspergillus nidulans VH1-TRSX6 and it is coding for acetamidase (Hynes et al. (1983) Isolation of genomic clones containing the amdS gene oi Aspergillus nidulans and their use in the analysis of the structural and regulatory mutations. Mol. Cell. Biol. 3 : 1430.). Acetamidase enables the strain to grow by using acetamide as the only nitrogen source and this characteristics has been used for selecting the transformants. The 3.1 kb fragment (Spel - Xbal) from the plasmid p3SR2 (Kelly J. and Hynes M. (1985) Transformation oi Aspergillus niger by the amdS gene oi Aspergillus nidulans . EMBOJ. 4: 475.) is used in the plasmids. The fragment contains 1007 bps of the promoter area, 1897 bps of the coding region (introns included) and the 183bps terminator area of the amdS gene. * cbhl 3 '-fragment: The fragment was isolated from T. reesei ALKO2466 by using plasmid rescue (1.7 kb, BamHI - EcoRI, starting 1.4 kb after the gene's STOP, Suominen et al. (1993) High frequency one-step gene replacement in Trichoderma reesei. II. Effects of deletions of individual cellulase genes. Mol. Gen. Genet. 241 : 523.). Strain ALKO2466 derives from the strain ALKO233 (Harkki et al. (1991) Genetic engineering of Trichoderma to produce strains with novel cellulase profiles. Enzyme Microb. Technol. 13: 227.). 3 '-fragment is used together with the promoter area to target the 20K- cellulase gene to the cbhl locus by homologous recombination. The plasmid pALK1235 contains: * hph gene: The gene encoding HmB phosphotransferase is originally isolated from E. coli K- 12 JM 109 (Yanish-Perron et al. ( 1985) Improved M 13 phage cloning vectors and host strains: nucleotide sequences of the Ml 3mp 18 and pUC19 vectors. Gene 33: 103.) and it confers resistance to hygromycin B (HmB). Resistance to hygromycin (inactivated by phosphorylation by HmB phosphotransferase) was used for selecting the transformants. The hph gene together with ύiepki promoter and cbh2 terminator (see below) is isolated from plasmid pRLM^ O (Mach et al ( 1994) Transformation of Trichoderma reesei based on hygromycin B resistance using homologous expression signals. Curr. Genet. 25: 567.) as a 2.2 kb Notl-RvwII fragment. * pki promoter: The about 0.75 kb pki (pyruvate kinase) promoter for expressing hph has been synthesized by PCR using T. reesei QM 9414 DNA as a template (Schindler et al. (1993) Characterization of the pyruvate kinase-encoding gene (pkil) of Trichoderma reesei. Gene 130: 271.). * cbh2 terminator: The cbh2 terminator sequence starts immediately after the STOP codon of the cbh2 gene (to the RvwII site 0.5 kb from the STOP codon; Mach et al. (1994) Transformation of Trichoderma reesei based on hygromycin B resistance using homologous expression signals. Curr. Genet.25 : 567.) and originates from plasmid pRLM ex 30. * eg/7 5 '-fragment: The 1.8 kb eg/7 5 '-fragment (Seal - Stul) has been isolated from T. reesei QM 6a (Mandels and Reese (1957) Induction of cellulase in Trichoderma viridae as influenced by carbon sources and metals. J. Bacteriol. 73: 269.). This fragment is situated about 1.35 kb upstream from the eg/7 coding region and it was used to target the integration of the the transforming DNA into the eg/7 locus. * eg/7 3 ' -fragment: The 1.6 kb eg/7 3 '-fragment (Seal -Xhol) was, like the 5 '-fragment, isolated from T. reesei QM 6a. The fragment is situated 0.3 kb downstream from the end of the eg/7 gene and it was used for targeting of the transforming DNA into the eg/7 locus. The standard DNA methods described by Sambrook et al. (1989) In: Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.were used in construction of the vectors. The restriction enzymes, T4 DNA ligase, Klenow fragment of the DNA polymerase I, T4 DNA polymerase, polynucleotide kinase and Taq polymerase were from Boehringer Mannheim, Germany) and New England Biolabs (USA). Each enzyme was used according to the supplier's instructions. Plasmid DNA was isolated by using Qiagen columns (Qiagen GmbH, Germany) or Promega Magic Minipreps (Promega, USA) according to the manufacturer's protocols. The oligonucleotides used in the PCR-reactions and in sequencing reactions were synthetized by a ABI (Applied Biosystems, USA) 381 A DNA Synthetizer. DNA sequencing was done as described in Example 19. DNA fragments for cloning or transformations were isolated from low-melting-point agarose gels (FMC Bioproducts, USA) by β-agarase I treatment (New England Biolabs, USA) or by using the QIAEX Gel Extraction Kit (Qiagen GmbH, Germany) according to the supplier's instructions. T. reesei ALKO3620 was transformed as described by Penttila et al. (1987) A versatile transformation system for the cellulolytic filamentous fungus Trichoderma reesei. Gene 61: 155.) with the modifications described in Karhunen et al. (1993) High frequency one-step gene replacement in Trichoderma reesei. I. Endoglucanase I overproduction. Mol Gen. Genet. 241 : 515.). T. reesei transformants were transferred on a selective medium and purified through conidia. Transformants were stabilized by growing them on selective slants for two generations prior to sporulating on potato dextrose agar. Example 30 Characteristics of the Melanocarpus albomyces ALK04237 20K-cellulase producing transformants The purified transformants were grown in shake flasks in a medium containing 4 % whey, 1.5 % complex nitrogen source derived from grain, 5 % KH 2 PO 4 and 0.5% (NH 4 ) 2 SO 4 . Cultures were grown at 30°C and 250 rpm for 7 days. The culture supernatants were blotted directly onto nitrocellulose filters by a dot-blot apparatus. CBHI was detected by immunostaining using a CBHI specific monoclonal antibody CI-258 and EGI by spesific monoclonal antibody EI-2 (Aho et al. (1991) Monoclonal antibodies against core and cellulose-binding domains of Trichoderma reesei cellobiohydrolases I and II and endoglucanase I. Eur. J. Biochem. 200: 643.) and the ProtoBlot Western blot AP system (Promega. USA) according to the recommondations of the manufacturer. The T. reesei strains ALKO3620/pALK1231 /14, ALKO3620/pALK1231/16, ALKO3620/pALK1231/20 and ALKO3620/pALK1231/59 do not contain the cbhl gene. The cbhl gene is replaced by the amdS marker gene and the 20K-cellulase construct in pALK1231 expression cassette. The cbhl gene replacement was verified in Southern hybridisations. The 7. reesei strains ALKO3620/pALK1235/40 and ALKO3620/pALK1235/49 do not contain the eg/7 gene. The eg/7 gene is replaced by the hph marker gene and the 20K-cellulase construct in pALK1235 expression cassettes. The eg/7 gene replacement was verified in Southern hybridisations. The host strain ALKO3620 used in the transformations is deficient of the egl2 gene (replaced by ble gene from Streptoalloteichus hindustanus (Mattern et al.., 1988, Drocourt et al., 1990). Thus the strains do not produce Trichoderma ' s cellulase components EGII and CBHI or EGI. Samples from the culture supernatants were run on polyacrylamide slab gels containing 0.1% SDS on Bio-Rad Mini Protean II electrophoresis system (USA). The polyclonal antibody prepared against the purified 20K-cellulase was used to detect the produced protein in Western blots. In the detection, Promega ' s ProtoBlot® AP System was used. The Western result is shown in Fig. 30. The transformants ALKO3620/pALK1235/49, ALKO3620/pALK1235/40, ALKO3620/pALK1231 /14 and ALKO3620/pALK1231/16 (lanes 1, 2, 4 and 5) produce a protein which reacts with the polyclonal 20K-cellulase antiserum. The size of the protein produced by transformants is same as the size of purified 20K-cellulase (lane 6). ALKO3620 (lane 3) does not produce corresponding protein. The endoglucanase activities of the transformants were determined as described in Example 10. When 2% carboxymethylcellulose (CMC) was used as a substrate reaction temperature was lifted up to 70 °C and thus the endoglucanase activity of ALKO362O was heat inactivated. When using 1 % hydroxyethylcellulose as a substrate heat inactivation was performed before enzymatic activity measurements. Samples from growth medium were diluted to 0.05 M HEPES, pH 7.0-buffer and incubated 20 min in 70°C. Heat inactivation of endoglucanase I (the major endoglucanase left in ALKO3620) was almost complete. The activity of eg/7-negative transformants dropped about 30% in heat inactivation which indicates the minor heat inactivation of 20K-cellulase. The endoglucanase activities are presented in Table XX. When HEC was the substrate, the 20K-cellulase activity was extrapolated to the activity before the heat treatment by dividing the activity obtained after the heat treatment with 0.7. Table XX. The endoglucanase activities of T. reesei transformants producing Melanocarpus albomyces 20K-cellulase. 20K-cellulase activity (artificial units/ml) Substrate CMC HEC 70 °C, pH 7.0 50 °C, pH 7.0 * not measured ** not heat inactivated, contains also 50K-cellulase, 50K-cellulase B and other cellulase activities. *** activity due to Trichoderma cellulases The endoglucanase activities of the T. reesei host strain ALKO3620 are almost totally heat inactivated at 70 °C. Melanocarpus albomyces 20K-cellulase producing transformants produce substantial amounts of relative heat stable 20K- cellulase. The endoglucanase production level of transformants is several times higher than that of 20K-cellulase parental strain ALKO4237. Example 31 Production of Melanocarpus albomyces ALK0423750K-cellulase in T. reesei The Trichoderma reesei strains were constructed for Melanocarpus albomyces ALKO4237 50K-cellulase production. Strains produce Melanocarpus 50K-cellulase and are unable to produce T. reesei's endoglucanase II and cellobiohydrolase I or endoglucanase I. In construction of the Melanocarpus albomyces 50K-cellulase producing strains, the parental Trichoderma reesei strain ALKO3620 was transformed with the expression cassettes from the plasmid pALK1238 or pALK1240 (Figs. 31 and 32). In the cassettes 50K-cellulase is expressed from the strong cbhl promoter. The integration of the expression cassettes results in the replacements of the parental cbhl (pALK1238) or the eg/7 (pALK1240) genes. Cloning and transformation were done as described in Example 29, except that 20K-cellulase gene was replaced by 50K-cellulase gene (1.7 kb fragment beginning from ATG-codon) described in Example 22. The Melanocarpus albomyces 50K-cellulase producing transformants are then characterized similar to example 30 with modifications obvious to a person skilled in the art. The Melanocarpus albomyces 50K- cellulase B and protein-with-CBD producing transformants can be created similar to Examples 29 and 30 with modifications obvious to a person skilled in the art. Having now fully described the invention, it will be understood by those with skill in the art that the invention may be performed within a wide and equivalent range of conditions, parameters and the like, without affecting the spirit or scope of the invention or any embodiment thereof. All references cited herein are fully incorporated herein by reference. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Primalco Ltd (B) STREET: Valta-a seli (C) CITY: Rajamaki (E) COUNTRY: Finland (F) POSTAL CODE (ZIP) : 05200 (G) TELEPHONE: +358 9 13311 (H) TELEFAX: +358 9 133 1236 (ii) TITLE OF INVENTION: NOVEL CELLULASES, GENES ENCODING THEM AND USES THEREOF (iii) NUMBER OF SEQUENCES: 37 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.30 (EPO) (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..30 (D) OTHER INFORMATION: /label= No 429 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: Ala Asn Gly Gin Ser Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Gly Trp Arg Gly Lys Gly Pro Val Asn Gin Pro Val Tyr Ser 20 25 30 (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..7 (D) OTHER INFORMATION:/label= No 430 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: Tyr Gly Gly He Ser Ser Arg 1 5 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..4 (D) OTHER INFORMATION: /label= No 431 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: Cys Gly Trp Arg 1 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..6 (D) OTHER INFORMATION:/label= No 432 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: Pro Ser Cys Gly Trp Arg 1 5 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATIO :1..6 (D) OTHER INFORMATION:/label= No 433 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: Tyr Trp Asp Cys Cys Lys 1 5 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..17 (D) OTHER INFORMATION: /label= No 439 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: Gin Glu Cys Asp Ser Phe Pro Glu Pro Leu Lys Pro Gly Cys Gin Trp 1 5 10 15 Arg (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..8 (D) OTHER INFORMATION:/label= fr9 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: Arg His Asp Asp Gly Gly Phe Ala 1 5 (2) INFORMATION FOR SEQ ID NO: 8 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..7 (D) OTHER INFORMATION:/label= frl4 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: Tyr Trp Asp Cys Cys Lys Pro 1 5 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..18 (D) OTHER INFORMATION:/label= frl6 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: Gly Lys Gly Pro Val Asn Gin Pro Val Tyr Ser Cys Asp Ala Asn Phe 1 5 10 15 Gin Arg (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 ammo acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..10 (D) OTHER INFORMATION:/label-- frl7 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: Val Gin Cys Pro Glu Glu Leu Val Ala Arg 1 5 10 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..15 (D) OTHER INFORMATIO :/label= fr28 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: Asp Trp Phe Gin Asn Ala Asp Asn Pro Ser Phe Thr Phe Glu Arg 1 5 10 15 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..30 (D) OTHER INFORMATION:/label= fr30 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: Thr Met Val Val Gin Ser Thr Ser Thr Gly Gly Asp Leu Gly Ser Asn 1 5 10 15 His Phe Asp Leu Asn He Pro Gly Gly Gly Val Gly Leu Phe 20 25 30 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..10 (D) OTHER INFORMATION: /label= No 507 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: Val Tyr Leu Leu Asp Glu Thr Glu His Arg 1 5 10 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..12 (D) OTHER INFORMATION:/label-- No 509 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: Xaa Xaa Leu Asn Pro Gly Gly Ala Tyr Tyr Gly Thr 1 5 10 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..17 (D) OTHER INFORMATION:/label= No 563 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: Met Ser Glu Gly Ala Glu Cys Glu Tyr Asp Gly Val Cys Asp Lys Asp 1 5 10 15 Gly (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 14 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:!..14 (D) OTHER INFORMATION: /label= No 565 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: Asn Pro Tyr Arg Val Xaa He Thr Asp Tyr Tyr Gly Asn Ser 1 5 10 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..24 (D) OTHER INFORMATION:/label= No 603 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: Asp Pro Thr Gly Ala Arg Ser Glu Leu Asn Pro Gly Gly Ala Tyr Tyr 1 5 10 15 Gly Thr Gly Tyr Xaa Asp Ala Gin 20 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 13 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..13 (D) OTHER INFORMATION: /label= No 605 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: Xaa Xaa Val Pro Asp Tyr His Gin His Gly Val Asp Ala 1 5 10 (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..12 (D) OTHER INFORMATION: /label= No 610 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: Asn Glu Met Asp He Xaa Glu Ala Asn Ser Arg Ala 1 5 10 (2) INFORMATION FOR SEQ ID NO: 20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:!..25 (D) OTHER INFORMATION:/label-- No 611 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: Leu Pro Xaa Gly Met Asn Ser Ala Leu Tyr Leu Ser Glu Met Asp Pro 1 5 10 15 Thr Gly Ala Arg Ser Glu Leu Asn Pro 20 25 (2) INFORMATION FOR SEQ ID NO: 21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..21 (D) OTHER INFORMATION:/label-- No 612 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: Val Glu Pro Ser Pro Glu Val Thr Tyr Ser Asn Leu Arg Xaa Gly Glu 1 5 10 15 He Xaa Gly Xaa Phe 20 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..19 (D) OTHER INFORMATION: /label= No 619 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: Asp Gly Cys Gly Trp Asn Pro Tyr Arg Val Val He Thr Thr Asp Tyr 1 5 10 15 Tyr Asn Asn (2) INFORMATION FOR SEQ ID NO: 23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..10 (D) OTHER INFORMATION:/label= No 620 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: Leu Pro Cys Gly Met Xaa Ser Ala Leu Tyr 1 5 10 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..22 (D) OTHER INFORMATION: /label= No 621 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: Ala Asp Gly Cys Gin Pro Arg Thr Asn Tyr He Val Leu Asp Asp Leu 10 15 Leu His Pro Xaa Xaa Gin 20 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 9 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..9 (D) OTHER INFORMATION:/label= No 534 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25: Val Gly Asn Pro Asp Phe Tyr Gly Lys 1 5 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..8 (D) OTHER INFORMATION:/label= No 535 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 26: Phe Gly Pro He Gly Ser Thr Tyr 1 5 (2) INFORMATION FOR SEQ ID NO: 27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..12 (D) OTHER INFORMATION:/label= No 631 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 27: Leu Ser Gin Tyr Phe He Gin Asp Gly Glu Arg Lys 1 5 10 (2) INFORMATION FOR SEQ ID NO: 28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 11 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATIONS..11 (D) OTHER INFORMATION:/label= No 632 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28: Phe Thr Val Val Ser Arg Phe Glu Glu Asn Lys 1 5 10 (2) INFORMATION FOR SEQ ID NO: 29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Peptide (B) LOCATION:1..19 (D) OTHER INFORMATION:/label-- No 636 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 29: His Glu Tyr Gly Thr Asn Val Gly Ser Arg Phe Tyr Leu Met Asn Gly 1 5 10 15 Pro Asp Lys (2) INFORMATION FOR SEQ ID NO: 30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 936 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:33..115 (D) OTHER INFORMATION: /codon_start= 33 /product= "20K-cellulase" (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:187..435 (D) OTHER INFORMATION:/product= "20K-cellulase" (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:506..881 (D) OTHER INFORMATION: /product= "20K-cellulase" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 30: TCGCCCCTAA CCGAGAACCA AAGACTCCAA GAATGCGCTC TACTCCCGTT CTCCGCGCCC 60 TCCTGGCCGC AGCATTGCCC CTCGGGGCCC TCGCCGCCAA CGGTCAGTCC ACGAGGTAAC 120 TGATCACCCG CCTCATTACG CGTGCCGACC GGACCGCGTT CAGGGCTCAC TGCTCACCGC 180 ATCCAGATAC TGGGACTGCT GCAAGCCGTC GTGCGGCTGG CGCGGAAAGG GCCCCGTGAA 240 CCAGCCCGTC TACTCGTGCG ACGCCAACTT CCAGCGCATC CACGACTTCG ATGCCGTCTC 300 GGGCTGCGAG GGCGGCCCCG CCTTCTCGTG CGCCGACCAC AGCCCCTGGG CCATTAATGA 360 CAACCTCTCG TACGGCTTCG CGGCGACTGC ACTCAGCGGC CAGACCGAGG AGTCGTGGTG 420 CTGTGCCTGC TACGCGTGAG TGTGCTTGGG CCCAACGTCG GTGATTCCGG AGTTCAGACC 480 ACTGACCCAG CGACCCGCTC GCCAGTCTGA CCTTTACATC GGGTCCCGTG GCCGGCAAGA 540 CCATGGTCGT CCAGTCGACC AGCACGGGCG GCGACCTCGG CAGCAACCAC TTCGACCTCA 600 ACATCCCCGG CGGCGGCGTC GGCCTCTTCG ACGGCTGCAC TCCCCAGTTC GGCGGCCTCC 660 CGGGCGCACG GTACGGCGGC ATCTCGTCGC GCCAGGAGTG CGACTCGTTC CCCGAGCCGC 720 TCAAGCCCGG CTGCCAGTGG CGCTTCGACT GGTTCCAGAA CGCCGACAAC CCGTCCTTTA 780 CCTTCGAGCG GGTCCAGTGC CCCGAGGAGC TGGTCGCTCG GACCGGCTGC AGGCGCCACG 840 ACGACGGCGG CTTCGCCGTC TTCAAGGCCC CCAGCGCCTG ATCCGTTTTT GGGCAGTGTC 900 CGTGTGACGG CAGCTACGTG GAACGACCTG GAGCTC 936 (2) INFORMATION FOR SEQ ID NO: 31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 235 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Protein (B) LOCATION:1..235 (D) OTHER INFORMATION: /label-- 20K-cellulase (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 31: Met Arg Ser Thr Pro Val Leu Arg Ala Leu Leu Ala Ala Ala Leu Pro 1 5 10 15 Leu Gly Ala Leu Ala Ala Asn Gly Gin Ser Thr Arg Tyr Trp Asp Cys 20 25 30 Cys Lys Pro Ser Cys Gly Trp Arg Gly Lys Gly Pro Val Asn Gin Pro 35 40 45 Val Tyr Ser Cys Asp Ala Asn Phe Gin Arg He His Asp Phe Asp Ala 50 55 60 Val Ser Gly Cys Glu Gly Gly Pro Ala Phe Ser Cys Ala Asp His Ser 65 70 75 80 Pro Trp Ala He Asn Asp Asn Leu Ser Tyr Gly Phe Ala Ala Thr Ala 85 90 95 Leu Ser Gly Gin Thr Glu Glu Ser Trp Cys Cys Ala Cys Tyr Ala Leu 100 105 110 Thr Phe Thr Ser Gly Pro Val Ala Gly Lys Thr Met Val Val Gin Ser 115 120 125 Thr Ser Thr Gly Gly Asp Leu Gly Ser Asn His Phe Asp Leu Asn He 130 135 140 Pro Gly Gly Gly Val Gly Leu Phe Asp Gly Cys Thr Pro Gin Phe Gly 145 150 155 160 Gly Leu Pro Gly Ala Arg Tyr Gly Gly He Ser Ser Arg Gin Glu Cys 165 170 175 Asp Ser Phe Pro Glu Pro Leu Lys Pro Gly Cys Gin Trp Arg Phe Asp 180 185 190 Trp Phe Gin Asn Ala Asp Asn Pro Ser Phe Thr Phe Glu Arg Val Gin 195 200 205 Cys Pro Glu Glu Leu Val Ala Arg Thr Gly Cys Arg Arg His Asp Asp 210 215 220 Gly Gly Phe Ala Val Phe Lys Ala Pro Ser Ala 225 230 235 (2) INFORMATION FOR SEQ ID NO: 32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1894 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:233..838 (D) OTHER INFORMATION:/product-- "50K-cellulase" (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:916..1596 (D) OTHER INFORMATION:/product-- "50K-cellulase" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 32: GAATTCGGGG GTTGCCAGGG AGTCGTACAG GGGTGGGTGG AGGGGGATGG GGGATGGAAG 60 GGGGATGGAG AAGAAAGCAT ATATGGGACG TTTGTGCTCG CCGGCTCCCC TCTGCCACGT 120 TCCCTTGCCT CCTTGCCTGG GTTGTTGTTG GTCTTCCCTT CACCATCCGA CAAACCAACC 180 TGCTGCGGGT GAACTCGCAG AGCGCCTTCG GACGACGACA GACAGACGCA CCATGACTCG 240 CAACATCGCC CTGCTCGGCG CCGCGTCGGC GCTCCTGGGC CTCGCCCACG GCCAGAAGCC 300 GGGCGAGACG CCCGAGGTGC ACCCGCAGCT GACGACGTTC CGGTGCACCA AGGCGGACGG 360 GTGCCAGCCG CGGACCAACT ACATTGTGCT GGACTCGCTG TCGCACCCGG TGCACCAGGT 420 GGACAACGAC TACAACTGCG GCGACTGGGG GCAGAAGCCC AACGCGACGG CGTGCCCGGA 480 CGTCGAGTCG TGCGCGCGCA ACTGCATCAT GGAGGGCGTG CCCGACTACA GCCAGCACGG 540 CGTCACGACG AGCGACACGT CGCTGCGCCT GCAGCAGCTC GTCGACGGCC GCCTCGTCAC 600 GCCGCGCGTC TACCTGCTCG ACGAGACCGA GCACCGCTAC GAGATGATGC ACCTGACCGG 660 CCAGGAGTTC ACCTTTGAGG TCGACGCCAC CAAGCTGCCC TGCGGCATGA ACAGCGCCCT 720 CTACCTGTCC GAGATGGACC CGACCGGCGC CCGGAGCGAG CTCAACCCCG GCGGTGCCTA 780 CTACGGCACC GGCTACTGCG ACGCCCAGTG CTTCGTGACG CCATTCATCA ACGGCATTGT 840 GAGTGTTCCC CTTTGGCCCC CCCCCTGAAA ATAGATGTAC CTGGGTGCTA ACCCCGGGGT 900 GTCGCACCAA AACAGGGCAA CATCGAGGGC AAGGGCTCGT GCTGCAACGA GATGGACATC 960 TGGGAGGCCA ACTCGCGGGC GACGCACGTG GCGCCGCACA CGTGCAACCA GACGGGTCTG 1020 TACATGTGCG AGGGCGCCGA GTGCGAGTAC GACGGCGTGT GCGACAAGGA CGGGTGCGGG 1080 TGGAACCCGT ACCGGGTCAA CATCACCGAC TACTACGGCA ACTCGGACGC GTTCCGCGTC 1140 GACACGCGGC GGCCCTTCAC CGTGGTGACG CAGTTCCCGG CCGACGCCGA GGGCCGGCTC 1200 GAGAGCATCC ACCGGCTGTA CGTGCAGGAC GGCAAGGTGA TCGAGTCGTA CGTCGTCGAC 1260 GCGCCGGGCC TGCCCCGGAC CGACTCGCTC AACGACGAGT TCTGCGCCGC CACGGGCGCC 1320 GCGCGCTACC TCGACCTCGG CGGCACCGCG GGCATGGGCG ACGCCATGAC GCGCGGCATG 1380 GTGCTGGCCA TGAGCATCTG GTGGGACGAG TCCGGCTTCA TGAACTGGCT CGACAGCGGC 1440 GAGGCCGGCC CCTGCCTGCC CGACGAGGGC GACCCCAAGA ACATTGTCAA GGTCGAGCCC 1500 AGCCCCGAGG TCACCTACAG CAACCTGCGC TGGGGCGAGA TCGGGTCGAC CTTTGAGGCC 1560 GAGTCCGACG ACGACGGCGA CGGCGACGAC TGCTAGATAA CTAACTAGTG GGCGGAAAGG 1620 GCGGGGGATG CGTAACTTAC ATACAGCCCG GAGTTGTTTT GAGTGTAGAG TATTGAGCTT 1680 TCGATGTGTT AGTTGAGTGG AATGGAAAAT TCGCGTCTTT GCCCCGGTGG TTGCGATAAA 1740 CAATAGTCGG CTGGTGCATT TGTGACACTT CAATTGCGCT GTTGGCTTGG TGACAGACAC 1800 GGCAGCGTCG ATGACCCGAC ACCCAGAATA ATTCGCATGG TTGATTATGT TATTGTGCTT 1860 TAAATCGGAG GCTGATGCTC ATCTCTTCGA ATTC 1894 (2) INFORMATION FOR SEQ ID NO: 33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 428 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Protein (B) LOCATION:1..428 (D) OTHER INFORMATION: /label= 50K-cellulase (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 33: Met Thr Arg Asn He Ala Leu Leu Gly Ala Ala Ser Ala Leu Leu Gly 1 5 10 15 Leu Ala His Gly Gin Lys Pro Gly Glu Thr Pro Glu Val His Pro Gin 20 25 30 -I l l- Leu Thr Thr Phe Arg Cys Thr Lys Ala Asp Gly Cys Gin Pro Arg Thr 35 40 45 Asn Tyr He Val Leu Asp Ser Leu Ser His Pro Val His Gin Val Asp 50 55 60 Asn Asp Tyr Asn Cys Gly Asp Trp Gly Gin Lys Pro Asn Ala Thr Ala 65 70 75 80 Cys Pro Asp Val Glu Ser Cys Ala Arg Asn Cys He Met Glu Gly Val 85 90 95 Pro Asp Tyr Ser Gin His Gly Val Thr Thr Ser Asp Thr Ser Leu Arg 100 105 110 Leu Gin Gin Leu Val Asp Gly Arg Leu Val Thr Pro Arg Val Tyr Leu 115 120 125 Leu Asp Glu Thr Glu His Arg Tyr Glu Met Met His Leu Thr Gly Gin 130 135 140 Glu Phe Thr Phe Glu Val Asp Ala Thr Lys Leu Pro Cys Gly Met Asn 145 150 155 160 Ser Ala Leu Tyr Leu Ser Glu Met Asp Pro Thr Gly Ala Arg Ser Glu 165 170 175 Leu Asn Pro Gly Gly Ala Tyr Tyr Gly Thr Gly Tyr Cys Asp Ala Gin 180 185 190 Cys Phe Val Thr Pro Phe He Asn Gly He Gly Asn He Glu Gly Lys 195 200 205 Gly Ser Cys Cys Asn Glu Met Asp He Trp Glu Ala Asn Ser Arg Ala 210 215 220 Thr His Val Ala Pro His Thr Cys Asn Gin Thr Gly Leu Tyr Met Cys 225 230 235 240 Glu Gly Ala Glu Cys Glu Tyr Asp Gly Val Cys Asp Lys Asp Gly Cys 245 250 255 Gly Trp Asn Pro Tyr Arg Val Asn He Thr Asp Tyr Tyr Gly Asn Ser 260 265 270 Asp Ala Phe Arg Val Asp Thr Arg Arg Pro Phe Thr Val Val Thr Gin 275 280 285 Phe Pro Ala Asp Ala Glu Gly Arg Leu Glu Ser He His Arg Leu Tyr 290 295 300 Val Gin Asp Gly Lys Val He Glu Ser Tyr Val Val Asp Ala Pro Gly 305 310 315 320 Leu Pro Arg Thr Asp Ser Leu Asn Asp Glu Phe Cys Ala Ala Thr Gly 325 330 335 Ala Ala Arg Tyr Leu Asp Leu Gly Gly Thr Ala Gly Met Gly Asp Ala 340 345 350 Met Thr Arg Gly Met Val Leu Ala Met Ser He Trp Trp Asp 355 360 365 Gly Phe Met Asn Trp Leu Asp Ser Gly Glu Ala Gly Pro Cys 370 375 380 Asp Glu Gly Asp Pro Lys Asn He Val Lys Val Glu Pro Ser 385 390 395 Val Thr Tyr Ser Asn Leu Arg Trp Gly Glu He Gly Ser Thr 405 410 Ala Glu Ser Asp Asp Asp Gly Asp Gly Asp Asp Cys 420 425 (2) INFORMATION FOR SEQ ID NO: 34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2000 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION: 154..729 (D) OTHER INFORMATION:/product-- "50K-cellulase B" (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:810..946 (D) OTHER INFORMATION: /product= "50K-cellulase B" (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:1018..1230 (D) OTHER INFORMATION:/product= "50K-cellulase B" (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:1308..1551 (D) OTHER INFORMATION: /product-- "50K-cellulase B" ( ix) FEATURE : (A) NAME/KEY: exon (B) LOCATION:1637..1767 (D) OTHER INFORMATION: /product-- "50K-cellulase B" (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:1831..1888 (D) OTHER INFORMATION:/product= "50K-cellulase B" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 34: CCCGGTCTGG AGACGGGGAG CGCGCCAGCG ACGCAGGATA AGAAGGCGAC GACCGCGCCT 60 CCGAGCCAGG CCCAGGACAG CAGGAGAACT CGCCACGCGC AAGCAGCACG CCCGATCGAC 120 AGTGTCCCGC TCTGCCCACA GCACTCTGCA ACCATGATGA TGAAGCAGTA CCTCCAGTAC 180 CTCGCGGCCG CGCTGCCGCT CGTCGGCCTC GCCGCCGGCC AGCGCGCTGG TAACGAGACG 240 CCCGAGAACC ACCCCCCGCT CACCTGGCAG AGGTGCACGG CCCCGGGCAA CTGCCAGACC 300 GTGAACGCCG AGGTCGTCAT TGACGCCAAC TGGCGCTGGC TGCACGACGA CAACATGCAG 360 AACTGCTACG ACGGCAACCA GTGGACCAAC GCCTGCAGCA CCGCCACCGA CTGCGCTGAG 420 AAGTGCATGA TCGAGGGTGC CGGCGACTAC CTGGGCACCT ACGGCGCCTC GACCAGCGGC 480 GACGCCCTGA CGCTCAAGTT CGTCACCAAG CACGAGTACG GCACCAACGT CGGCTCGCGC 540 TTCTACCTCA TGAACGGCCC GGACAAGTAC CAGATGTTCA ACCTCATGGG CAACGAGCTT 600 GCCTTTGACG TCGACCTCTC GACCGTCGAG TGCGGCATCA ACAGCGCCCT GTACTTCGTC 660 GCCATGGAGG AGGACGGCGG CATGGCCAGC TACCCGAGCA ACCAGGCCGG CGCCCGGTAC 720 GGCACTGGGG TGAGTTGAGC TCCGCTTTGT TTCGAGTCGC AACGAGGCAC TTTCTGGGCG 780 CCGGCTAACT CTCTCGATTC CTCCGACAGT ACTGCGATGC CCAATGCGCT CGTGATCTCA 840 AGTTCGTTGG CGGCAAGGCC AACATTGAGG GCTGGAAGTC GTCCACCAGC GACCCCAACG 900 CTGGCGTCGG CCCGTACGGC AGCTGCTGCG CTGAGATCGA CGTCTGGTGA GTGCGAGACC 960 GTCCACCCAG GTTCGGATGC GGGGTGGAAA TTTCGCGGCT AACGGAGCAC CCCCCAGGGA 1020 GTCGAATGCC TATGCCTTCG CTTTCACGCC GCACGCGTGC ACGACCAACG AGTACCACGT 1080 CTGCGAGACC ACCAACTGCG GTGGCACCTA CTCGGAGGAC CGCTTCGCCG GCAAGTGCGA 1140 CGCCAACGGC TGCGACTACA ACCCCTACCG CATGGGCAAC CCCGACTTCT ACGGCAAGGG 1200 CAAGACGCTC GACACCAGCC GCAAGTTCAC GTGCGTGACC CCTTGTGGCG CAACCTTTCT 1260 CTGCCTGCCT GGACACACTG AAACTGACAC GTCGTTTTCG GCTGCAGCGT CGTCTCCCGC 1320 TTCGAGGAGA ACAAGCTCTC CCAGTACTTC ATCCAGGACG GCCGCAAGAT CGAGATCCCG 1380 CCGCCGACGT GGGAGGGCAT GCCCAACAGC AGCGAGATCA CCCCCGAGCT CTGCTCCACC 1440 ATGTTCGATG TGTTCAACGA CCGCAACCGC TTCGAGGAGG TCGGCGGCTT CGAGCAGCTG 1500 AACAACGCCC TCCGGGTTCC CATGGTCCTC GTCATGTCCA TCTGGGACGA CGTAAGTACC 1560 CGCCGACCTC CCTAGCCACA CAAGCCGCAT CCGGCGAGGC ACGCCATCGC TGCTGCTAAC 1620 ACGAGACCGT TCGTAGCACT ACGCCAACAT GCTCTGGCTC GACTCCATCT ACCCGCCCGA 1680 GAAGGAGGGC CAGCCCGGCG CCGCCCGTGG CGACTGCCCC ACGGACTCGG GTGTCCCCGC 1740 CGAGGTCGAG GCTCAGTTCC CCGACGCGTA AGACTTGCCC CCGACCCCAA GCTTCCACTT 1800 CTGGATGCCG AATGCTAACA CGCGAAACAG CCAGGTCGTC TGGTCCAACA TCCGCTTCGG 1860 CCCCATCGGC TCGACCTACG ACTTCTAAGC CGGTCCATGC ACTCGCAGCC CTGGGCCCGT 1920 CACGCCCGCC ACCTCCCCTC GCGGAAACTC TCCGTGCGTC GCGGGCTCCA AAGCATTTTG 1980 GCCTCAAGTT TTTTTCGTTC 2000 (2) INFORMATION FOR SEQ ID NO: 35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 452 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Protein (B) LOCATION:1..452 (D) OTHER INFORMATION:/label= 50K-cellulase-B (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 35: Met Met Met Lys Gin Tyr Leu Gin Tyr Leu Ala Ala Ala Leu Pro Leu 1 5 10 15 Val Gly Leu Ala Ala Gly Gin Arg Ala Gly Asn Glu Thr Pro Glu Asn 20 25 30 His Pro Pro Leu Thr Trp Gin Arg Cys Thr Ala Pro Gly Asn Cys Gin 35 40 45 Thr Val Asn Ala Glu Val Val He Asp Ala Asn Trp Arg Trp Leu His 50 55 60 Asp Asp Asn Met Gin Asn Cys Tyr Asp Gly Asn Gin Trp Thr Asn Ala 65 70 75 80 Cys Ser Thr Ala Thr Asp Cys Ala Glu Lys Cys Met He Glu Gly Ala 85 90 95 Gly Asp Tyr Leu Gly Thr Tyr Gly Ala Ser Thr Ser Gly Asp Ala Leu 100 105 110 Thr Leu Lys Phe Val Thr Lys His Glu Tyr Gly Thr Asn Val Gly Ser 115 120 125 Arg Phe Tyr Leu Met Asn Gly Pro Asp Lys Tyr Gin Met Phe Asn Leu 130 135 140 Met Gly Asn Glu Leu Ala Phe Asp Val Asp Leu Ser Thr Val Glu Cys 145 150 155 160 Gly He Asn Ser Ala Leu Tyr Phe Val Ala Met Glu Glu Asp Gly Gly 165 170 175 Met Ala Ser Tyr Pro Ser Asn Gin Ala Gly Ala Arg Tyr Gly Thr Gly 180 185 190 Tyr Cys Asp Ala Gin Cys Ala Arg Asp Leu Lys Phe Val Gly Gly Lys 195 200 205 Ala Asn He Glu Gly Trp Lys Ser Ser Thr Ser Asp Pro Asn Ala Gly 210 215 220 Val Gly Pro Tyr Gly Ser Cys Cys Ala Glu He Asp Val Trp Glu Ser 225 230 235 240 Asn Ala Tyr Ala Phe Ala Phe Thr Pro His Ala Cys Thr Thr Asn Glu 245 250 255 Tyr His Val Cys Glu Thr Thr Asn Cys Gly Gly Thr Tyr Ser Glu Asp 260 265 270 Arg Phe Ala Gly Lys Cys Asp Ala Asn Gly Cys Asp Tyr Asn Pro Tyr 275 280 285 Arg Met Gly Asn Pro Asp Phe Tyr Gly Lys Gly Lys Thr Leu Asp Thr 290 295 300 Ser Arg Lys Phe Thr Val Val Ser Arg Phe Glu Glu Asn Lys Leu Ser 305 310 315 320 Gin Tyr Phe He Gin Asp Gly Arg Lys He Glu He Pro Pro Pro Thr 325 330 335 Trp Glu Gly Met Pro Asn Ser Ser Glu He Thr Pro Glu Leu Cys Ser 340 345 350 Thr Met Phe Asp Val Phe Asn Asp Arg Asn Arg Phe Glu Glu Val Gly 355 360 365 Gly Phe Glu Gin Leu Asn Asn Ala Leu Arg Val Pro Met Val Leu Val 370 375 380 Met Ser He Trp Asp Asp His Tyr Ala Asn Met Leu Trp Leu Asp Ser 385 390 395 400 He Tyr Pro Pro Glu Lys Glu Gly Gin Pro Gly Ala Ala Arg Gly Asp 405 410 415 Cys Pro Thr Asp Ser Gly Val Pro Ala Glu Val Glu Ala Gin Phe Pro 420 425 430 Asp Ala Gin Val Val Trp Ser Asn He Arg Phe Gly Pro He Gly Ser 435 440 445 Thr Tyr Asp Phe 450 (2) INFORMATION FOR SEQ ID NO: 36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 887 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION:351..455 (D) OTHER INFORMATION:/product-- "protein-with-CBD" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 36: CCATGGACGC GAACTGCGAC GTCTTCTGCC CCGAGCTGAA GACCCAGAGC ATCCAGACCG 60 GCAACCAGTG CACCCAGGAG ATGAAGGTCT ACGAGAACAT TGACGGCTGG CTCGACAGCC 120 TGCCCGGCAA CGTCCCCATC ACCGGTCCGC AGCCCGGCTC TGGTAAGTCA AAGAGATGAT 180 GCCTACCTAC CTTCCCACCT TCCCACCCAG CCGCAAATAC CTTTCTCCCT CCCCGTGCCC 240 CGTATTCTTT CAACGCCCCG AGACTGACAG ACCCGCTCGT CCCAGGCGGC AACCCCGGCA 300 ACGGCGGCGG CAGCAACCCG GGCAACGGCG GCGGCGGCGG CTGCACCGTC CAGAAGTGGG 360 GCCAGTGCGG CGGCATCGGC TACTCGGGCT GCACCACCTG CAAGGCCGGC TCGACCTGCC 420 CGGCCCAGAA CGAGTACTAC TCGCAGTGCC TGTAAAGCGG CCGTGGGCTA GGTGGCCGAG 480 CGGGGGGGTT TCTTCATTGG TTGAGCAAAT AGAACAGGAT TTCCGGCTCG TTGGCAGCGG 540 CGCGCCGCGG GGATGGTGTT GTACAATTCA AGACCTCAGT ACCGAGGGAC CTGGAAAGGA 600 GTCAGTCTGC TTGTACGGAG GCTGGCTGCC CCGTGGCGGC GCTGGCAAGG TAGATAGCCC 660 TTCATTGCTG TAACTAGTAT GCTATATACC TCTGCACATT TGCAGCCCCA TGGTGTGAAC 720 AACAAGTGAC AAGGCTTCCA GTTCCAGCCT CGCGCAATTG TCACGATATC CTTGGTCCAT 780 CTATATGTAT GGGCATGAGC GAGTCGAGAA AATGTACCGC GAAAAATCGT AGTGACCTGC 840 GCACTGCGCC GTTCTACCAC CGTAGGATTG AAGTGAATCT CGAATTC 887 (2) INFORMATION FOR SEQ ID NO: 37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 34 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (vi) ORIGINAL SOURCE: (A) ORGANISM: Melanocarpus albomyces (B) STRAIN: ALK04237 (ix) FEATURE: (A) NAME/KEY: Protein (B) LOCATION:1..34 (D) OTHER INFORMATION: /label= prot-with-CBD (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 37: Gin Lys Trp Gly Gin Cys Gly Gly He Gly Tyr Ser Gly Cys Thr Thr 1 5 10 15 Cys Lys Ala Gly Ser Thr Cys Pro Ala Gin Asn Glu Tyr Tyr Ser Gin 20 25 30 Cys Leu INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule I3£>u) Enclosed recognition of receipt and viability statement D. DESIGNATED STATES FOR WHICH INDICATIONS -.RE NUDE ( ii i t indications are not lor ail desifrnaiea Stales, E SEPARATE FURNISHING OF INDICATIONS ileaie oiaπn u not aooltcaoiei The inaicaiions listed below will be suomiπeα lo ihc Iniemaiionai Bureau later ispeciiv me ge eral nature ot ihe inaicano s e . i nmoer oi Deposit ' < I'C ' T KIVI ,4< IW, Primalco Ltd, Biotec Valta-akseli 05200 Rajamaki Finland ιόencι:. e:_ 3. -.-.= _ .-≤uπe ana aaareεs zepos zcr I . IDENTIFICATION OF THE MICROORGANISM Identification reference given cy t.-.e Accession r.uπiDer given cy the DEPOSITOR: INTERNATIONAL DEPOSITARY AUTHORITY: ALKQ4179 CBS 689.95 II . SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION rhe microorganism identified under 1 above was accompanied by: I X I a scientific description a proposed taxonomic designation i.Tiarx' wit.-i a cross wnere appiicaDiei The microorganism identified under I aoove was received by cnis International Depositary Authority cn not applicable (date of the original deposit: and a request :: convert the or gmai deposit o a deposit ir.αer tr,e Budapest Treaty was received by it cn not applicable .cats cf receipt of re uest for conversion) INTERNATIONAL DEPOSITARY AUTHORITY Centraalbureau voor Schimmelcultures ■ gnatureisi _r perscr.isi r.avmg t e power :: represent tr.e International Depositary Utr.or ty or oi autncrized - i c aiisi : idress: Oosterstraat 1 van Asma P.O. Box 273 Agterberg 3740 AG BAARN The Netherlands ;ace : Monday, 30 October 1995 '. ■ Jnere -_. ■~ . -, '• _) applies . -uc r.e status rnacionai epositai autr.on y was acqu -~—- OS'. Pπmalco Ltd. Biotec ----- — .. Valta-a seh 05200 Raiamaki ;rτΕr---.T--" Finland _er.t -:.--i -.c^-rα race r.ame ana aaaress c: ire va: :z - c "iaoi-izy statement . ssueα DEPOSITOR II. IDENTIFICATION OF THE MICROORGANISM Pπmalco Ltd, Biotec Accession n mDer given DV the INTERNATIC.IA DEPOSITARY AUTHORITY: CBS 689.95 Address: Valta-akseli 05200 Rajamaki Date of the deposit or of the transfer: Finland Thursday, 12 October 1995 II . VIABILITY STATEMENT The viaoility or the microorganism .α.r.tn.e- -.r.αer II aDove was t stec on Thursday, 19 October 1995 - Cr. tnat αate, tr.e saiα rucrcorganisπ was • -ab.e "0 .;nger " acie Indicate -he ate of the original αeoosit or, .nere a new αeposit a transrer r.as Deen maαe :ne most recent relevant αate nacs o tπe r.ew αeoosit or αate :: 5 transreπ me oases rererre to .n .-u_.e .aι i ... ana :re most receno :arκ tr. a oross ;rτ 5?' - IV. CONDITIONS UNDER WHICH THE VIABILITY HAS BEEN PERPORMED V. INTERNATIONAL DEPOSITARY AUTHORITY Maine : Centraalbureau voor Schimmelcultures Signature is) or personis) navir.g tne power represent the International Depositary Autnority or ot " authorized official (s) : Address : Oosterstraat 1 drs F.M. van Asma P.O. Box 273 dr M.C. Agterberg 3740 AG BAARN The Netherlands Mondav, 30 October 1995 intormat : -.as oeen requesteα ar.α ie results of the test were negative. ?crm cP' seccr.α ana -as: INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule I5£>..) E SEPARATE FURNISHING OF INDICATIONS ileaie otanx. ,1 not aopticaotei The indications listed below will be submiπed lo ine iniemaiionai Bureau later the genera, nature oi the inaicaiions e p \ umoer oi Deposit i l'( T RO-I UiJul. IW-1 Primalco Ltd. Biotec Valta-akseli 05200 Raiamaki JTHCRITY Finland : -.-.is caαe r.a e ar.α aααress :: epositoz IDENTIFICATION OF THE MICROORGANISM :αent::::at;cn reterence given oy ene Accession numoer given oy the DEPOSITOR: I INTERNATIONAL DEPOSITARY AUTHORITY: ALKQ4124 CBS 687.95 II . SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under I aoove was accompanied by: I X I a scientific description a proposed taxonomic designacicr. ιmarκ w th a cress wnere applicable,' III. RECEIPT AND ACCEPTANCE Th s International Depositary accepts tne micro; rσanism identified unαer I above, wnich was received by it on Thursday, 12 October 1995 i ate of the original deposit ) ' IV. RECEIPT OF REQUEST FOR CONVERSION The microorganism identified unαer Z acove was received ry tr.is International Depositary Autnority on not applicable .dace of the original deposit! and a request to convert tr.e original αeposit to deposit u der the Budapest Treaty was received cy it cn not applicable .dace of receipt of request for conversion: INTERNATIONAL DEPOSITARY AUTHORITY .lame : Centraalbureau voor Schimmelcultures s gnatur ' si :: cersonisi r.avmς tr.e power represent tn< International Depositary Autnority or .: a tnoπzeα official Is > : Address: Oosterstraat 1 drs F.M. van Asma P.O. Box 273 3740 AG BAARN Yϊ =^=^- dr M.C. Agterberg The Netherlands Mondav, 30 October 1995 • Jnere u-e -Ξ . -i ' -iJ applies. .. :e tn wmon tne status .r interna ional depositary autnority was aocru orm BF' ;Cιi caαe > Primalco Ltd, Biotec Valta-akseli sueα pursuant :c .- .e .. .. oy t. 05200 Raiamaki Finland I. DEPOSITOR II. IDENTIFICATION 07 THE MICROORGANISM Primalco Ltd, Biotec accession nutiDer αiven cy tr.e INTERNATIONAL DEPOSITARY AUTHORITY: CBS687.95 Address : Valta-akseli 05200 Rajamaki Date ot the deposit or of the transfer: Finland Thursday, 12 October 1995 III . VIABILITY STATEMENT The viacmty o r t e micrccroani sr ice.nt iiea unαer - aoove was testeα cn Thursday, 19 October 1995 : Zr. t.-.at race, tr.e said microorganism was no longer v aio -nαicate t e αate oi t e or oir.a. oepoεit tr, nere a αeposit or a transrer nas ceen r.aαe. tr.e most recent relevant oate 'date of tr.e new deposit or date of tne transfer) . oases reterreα reter to tne most recent v am-ity test. !!arκ wit a cross r.s a-.::: rst taαe i IV. CONDITIONS UNDER WHICH THE VIABILITY HAS BEEN PERFORMED V. INTERNATIONAL DEPOSITARY AUTHORITY Name: Centraalbureau voor Schimmelcultures ignature tsi or personis) naving tne power t- represent the International Depositary Authority or of autnorited of icial I s ) : Address: Oosterstraat 1 drs F.M. van Asma I P.O. Box 273 dr M.C. Agterberg j 3740 AG BAARN The Netherlands oat e : Monday, 30 October 1995 r.as ceen reσuesceα and if the results of the test were negative. rOrlT =? r •co α ana INDICATIONS RELATING TO A DEPOSITED MICROORGANISM ( PCT Rule I 3i« ) Date oi deposn 1 Accession Numoer 1 1 Oc t ober 1995 CBS 685 . 95 C. ADDITIONAL INDICATIONS (leave blank if not appucaolei This information is coniiπucd on ar additional sheei | X EP The microorganism shall be made available as provided in Rule 28(3) and 28(4) of the implementing regulations of EPC. FI The microorganism shall be made available as provided in Finnish j Patent Law 22 § 7. I ' Enclosed recognition of receipt and viability statement i D DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (it tne inaicaiions are not lor all designaiea Stales, E. SEPARATE FURNISHING OF INDICATIONS i/ o.e lanκ ,ι not aoplicaote. The inaicaiions listed below will be suDmiπeα to the Intemauonal Bureau later tsoeciti- ine general nature ot the inatcanons e g \ moer ol Deposit") Primalco Ltd, Biotec Valta-akseli -=sueα p rs an 1 - ■ / tr.e 05200 Rajamaki Finland name a-α aaaress zz depositor IDENTIFICATION OF THE MICROORGANISM lαenti-icacicn reterence given cy Accession π.uiriDer given cy the :EPOΞITOR: I.ΓΓESNATIONA DEPOSITARY AUTHORITY: ALKQ4237 CBS 685.95 II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOXIC DESIGNATION The microorganism identified under I above was accompanied by: I X I a scientific description T 1 a proposed ca.κonomιc designation (mark with a cross wnere applicable. III. RECEIPT AND ACCEPTANCE This International Depositary accepts tne microorganism identified under I aoove, wnich was received cy it cn Wednesday, 11 October 1995 (date of the original deposit) ' IV. RECEIPT OP REQUEST FOR CONVERSION The microorganism identified under Z aoove was received by this International Depositary Authority or. not applicable ,date of the original deposit! and a request to convert tr.e original deposit c_ a deposit under the Budapest Treaty was received it on not applicable idaεe of receipt of request for conversion/ V . INTERNATIONAL DEPOSITARY AUTHORITY Centraalbureau voor Schimmelcultures Signature's) cr person(≤ι having the power :z represent tr.e International Depositary Autnority or of authorized official <sι: -άdress: Oosterstraat 1 drs F.M. van Asma P.O. Box 273 ■ ) - C7 rάs-≡-=---. dr M.C Agterberg 3740 AG BAARN The Netherlands Date : Mondav, 30 October 1995 ' .. ' nere r.uie .i :-l applies, sucr. za ".e _at tr. wnicn tr.e status '.ternationai -epos tary -ut.-.cr ty was acαuireo. r orτ, EF'-J soie page) Pπmalco Ltd, Biotec Valta-akseli .=5_eα o-rsuar.t ;: 05200 Raiamaki C? ZT. Finland .oentι: eo o- oaαe r.ame ar.a aaaress c: tr.e a Jnom ■ laoil ty statement ueα Indicate tr.e da e ot t-.e cri-ma. deposit :r wnere a e deposit z: transrer -as oeen the most recent relevant αate αate or tr.e new deposit tr date z z tr.e trar.sre i . tr.e cases reterreα tt tne -lost :abi-_: .arκ acp-i -orm BP - rst page' IV . CONDITIONS UNDER WHICH THE VIABILITY HAS BEEN PERFORMED V . INTERNATIONAL DEPOSITARY AUTHORITY Mane : Centraalbureau voor Schimmelcultures Signature is) of person is) having the power to I represent the International Depositary I Authority or of authorized o ficial (s) : I I Address : Oosterstraat 1 drs F.M. van Asma i P.O. Box 273 dr .C. Agterberg 3740 AG BAARN The Netherlands :a e : Mondav, 30 October 1995 :he mtormacion nas Dsβn requested and f the results or the test were negative. :r c? ■ ' INDICATIONS RELATING TO A DEPOSITED MICROORGANISM \. The inaicaiions maαe below relate 10 the microorganism rcserreα to in the αescπption υn page line 12 - 14 B. IDENTIFICATION OF DEPOSIT Further oeposus arc identified on an additional sheet I y J Name ol deposuarv institution Centraalbureau voor Schimmelcultures Address of depositary institution t including posiat coae ana counin./ Oosterstraat 1 P.O. Box 273 3740 AG BAARN The Netherlands Date ot deposit Accession Numoer 12 Oc t ober 1995 CBS 688 . 95 C ADDITIONAL INDICATIONS Heave olanκ it not appticaotei This intormation is continued on an additional sheet EP The microorganism shall be made available as provided in Rule 28(3) and 28(4) of the implementing regulations of EPC. FI The microorganism shall be made available as provided in Finnish I Patent Law 22 § 7. I Enclosed recognition of receipt and viability statement i D DESIGNATED STATES FOR WHICH INDICATIONS A RE NUDE (if the aicaiions are not lor ail designatea States, E SEPARATE FURNISHING OF INDICATIONS ileaie otann u not aopiicaote, The inaicaiions listed below will be suomiπcα to ine iniemaiionai Bureau later isoeari' the general nature ot tne truncations e g \ umoer oi Deposit ) ihe International Bureau υn Primalco Ltd, Biotec .--I C?.I3I"J-J DΞFCS Valta-akseli :Ξsueα curs ar.t 1 cy cr.e 05200 Rajamaki Finland ~ c: -.-. s page name ana aaaress :z zeposizzr IDENTIFICATION OF THE MICROOROANISM denciπcaticn rererence given cy -.ie Accession nutiDer given cy the EPOSITDR: INTERNATIONAL DEPOSITARY AUTHORITY: ALK04125 CBS 688.95 II . SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under I above was accompanied by: I X I a scientific description a proposed caκonomic esignaticr. tmarx. with a cross where applicable: III. RECEIPT AND ACCEPTANCE is International Depositary accepts tr.e -tic.roorgamsm lαentitieα unαer I apove, wnicn was received cy it =n Thursday, 12 October 1995 (date of the original deposit : ' IV . RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under I aoove was received by tnis International Depositary Authority on not applicable idate of the original deposit) and a request to convert the original deposit to a deposit under the Budapest Treaty was received z. t on not applicable .date of receipt f request for conversion: V . INTERNATIONAL DEPOSITARY AUTHORITY .lame : Centraalbureau voor Schimmelcultures -igr.ature ' s i _ ; cersonisi r.aving tne power tt represent tr.e I.-.ternaticna- Depositary Aut cr y tr t: aut.ncrι_eα of icial's: : Address: Oosterstraat 1 drs F.M. van Asma P.O. Box 273 Jr M.C. Agterberg 3740 AG BAARN The Netherlands Da t : Monday, 30 October 1995 VJhere Rule i.Aidi applies, sucr. tne status c: international deposicary autnority was accuir; : m c.-/ i soie pag i ' Primalco Ltd Biotec Valta-akseli 05200 Rajamaki Finland -aτιe α-c aaaress cz ~~e laci..:. stateme" JSUS- I. DEPOSITOR II. IDENTIFICATION OF THE MICROORGANISM I :ame Pπmalco Ltd, Biotec Accessj.cn -_-.Der -.,en z t-e :rrE°_iATioiiAL DEPOSITOR/ -JT U ORITY CBS 688.95 Aαdress Valta-akseli 05200 Rajamaki Date or the αeposit or cr the transrer Finland Thursday, 12 October 1995 III . VIABILITY STATEMENT τl ~e vi.Dii.:, cr tne ir-crcorgamsii ιαent.:..α -αer II aoove was -estec c Thursday, 19 October 1995 - - --at cat-: --e saiα -ucrcσrαar_s-ι j s Hj n- .onσer -ao»e nd.cate t-e αate or t-e or.α.-ai -eDOsit rr wnere a -»w αeDosit _r a -ra-si -as ceen "e Tiost recent relevant .ace nate cr t-e new αepcs_t tr αate _r t-e tra-sr= t-e cases rere: -os: recent ιao : 'ar . w.t- a ■ -= axi.caci- re- IV. CONDITIONS UNDER WHICH THE VIABILITY HAS BEEN PERFORMED INTERNATIONAL DEPOSITARY AUTHORITY Na e : Centraalbureau voor Schimmelcultures Signatureis) or psrsonisi having tne power tc represent the International Depositary Autnority or of authorized official Is I : Address : Oosterstraat 1 - . i d αrrss F r..MM.. v vaann A Λssmmaa P.O. Box 273 VO C j > - dr M.C. Agterberg 3740 AG BAARN The Netherlands Dat e : Monday, 30 October 1995 -e lr.rormation nas ceen requested ana if t e results the test were negati-. : cr:n E? =ecoπα aπα last cage ι INDICATIONS RELATING TO A DEPOSITED MICROORGANISM ( PCT Rule l lbts [> DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if tne maicaiions arc not lor ail designatea States, E SEP ARATE FURNISHING OF INDICATIONS neaxe oιanκ ,ι not aopticaoiei The inaicaiions listeα below will be suomiπed to ine intemauonal Bureau later tstxctn tne genera, nature ol me truncations e g . umoer ot Deposit ) : or Intemauonal Bureau use D This sneet was rcceivtu b ihe Intemauonal Bureau un λuitioπzeα otiiccr Primalco Ltd, Biotec Valta-akseli 05200 Raiamaki Finland zame ar.c zress z: zeoositz IDENTIFICATION OF THE MICROORGANISM .αent iti: :r. rererence given rv tr.e AccessICΓ. r.uir.per given cy the .EP03IT3K: ::.TEK:ATIC.IAL DEPOSITARY AUTHORITY: ALKQ4265 CBS 730.95 II . SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under Z above was accompanied by. a sciencific descr pcion I X I a proposed caxonomic designation i arx witn a cross wnere applicacle. III. RECEIPT AND ACCEPTANCE Th s Interna ional -.eposicary acceccs zr.e micro: rgar.isπ lαencmeα unαer . aoove, nicn '«as recei ed =y :. o Wednesday, 8 November 1995 <date cf tne original deposit ' IV. RECEIPT OF REQUEST FOR CONVERSION The microorganism lαentiried under Z aoove was received cy cms International Deposicary Authority cr. not applicable ,date cf the original deposit) ana a request to ccnvert the original deposit to a deposit unαer tr.e Budapest Treaty was received t on not applicable -date cf receipt zf request for conversion: V . INTERNATIONAL DEPOSITARY AUTHORITY Centraalbureau voor Schimmelcultures . cnature < s> tersor. is r.avmg tr.e power ϊcrese.nt .-.ι .ernacior.ai Depositary -tr.cπtv tr sutr.or teα c-f πal i s i : ;εs: Oosterstraat 1 drs F.M. van Asma P.O. Box 273 dr M.C. Agterberg 3740 AG BAARN The Netherlands 1995 Where ? z . -t izt aopiιe= . ; .i status -scosi: autnority was ac_ scie oaαe i Primalco Ltd. Biotec Valta-akseli 05200 Raiamaki Finland - ^caress oz t-e oar . cm ■ -acil-z statement . sueα DEPOSITOR II. IDENTIFICATION OF THE MICROORQANISM lame- Pπmalco Ltd, Biotec .-.ccassj.cn -jmcer given pj ne ::;TΞP.JNATIC.IAI, ;E?CS:T.--.' -JTHC-ITY CBS 730.95 Aααress. Valta-akseli 05200 Rajamaki Dace or e αeDosic cr cr the cransrer: Finland Wednesday, 8 November 1995 III. VIABILITY STATEMENT he vιaDi_-C c∑ :ι. -iicrcorαam cenc r.eα -inαer -. aDove was cesceα - Mondav, 20 November 1995 1 crac cace tr.e saiα -iicr orcar.-sn «as -o - nσer -.aoie ..-.αicac- c-e αace c: .-- cr.: 1-c.s.: cr vnere 3 new αeicosic cr a cransrer nas Deen -aα€ r.ne nos recenc re.evar; ar * :e :: ere new αeDOs.. cr .ace cr ere -ransrer .-. cr.e cases r.rerreα c- " _._ _ _ a ~e -os. r cerc -acii-t *ar iC- - : cp-. IV. CONDITIONS UNDER WHICH THE VIABILITY HAS 3EEN PERFORMED INTERNATIONAL DEPOSITARY AUTHORITY Mame : Centraalbureau voor Schimmelcultures signature ιsι cr person(si having tne power represent tr.e Incernacionai Deposicary Auchoricy cr of auchcriced official Is) : Address : Oosterstraat 1 drs F.M. van Asma P.O. Box 273 3740 AG BAARN The Netherlands £^ dr M.C. Agterberg Dae e : Mondav, 20 November 1995 ".as cee requested ar.c :: tr.e results cr tr.e test vere negative. INDICATIONS RELATING TO A DEPOSITED MICROORGANISM ( PCT Rule \ jbιsι Date oi dcposn Acc ssion Numoer 2 1 June 1 996 DSM 1 1024 C ADDITIONAL INDICATIONS (leave olann a not aopucaolei This iniormaiion is continued on an additional sneei ( I EP The microorganism shall be made available as provided n Rule 28(3) and 28(4) of the implementing regulations of EPC . i FI The microorganism shall be made available as provided in Finnish Patent Law 22 § 7. ι Enclosed recognition of receipt and viability statement 1 D DESIGNATED STATES FOR WHICH INDICATIONS -.RE NUDE ul me maicaiions are not lor ail aesignaiea States, E SEPARATE FURNISHING OF INDICATIONS ileaie o,anκ n noi aopucao < The inaicaiions listed below will be suommeα 10 ine Iniemaiionai Bureau αiα t oec r ne genera, nature oi me maicanυns e t ' ' umoer oi Deposit < ■ it lniLmauonal Bureau use I ' his sne.i «as receu eu the intemauonal Bureau υn -. inoπzeα otn.α . rn l'< τ »< ) I > » ι I "' )"1 ) BUDAPEST TRE ATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATION AL TORM Primalco Ltd. 3ιotec Valta-Akseli FIN-05200 aiamaki RECEIPT TN THE C ASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7 I bv the INTERNATIONAL DEPOSITARY \UTHORITY identified at the bottom ot this page I IDENTIFICATION OF THE MICROORGANISM Identification reference given bv the DEPOSITOR Accession number given bv the INTERNATIONAL DEPOSITARY AUTHORITY pALK1221 DSM 11024 II SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under I above was accompanied bv (X ) a scientific description ( ) a proposed taxonomic desi nauon (Mark with a cross where applicable) III RECEIPT AND ACCEPTANCE This International Deposiiarv Authoritv accepts the microorganism identified under I above which was received bv tt on 1 9 96 - 0 6 - 2 1 (Date ot the original deposit) IV RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under i above was received bv this International Depositary Authoritv on (date ot original deposit) and a request to convert the original deposit to a deposit under die Budapest Treatv was received bv it on (date ot receipt ot request for conversion i V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE SAMMLUNG VON Signaturels) ot person! s) havins the power to represent the MIKROORGANISMEN UND ZELLKULTUREN GmbH International Deposiiarv Authoritv or ot authorized otfιcιal(S) Address Mascheroder Wee i b D-38124 Braunschweiε U. c --- "«£- Date 1996 - 06 - 27 Where Rule 6 4 (d) applies such date is die date on which the status ot international depositary authoritv was acquired BUDAPEST TRE ATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORG \NISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Pπmai cc Lt d . B iot ec Valta - Aksel i F I - 052 00 Raj amaki VIABILITY STATEMENT issued pursuant to Rule 10 2 bv the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page Indicate the date ot original deposit or where a new deposit or a uanster has been maαe. the most recent relevant date (date ot the new deposit or date ot die transterl In the cases reterred to in Rule 10 2(a) In) and (ml. reter to the most recent viability test Mark with a cross the anphcable box ' Fill in if die intormation has been requested and it die results ot the test were negative Form DSMZ-BP/9 (sole page) 0196 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM ( PCT Rule \ 2bts ) A. The indications maαe Below relate to the microorganism reterreα 10 in tne description on page 9 ne - 9-22 B. IDENTIFICATION OF DEPOSIT Fuπher deposits are identified on an additional sheet |γ | Name ot αeϋositarv institution DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GmbH Address ot depositary institution /including postal coae ana country/ Mascheroder Weg lb D-38124 Braunschweig Date ot deposit Accession Numoer 2 1 June 1 996 DSM 1 10 12 C. ADDITIONAL INDICATIONS /leave blann it not appacaolei This information is continued on an additional sheet |X | EP The microorganism shall be made available as provided in Rule 28 ( 3 ) and 28 ( 4 ) of the implementing regulations of EPC . FI The microorganism shal l be made available as provided in Finnish Patent Law 22 § 7 . Enc losed recognition of receipt and viability statement D. DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if the maicaiions are not lor ail designatea States/ E. SEPARATE FURNISHING OF INDICATIONS otanκ if not aopucaoiei The indications listed below wul be suDmiπeα to tne International Bureau later tsixciH the genera, narure oi tne inaicanons e g \ moer oi Deposit " ) For reccivine Office use oπlv Tor Intemauonal Bureau use oniv E This sneet was received with the international application I j This sheet was rcceneα bv the International Bureau υn Authorized otficer orm H(_T RD' l iJ Uul . I 'W) BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM PriTiaicc Ltd . Biotec Valta -Akseli FIN-05200 Ranamaki RECEIPT IN THE C ASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7 1 bv the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page I IDENTIFICATION OF THE MICROORGANISM Identification reference aiven bv the DEPOSITOR Accession number given bv the INTERNATIONAL DEPOSITARY AUTHORITY lamoda 4237/5.1 DSM 11012 II SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism idenufied under I above was accompanied bv (X ) a scientific description ( ) a proposed laxonomic designation (Mark with a cross where applicable) III RECEIPT AND ACCEPTANCE This Intemauonal Deposiiarv Authoritv accepts the microorganism identified under 1 above which was received by it on 1 9 9 6 - 0 6 - 2 1 (Date of the original deposit)' IV RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under 1 above was received bv this International Depositarv Authority on (date ot original deposit) and a reαuest to convert the onginal deposit to a deposit under the Budapest Treatv was received by it on (dale ot receipt ot request for conversion) V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE S AMMLUNG VON Siεnaturets) ot person(s) having the power to represent the MIKROORGANISMEN UND ZELLKULTUREN GmbH International Deposiiarv Authoritv or of authorized official! si Address Mascheroder Weg l b D-38124 Braunschweie (/. ^ ^ Date 1996 - 06 - 27 Where Rule 6 4 (d) applies such date is the date on which the status ot international depositarv authoritv was acquired Fnrm n<;M7.nP/-l fsnle na-el 019ft BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Primalco Ltd. Bictec Valta-Akseli FIN-05200 Raπamaki VIABILITY STATEMENT issued pursuant to Rule 10 2 by the INTERNATIONAL DEPOSITARY AUTHORITY idenufied at the bottom ot this page Indicate the date ot original deposit or. where a new deposit or a transfer has been made, the most recent relevant date (date ot the new deposit or date ot the transfer) In the cases referred to in Rule 10 2(a) (in and i nn. refer to the most recent viabilitv test Mark with a cross the applicable box ' Fill in if the information has been requested and if the results ot the test were negative Form DSMZ-BP/9 (sole page) 0196 IND ICATIONS RELATING TO A DEPOSITED MICROORGANISM ( PCT Rule ϊ z ' bts Mascheroder Weg lb D-38124 Braunschweig Date oi deposit Accession Nu oer 2 1 June 1996 1 1025 C. ADDITIONAL INDICATIONS (leave oiank u not appticaolei This iniormation is continued on an additional sneei |X EP The microorganism shall be made available as provided in Rule 28(3) and 28(4) of the implementing regulations of EPC. FI The microorganism shall be made available as provided in Finnish Patent Law 22 § 7. Enclosed recognition of receipt and viability statement D. DESIGNATED STATES FOR WHICH INDICATIONS ARE NUDE (ti e maicaiions are not lor a/1 aesignaiea Slates, E. SEPA RATE FURN ISHING OF INDICATIONS σιanκ ,ι not aopiicace, The indications listed below wul be suomirteα io n; Iniemaiionai Bureau later i pec.r. ine genera, nature ot e truncations e v \ nmoer ot Deposit") or inicmauon i Bureau use D ϊhib sne.i w as rcceiM'u π - ihe International Bureau υn Auinoπzeα oϋiccr BUDAPEST TREATY ON THE INTERNATION AL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF P ATENT PROCEDURE INTERN ATIONAL FORM Primalcc _ . 3iocec Valca-Akseli FIN-C5200 Raiamaki RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7 1 bv the INTERNATIONAL DEPOSITARY AUTHORITY identified at the boπom ot tins page I IDENTIFICATION OF THE MICROORGANISM Identification reference given bv the DEPOSITOR Accession number given bv the INTERNATIONAL DEPOSITARY AUTHORITY PALK1227 DSM 11025 II SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under I above was accompanied by (X ) a scientific descπption ( ) a proposed taxonomic designation (Mark with a cross where applicable) III. RECEIPT AND ACCEPTANCE This International Deposiiarv Authorirv accepts the microorganism identified under I above, which was received bv it on 1 9 9 6 - 0 6 - 2 1 (Date of die original deposit)' IV RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under 1 above was received bv this International Depositarv Authoritv on (date of original deposit) and a request to convert the original deposit to a deposit under die Budapest Treatv was received bv it on (date ot receipt ot request for conversion) V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE SAMMLUNG VON Sienarureis) ot persoms) having the power to represent the MIKROORGANISMEN UND ZELLKULTUREN GmbH International Depositarv Authority or of authorized official! s I Address Mascheroder Weg l b D-38124 Braunschweie Date. 1996 - 06 - 27 Where Rule 6 4 (d) applies, such date is the date on which the status ol international depositarv audioπrv was acquired nrιi7 BUDAPEST TRE.ATΥ ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORG ANISMS FOR THE PL POSES OF PATENT PROCEDURE INTERNATIONAL FORJM Pππa o Ltd . Biotec Valta -Akseli FIN- 05200 Rai amaki V IABILITY STATEMENT issued pursuant to Rule 10 2 bv the INTERNATIONAL DEPOSITARY AUTHORITY identified at die bottom ot this page Indicate the date ot original deposit or where a new deposit or a transfer has been made, the most recent relevant dale (date ot the new deposit or date ot the transfer) in die cases reterred to in Rule 10 2(a) (n) and ( in), reter to die most recent viabilitv test Mark with a cross the applicable box Fill in it the information has been reαuested and it the results ot the test were neεauve Form DSMZ-BP 9 (sole page) 0196 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM E SEPARATE FURNISHING OF INDICATIONS neaie oιanκ u not aoDiicaoiei The indications listed below wul be uomirtcα 'o me Iniemaiionai Bureau ι_ιer ispecm tnegenerai nature oi ine matcanons e g , cession . iimoer ot Deposit ) For receivine Olfice use oniv, 1 or Iniemaiionai Bureau ub>e υnl. \X \ This sneet was received with the international aopiication j This sheet was recei ed bv ihc Intemauonal Bureau un Autnoπzed otlicer l'( 1 Rt) I >4 iJulv I '»•<-> i BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORiM Primalco Ltd. Biotec Valta-Akseli FIN-05200 Raiamaki RECEIPT IM THE CASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7 1 by die INTERNATIONAL DEPOSITARY AUTHORITY identified at die bottom ot this page I. IDENTIFICATION OF THE MICROORGANISM Identification reference given bv die DEPOSITOR Accession number given bv the INTERNATIONAL DEPOSITARY AUTHORITY lambda 4237/35 DSM 11014 II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism idenufied under I. above was accompanied by (X ) a scientific description ( ) a proposed taxoπomic designation (Mark with a cross where applicable) III. RECEIPT AND ACCEPTANCE This International Depositary Authoritv accepts the microorganism identified under I above, which was received by it on 1 9 96 - 0 6 - 2 1 (Date of die original deposit)' IV RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under I above was received by tins International Depositarv Authorirv on (date ot original deposit) and a request to convert die original deposit to a deposit under die Budapest Treatv was received bv it on I date ot receipt ot request for conversion) V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE SAMMLUNG VON Signature! s) ot person! si having the power to represent the MlKROORG-\NISMEN UND ZELLKULTUREN GmbH International Depositarv Authoritv or ot authorized orficιal(s| Address Mascheroder Weg I b D-38124 Braunschweig c . Date 1996 - 06 - 27 1 Where Rule 6.4 (d) applies, such date is die date on which the status ol international depositarv authorirv was acquired Form DSMZ-BP/4 (sole page) 0196 BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Primalco Ltd. Biotec Valta-Akseii FIN-05200 Rajamaki VIABILITY STATEMENT issued pursuant to Rule 10.2 by the INTERNATIONAL DEPOSITARY AUTHORITY Identified at die bottom of this page I. DEPOSITOR II. IDENTIFICATION OF THE MICROORGANISM Name. Primalco Ltd . Biotec Accession number given by die Valta-Akseli INTERNATIONAL DEPOSITARY AUTHORITY Address: DSM 11014 FIN-05200 Rajamaki Date of die deposit or the transfer': 1996 - 06 - 21 III. VIABILITY STATEMENT The viability of the microorganism identified under II above was tested on 1 9 9 6 - 06 - 24 On that date, die said microorganism was (X) J viable ( )' no longer viable (v. CONDITIONS UNDER WHICH THE VIABILITY TEST HAS BEEN PERFORMED 4 V. INTERNATIONAL DEPOSITARY AUTHORITY Name. DSMZ-DEUTSCHE SAMMLUNG VON Signamre(s) of person(s) having the power to represent die MIKROORGANISMEN UND ZELLKULTUREN GmbH International Depositarv Authonty or of authorized officialls) Address: Mascheroder Weg lb D-38124 Braunschweie ( . ?U Z Date: 1996 - 06 - 27 Indicate the date of original deposit or. where a new deposit or a transter has been made, die most recent relevant date (date of die new deposit or date of die transter) In die cases reterred to in Rule 10.2(a) (ul and mil. refer to die most recent viabilitv test. Mark with a cross the applicable box Fill in if the mtormation has been requested and if die results of the test were negative Form DSMZ-BP/9 (sole page) 0196 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM λ. The inaicaiions maαe below relate to ihe microoreanism relcrτcd to in me αescπption on paec 9 and 10 line 28-30, 1-4 B. IDENTIFICATION OF DEPOSIT Further αeoosns arc identified on an additional sheet , I Name ol αeDosuarv institution DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGA ISMEN UND ZELLKULTUREN GmbH Address ot depositarv institution iinciuaing postal coae ana coumrvi Mascheroder Weg lb D-38124 Braunschweig Date oi deposit Accession Numoer 21 June 1996 11026 C. ADDITIONAL INDICATIONS lleave olanκ it not aopiicaolei This iniormation is, continued on an additional sneei JX EP The microorganism shall be made available as provided in Rule 28(3) and 28(4) of the implementing regulations of EPC . FI The microorganism shall be made available as provided in Finnish Patent Law 22 § 7. Enclosed recognition of receipt and viability statement D. DESIGNATED STATES FOR WHICH INDICATIONS ARE WADtttfihe aicaiions are noi lor atl designatea Mates, E. SEP-.RATE FURNISHING OF INDICATIONS r/eαv. oiant u not aopucaoie, The inaicaiions listed below wul be submiπcα to ine iniemaiionai Bureau later ispecm- tne genera, nature oi ihe maications e υ v-icioer oi Deposit ' i nr Iniemaiionai Bureau u_ > e υnlv j ! This sheet was rccei eu ihe International Bureau υn -.uihoπzed olliccr !'< . U< 1 I . I I lulv I 'i'l 1 ! BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FOR.M Pr ialco Ltd. Biotec Vaita-A seli FIN-G5200 Rajamaki RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7.1 by ihe INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page I. IDENTIFICATION OF THE MICROORGANISM Identification reference given bv die DEPOSITOR Accession number given by die INTERNATIONAL DEPOSITARY AUTHORITY pAL,K.1229 DSM 11026 II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMJC DESIGNATION The microorganism identified under I. above was accompanied by (X ) a scientific description ( ) a proposed taxonomic designation (Mark with a cross where applicable) III. RECEIPT AND ACCEPTANCE This intemauonal Depositary Authority accepts die microorganism identified under I. above, which was received by it on 1 9 9 6 - 0 6 - 2 1 (Date ot the oπginal deposit)' IV. RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under I above was received by this Intemauonal Depositary Authorirv on (date of original deposit) and a request to convert die original deposit to a deposit under die Budapest Treaty was received by it on (date ot receipt of request for conversion) V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE SAMMLUNG VON Signatureis) ot personls) having die power to represent the MIKROORGANISMEN UND ZELLKULTUREN GmbH international Depositarv Auuiorirv or ot authorized orficiallsl Address Mascheroder Weg I b D-38124 Braunschweie Date. 1996 - 06 - 27 Where Rule 6 4 (d) applies, such date is die date on which die status ot iniemaiionai depositarv authoritv was acquired Form DSMZ-BP/4 (sole raeel 0196 BUDAPEST TRE VTY ON THE INTERNATIONAL RECOGNITION OF TOE DEPOSIT OF MICROORG ANISMS FOR THE PURPOSES OF PVTT-YT PROCEDURE INTERNATIONAL FORM Primalco Ltd. 3ιctec Valta-Akseli FI -05200 Raiamaki VIABILITY STATEMENT issued pursuant to Rule 10 2 bv die INTERNATIONAL DEPOSITARY AUTHORITY identified at die bottom ot this page I DEPOSITOR II IDENTIFICATION OF THE MICROORGANISM Name Primalco Ltd . Biotec Accession number given bv the Valta -Aksel i INTERNATIONAL DEPOSITARY AUTHORITY Address DSM 11026 FIN- 05200 Raj amaki Date of die deposit or die transter' 1996 - 06 - 21 III. VIABILITY STATEMENT The viabilitv of the microorganism identified under II above was tested on 1 9 9 6 - 0 6 - 2 6 On dial date, die said microorganism was (X)' viable ( )' no longer viable IV CONDITIONS UNDER WHICH THE VIABILITY TEST HAS BEEN PERFORMED' V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE SAMMLUNG VON Signature! s ) ot personls) having die power to represent die MIKROORGANISMEN UND ZELLKULTUREN GmbH International Depositarv Authorirv or ot authorized officιal(s) Address Mascheroder Weg lb D-38124 Braunschweig Date 1996 - 06 - 27 indicate die date ot original deposit or. where a new deposit or a transter has been made the most recent relevant date (date ot die new deposit or date ot die transter) In die cases referred to in Rule 10 2(a) (n) and ( in), reter to die most recent viabilitv test Mark with a cross die applicable box Till in if die lnlormation has been requested and if die results ot die test were negative Form DSMZ-BP/9 (sole page) 0196 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM Tne inaicaiions made below relate 10 the microoreanism rcicrred 10 in ihe oescripuon on page 9 and 10 l, nc _ 29 , 1 -4 B. IDENTIFICATION OF DEPOSIT Further oeposns are identified on an additional sheet | γ [ Name oi dcDOsuarv institution DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GmbH Address OI deposiiarv institution r including postal code ana country i Mascheroder Weg lb D-3812-ι Braunschweig Date oi deoosn Accession Numoer 2 1 June 1 996 1 101 1 C. ADDITIONAL INDICATIONS llecrve oianK if not appucaolei This iniormauon is continued on an additional sheei lχ i EP The microorganism shall be made available as provided in Rule 28(3) and 28(A) of the implementing regulations of EPC. FI The microorganism shall be made available as provided in Finnish I Patent Law 22 § 7. 1 Enclosed recognition of receipt and viability statement I D DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (it tne maicaiions are not lor ail designatea States, I E SEPA RATE FURNISHING OF INDICATIONS tleaie otanκ u not aopticaoie/ The inaicaiions listed below will be submiπeα to ihe Iniemaiionai Bureau later ispecm the general nature ot the truncations e g numoer pi Deposit / ■ or Iniemaiionai Bureau uie onlv I This sheei was rcceiv eα fiv ihe Iniemaiionai Bureau υn λuinoπzeα olficer .irm l'( 1 R O I 4 l iulv I 'W. ) BUDAPEST TRE AT 1 ! ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Primalco Ltd. Biotec Valta-Akseli FIN-05200 Rajamaki RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7 1 bv the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page I IDENTIFICATION OF THE MICROORGANISM Identification reference given bv the DEPOSITOR Accession number given bv the INTERNATIONAL DEPOSITARY AUTHORITY lambda 4237/3 DSM 11011 II SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under I above was accompanied by (X ) a scientific description ( ) a proposed taxonomic designation (Mark with a cross where applicable) HI RECEIPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above which was received bv it on 19 9 6 - 0 6 - 2 1 (Date ot the original deposit) 1 rv RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under I above was received bv this Intemauonal Depositarv Authoritv on (date of original deposit) and a request to convert the original deposit to a deposit under the Budapest Treatv was received bv it on (date ot receipt ot request for conversion) V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE SAMMLUNG VON Signarurelsl ot personls) having the power to represent the MJKROORGiANISMEN UND ZELLKULTUREN GmbH Intemauonal Depositary Authoritv or ot authorized otTιcιal(s) Address Mascheroder Weg I b D-38124 Braunschweiε U. t ^ r> Date 1996 - 06 - 27 Where Rule 6 4 (d) applies such date is the date on which the status ot international depositarv authoritv was acquired Form DSMZ-BP/4 (sole page) 0196 BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Primalco Ltd. Biotec Valta-Akseli FIN-05200 Rajamaki VIABILITY STATEMENT issued pursuant to Rule 102 bv the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom of this page ' Indicate the date ot original deposit or. where a new deposit or a transter has been made, the most recent relevant date (date of the new deposit or date of the transfer) In the cases referred to in Rule 102(a) (n) and (in), reter to the most recent viabilitv test Mark with a cross the applicable box ' Fill in if the information has been requested and if the results ot the test were negative Form DSMZ-BP/9 (sole page) 0196 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM A. The indications made below relate to the microoreanism referred to in the description υn page 9 and 10 |, ne 30 . 1 -4 B. IDENTIFICATION OF DEPOSIT Further Deposits are identified on an additional sheet [A] Name ot dcDosiiarv institution DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGA ISMEN UND ZELLKULTUREN GmbH Address ot depositarv institution (including postal coae ana country i Mascheroder Weg lb D-3812A Braunschweig Date of dcposn Accession Numocr 2 1 June 1996 DSM 1 1013 C ADDITIONAL INDICATIONS (leave oiann ι/ noi aopticaole/ This inioπnation is connnued on an additional sneei |X EP The microorganism shall be made available as provided in Rule 28(3) and 28(4) of the implementing regulations of EPC. FI The microorganism shall be made available as provided in Finnish j Patent Law 22 § 7. i Enclosed recognition of receipt and viability statement 1 D DESIGNATED STATES FOR WHICH INDIC ATIONS ARE MADE (if the aicaiions are not lor at! designatea States, E SEP ARATE FURNISHING OF INDICATIONS nea e σιanκ ,ι not aopiicaote, The indications listed below will be suomiπeα lo in iniemaiionai Bureau laier ispecm tne genera, nature on he truncations e i \ iimner oi Deposit > l-or receivine Olfice use oniv or Iniemaiionai Bureau ube onlv CD This sneei was received with the iniemaiionai aooiicauon I I This sneei was receiv ed Bv ihe International Bureau un Autnoπzed olticer |'( ι I!O I <4 i lulv I W i BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Primalco Ltd. Biotec Valta-Akseli FIN-05200 Rajamaki RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT issued pursuant lo Rule 7.1 by the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page I. IDENTIFICATION OF THE MICROORGANISM Identification reference given by the DEPOSITOR: Accession number given by the INTERNATIONAL DEPOSITARY AUTHORITY: lambda 4237/18 DSM 11013 II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under I. above was accompanied by (X ) a scientific description ( ) a proposed taxonomic designation (Mark with a cross where applicable). III. RECEIPT .AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under 1. above, which was received by it on 1 9 9 6 - 0 6 - 2 1 (Date of the original deposit)'. IV. RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under I above was received by this International Depositarv Authonty on (date of original deposit) and a request to convert the original deposit to a deposit under the Budapest Treaty was received by it on (date of receipt ot request for conversion). V INTERNATIONAL DEPOSITARY AUTHORITY Name: DSMZ-DEUTSCHE SAMMLUNG VON Signatureis) of person(s) having the power to represent the MIKROORGANISMEN UND ZELLKULTUREN GmbH International Depositarv Authority or ot authorized offιciai(s) Address: Mascheroder Weg Ib D-38124 Braunschweie /. dJ Date: 1996 - 06 - 27 1 Where Rule 6.4 (d) applies, such date is the date on which the status ot international depositary authority was acquired. Torm DSMZ-BP/4 (sole page) 0196 BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF ICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Primalco Ltd. Biotec Valta-Akseli FIN-05200 Rajamaki VIABILITY STATEMENT issued pursuant to Rule 10 2 by the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page I DEPOSITOR II IDENTIFICATION OF THE MICROORGANISM Name Primalco Ltd . Biotec Accession number given bv the Valta-Akseli INTERNATIONAL DEPOSITARY AUTHORITY Address DSM 11013 FIN-05200 Rajamaki Date of the deposit or the transter 1 1996 - 06 - 21 III. VIABILITY STATEMENT The viability of the microorganism identified under II above was tested on 1996 - 06 - 24 On that date, the said microoreanism was (X)' viable ( )' no longer viable IV CONDITIONS UNDER WHICH THE VIABILITY TEST HAS BEEN PERFORMED' V INTERNATIONAL DEPOSITARY AUTHORITY Name DSMZ-DEUTSCHE SAMMLUNG VON Sιgnature(s) of person(s) having the power to represent the MIKROORGANISMEN UND ZELLKULTUREN GmbH IniemauonaJ Depositarv Authority or of authorized orfιcιai(s) Address Mascheroder Weg lb D-38124 Braunschweig tS„ ^ώ ^) Date 1996 - 06 - 27 Indicate the date ot original deposit or where a new deposit or a transter has been made, the most recent relevant date (date oi the new deposit or date of the transter) In the cases referred to in Rule 10 2(a) (n) and (in), refer to the most recent viabilitv test Mark with a cross the applicable box Fill in if the information has been requested and if the results ot the test were negative Form DSMZ-BP/9 (sole page) 0196 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM E SEPARATE FURNISHING OF INDICATIONS linage o,anκ u not aopticaote. The inαications listed below wul be suommeα IO 'flc iniemaiionai Bureau later ispecm ihe genera, nature ot tlie truncations e g \ nmoer oi Deposit i or Iniemaiionai Bureau use υnlv j i This sneei was receiv eu bv the Iniemaiionai Bureau on Auinoπzeα olticcr BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORGANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM Primalco Ltd. Biotec Valca-Akseii FIN-05200 Raiamaki RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7 1 by the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page I. IDENTIFICATION OF THE MICROORGANISM Identification reterence given by the DEPOSITOR Accession number given by the INTERNATIONAL DEPOSIT/VRY AUTHORITY pALK123 0 DSM 11027 II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMIC DESIGNATION The microorganism identified under I. above was accompanied by (X ) a scientific description ( ) a proposed taxonomic designation (Mark with a cross where applicable). III. RECEIPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above, which was received by it on 1 9 9 6 - 0 6 - 2 1 (Date of the original deposit) 1 IV. RECEIPT OF REQUEST FOR CONVERSION The microorganism identified under I above was received by this international Depositary Authoritv on (date ot original deposit) and a request to conveπ the original deposit to a deposit under the Budapest Treaty was received bv it on (date ot receipt ot request for conversion ι. V INTERNATIONAL DEPOSITARY AUTHORITY Name: DSMZ-DEUTSCHE SAMMLUNG VON Signaturets) ot personls) having the power to represent the MIKROORGANISMEN UND ZELLKULTUREN GmbH International Depositary Authoritv or ot authorized official! s i Address Mascheroder Wee l b D-38124 Braunschweie (J„ Ci^^r ^ Date 1996 - 06 - 27 ' Where Rule 6 4 (d) applies, such date is the date on which the status ot international depositarv authorirv was acquired Form DSMZ-BP/4 (sole page) 0196 BUDAPEST TREATY ON THE INTERNATIONAL RECOGNITION OF THE DEPOSIT OF MICROORG ANISMS FOR THE PURPOSES OF PATENT PROCEDURE INTERNATIONAL FORM PriT.alcc Ltd. Biotec Valta-Akseli FIN-Q5200 Rajamaki VIABILITY STATEMENT issued pursuant to Rule 102 bv the INTERNATIONAL DEPOSITARY AUTHORITY identified at the bottom ot this page Indicate the date ot original deposit or where a new oeposit or a transter has been made, the most recent relevant date (date ot the new deposit or date of the transfer! In the cases retened to in Rule 10 2(a) (n) and (in) reter to the most recent viability test Mark with a cross the applicable box Fill in it the information has been requested and if the results ot the lest were negative Form DSMZ-BP/9 (sole page) 0196

Claims: CLAIMS 1. A nucleic acid molecule encoding a polypeptide having the enzymatic activity of a cellulase, selected from the group consisting of: (a) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence as depicted in Figure 19 or 21 ; (b) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence as depicted in Figure 23 or 27; (c) nucleic acid molecules comprising the coding sequence of the nucleotide sequence as depicted in Figure 19 or 21; (d) nucleic acid molecules comprising the coding sequence of the nucleotide sequence as depicted in Figure 23 or 27; ( e) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence encoded by the DNA insert contained in DSM 11024, DSM 11012, DSM 11025 or DSM 11014; (f) nucleic acid molecules encoding a polypeptide comprising the amino acid sequence encoded by the DNA insert contained in DSM 1 1026, DSM 1 101 1, DSM 11013 or DSM 11027; ( g) nucleic acid molecules comprising the coding sequence of the DNA insert contained in DSM 11024, DSM 11012, DSM 11025 or DSM 11014; (h) nucleic acid molecules comprising the coding sequence of the DNA insert contained in DSM 11026, DSM 11011, DSM 11013 or DSM 1 1027; ( i) nucleic acid molecules hybridizing to a molecule of any one of (a), (c), (e) or (g); and (j) nucleic acid molecules the coding sequence of which differs from the coding sequence of a nucleic acid molecule of any one of (a) to (i) due to the degeneracy of the genetic code, (k) nucleic acid molecules encoding a polypeptide having cellulase activity and having an amino acid sequence which shows at least 80 % identity to a sequence as depicted in Figure 19, 21, 23 or 27. 2. The nucleic acid molecule of claim 1 which is RNA. 3. The nucleic acid molecule of claim 1 which is DNA. 4. The DNA of claim 3 which is genomic DNA or cDNA. 5. A vector containing a nucleic acid molecule of any one of claims 1 to 4. 6. The vector of claim 5, in which the nucleic acid molecule is operably linked to expression control sequences allowing expression in prokaryotic or eukaryotic host cells. 7. A host cell transformed with a nucleic acid molecule of any one of claims 1 to 4 or with a vector of claim 5 or 6. 8. The host cell of claim 7 which belongs to filamentous fungi. 9. The host cell of claims 7 to 8 which belongs to the genus Trichoderma or Aspergillus. 10. The host cell of claim 9 which is Trichoderma reesei. 1 1. A process for the production of a polypeptide having cellulase activity comprising the steps of culturing the host cell of any one of claims 7 to 10 and recovering the protein from the culture medium. 12. A polypeptide having cellulase activity encoded by a nucleic acid molecule of any one of claims 1 to 4, a vector of claim 5 or 6 and obtainable by the process of claim 1 1. 13. An antibody specifically recognizing the polypeptide of claim 12. 14. An oligonucleotide specifically hybridizing to a nucleic acid molecule of any one of claims 1 to 4. 15. A process for the preparation of an enzyme preparation comprising a polypeptide of claim 12 comprising the steps of culturing a host cell of any one of claims 7 to 10 and either recovering the polypeptide from the cells or separating the cells from the culture medium and obtaining the supernatant. 16. An enzyme preparation obtainable by the process of claim 15. 17. An enzyme preparation comprising at least one cellulase of a fungal species belonging to a fungal genus selected from the group consisting of Melanocarpus, Myriococcum, Sporotrichum, Myceliophthora or Chaetomium. 18. The enzyme preparation of claim 17, wherein the fungal species is Melanocarpus albomyces, Myriococcum albomyces, Myriococcum sp. species represented by CBS 687.95, Sporotrichum thermophile, Myceliophthora thermophila or Chaetomium thermophilum. 19. The enzyme preparation of claim 17 or 18, wherein the fungus is Melanocarpus albomyces or Myriococcum albomyces CBS 685.95, Myriococcum sp. CBS 687.95, Sporotrichum thermophile CBS 688.95 or Myceliophthora thermophila CBS 689.95 or Chaetomium thermophilum CBS 730.95. 20. The enzyme preparation of claims 16 to 19, which is liquid. 21. The enzyme preparation of any one of claims 16 to 19, which is dry. 22. A method for biostoning which comprises the step of adding the preparation of any one of claims 16 to 19 to cotton containing fabric or garments. 23. The method of claim 22, wherein the fabric or garments is denim. 24. A method for biofinishing, which comprises the step of adding the preparation of any one of claims 16 to 19 to textile materials like fabrics or garments or yarn. 25. The method of claim 24, wherein the textile materials are manufactured of natural cellulose containing fibers or manmade cellulose containing fibers or are mixtures thereof. 26. The method of claim 24, wherein the textile materials are blends of synthetic fibers and cellulose containing fibers. 27. A detergent composition comprising the enzyme preparation of claims 16 to 19 and a surface active agent or surfactant. 28. A method of treating cellulosic fiber containing textile material, wherein said method comprises mixing said textile material with the detergent composition of claim 27. 29. A method for treating wood-derived pulp or fiber, which comprises the step of adding the enzyme preparation of any one of claims 16 to 19 to wood-derived mechanical or chemical pulp or secondary fiber. 30. A method for improving the quality of animal feed, which comprises treating plant material with the enzyme preparation of any one of claims 16 to 19.

Inventors: ELOVAINIO MINNA, HAAKANA HELI, JOUTSJOKI VESA, LANTTO RAIJA, LONDESBOROUGH JOHN, MAENTYLAE ARJA, MIETTINEN-OINONEN ARJA, PALOHEIMO MARJA, SUOMINEN PIRKKO, VEHMAANPERAE JARI, ELOVAINIO, MINNA, HAAKANA, HELI, JOUTSJOKI, VESA, LANTTO, RAIJA, LONDESBOROUGH, JOHN, MAENTYLAE, ARJA, MIETTINEN-OINONEN, ARJA, PALOHEIMO, MARJA, SUOMINEN, PIRKKO, VEHMAANPERAE, JARI
Applicants: ELOVAINIO MINNA, HAAKANA HELI, JOUTSJOKI VESA, LANTTO RAIJA, LONDESBOROUGH JOHN, MAENTYLAE ARJA, MIETTINEN OINONEN ARJA, PALOHEIMO MARJA, PRIMALCO LTD, SUOMINEN PIRKKO, VEHMAANPERAE JARI, ELOVAINIO, MINNA, HAAKANA, HELI, JOUTSJOKI, VESA, LANTTO, RAIJA, LONDESBOROUGH, JOHN, MAENTYLAE, ARJA, MIETTINEN-OINONEN, ARJA, PALOHEIMO, MARJA, PRIMALCO LTD., SUOMINEN, PIRKKO, VEHMAANPERAE, JARI
Application year: 1996
Main classification: C12N15
IPC codes: C11D3, C12N9, C12N15